{ "company_details": [ { "company_id": "0000895930", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000895930.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000895930.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000895930_main_keyfigs.svg", "name": "Amsurg CORP", "rank": 1, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000895930.svg", "report_text": "The relative strengths and weaknesses of Amsurg CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Amsurg CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 120% points.The greatest weakness of Amsurg CORP is the variable Other Revenues, reducing the Economic Capital Ratio by 46% points.

The company's Economic Capital Ratio, given in the ranking table, is 292%, being 131% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000895930_2012_Amsurg_CORP.pdf", "shrinked_graph_json": { "2010": { "Assets": "2.73", "Stockholders Equity": "103", "ECR before LimitedLiability": "103", "Intangible Assets": "7.64", "Other Liabilities": "22.2", "Liabilities": "89.9", "Liabilities, Current": "26.2", "Long Term Liabilities": "60.7", "Other Expenses": "15.2", "Expenses": "7.92", "Revenues": "-42.0", "Net Income": "12.6", "Cost of Goods and Services Sold": "13.6", "General and Administrative Expense": "6.31", "Labor Expense": "-18.3", "Operating Costs and Expenses": "-8.44", "Other Revenues": "-42.0", "Comprehensive Net Income": "-3.07", "Other Net Income": "42.3", "Other Compr. Net Income": "-16.2", "Economic Capital Ratio": "105" }, "2011": { "Assets": "6.83", "Stockholders Equity": "120", "ECR before LimitedLiability": "138", "Intangible Assets": "17.0", "Other Liabilities": "14.7", "Liabilities": "78.9", "Long Term Liabilities": "43.2", "Liabilities, Current": "36.8", "Expenses": "29.7", "Revenues": "-45.6", "Net Income": "34.1", "Other Expenses": "18.0", "Operating Costs and Expenses": "-9.07", "Labor Expense": "-11.6", "General and Administrative Expense": "19.1", "Cost of Goods and Services Sold": "7.52", "Other Revenues": "-45.6", "Other Net Income": "45.0", "Comprehensive Net Income": "21.8", "Other Compr. Net Income": "-13.5", "Economic Capital Ratio": "131" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000895930_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "132,956", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "24,910", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "905,858", "Labor Expense": "213,274", "Liabilities, Current": "43,563", "Long Term Liabilities": "0", "Operating Costs and Expenses": "148,878", "Other Assets": "7,897", "Other Compr. Net Income": "-129,337", "Other Expenses": "141,759", "Other Liabilities": "0", "Other Net Income": "709,317", "Other Revenues": "0", "Property Plant and Equipment": "119,167", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,165,878", "Liabilities": "43,563", "Expenses": "528,821", "Revenues": "0", "Stockholders Equity": "1,122,315", "Net Income": "180,496", "Comprehensive Net Income": "51,159", "BaseVar": "1,288,458", "ECR before LimitedLiability": "278%", "Economic Capital Ratio": "295%" } }, "2011": { "input_variables": { "Assets, Current": "173,215", "Assets, Non-Current": "10,522", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "26,175", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,244,723", "Labor Expense": "243,094", "Liabilities, Current": "63,654", "Long Term Liabilities": "0", "Operating Costs and Expenses": "171,759", "Other Assets": "0", "Other Compr. Net Income": "-139,602", "Other Expenses": "155,195", "Other Liabilities": "0", "Other Net Income": "786,337", "Other Revenues": "0", "Property Plant and Equipment": "144,558", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,573,018", "Liabilities": "63,654", "Expenses": "596,223", "Revenues": "0", "Stockholders Equity": "1,509,364", "Net Income": "190,114", "Comprehensive Net Income": "50,512", "BaseVar": "1,579,417", "ECR before LimitedLiability": "274%", "Economic Capital Ratio": "292%" } } }, "top_rated": true, "trend": 0.0, "value": 2.9202678344717685, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000895930.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000895930.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000895930.svg" }, { "company_id": "0001091312", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001091312.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001091312.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001091312_main_keyfigs.svg", "name": "Symbion INC TN", "rank": 2, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001091312.svg", "report_text": "The relative strengths and weaknesses of Symbion INC TN are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Symbion INC TN compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 110% points.The greatest weakness of Symbion INC TN is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 41% points.

The company's Economic Capital Ratio, given in the ranking table, is 275%, being 115% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001091312_2012_Symbion_INC_TN.pdf", "shrinked_graph_json": { "2011": { "Assets": "14.9", "Stockholders Equity": "110", "ECR before LimitedLiability": "121", "Intangible Assets": "22.4", "Other Liabilities": "12.9", "Liabilities": "63.8", "Long Term Liabilities": "38.4", "Liabilities, Current": "22.6", "Expenses": "17.3", "Revenues": "23.8", "Net Income": "16.4", "Research And Development Expense": "2.10", "Other Expenses": "52.9", "Operating Costs and Expenses": "-13.0", "Labor Expense": "-6.84", "General and Administrative Expense": "14.3", "Cost of Goods and Services Sold": "-40.9", "Other Revenues": "23.8", "Other Net Income": "-26.4", "Comprehensive Net Income": "16.6", "Economic Capital Ratio": "115" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001091312_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "159,862", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "316,978", "Depreciation, Depletion, Amortization": "20,263", "General and Administrative Expense": "22,723", "Goodwill Impairment Loss": "0", "Intangible Assets": "657,064", "Labor Expense": "123,085", "Liabilities, Current": "70,841", "Long Term Liabilities": "0", "Operating Costs and Expenses": "137,202", "Other Assets": "31,363", "Other Compr. Net Income": "0", "Other Expenses": "-182,325", "Other Liabilities": "0", "Other Net Income": "207", "Other Revenues": "444,653", "Property Plant and Equipment": "129,805", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "978,094", "Liabilities": "70,841", "Expenses": "437,926", "Revenues": "444,653", "Stockholders Equity": "907,253", "Net Income": "6,934", "Comprehensive Net Income": "6,934", "BaseVar": "965,860", "ECR before LimitedLiability": "252%", "Economic Capital Ratio": "275%" } } }, "top_rated": true, "trend": null, "value": 2.7543712093516843, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001091312.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001091312.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001091312.svg" }, { "company_id": "0001043000", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001043000.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001043000.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001043000.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001043000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001043000_main_keyfigs.svg", "name": "Sonida Senior Living INC", "rank": 3, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001043000.svg", "report_text": "The relative strengths and weaknesses of Sonida Senior Living INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Sonida Senior Living INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Sonida Senior Living INC is the variable Other Expenses, reducing the Economic Capital Ratio by 36% points.

The company's Economic Capital Ratio, given in the ranking table, is 270%, being 109% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001043000_2012_Sonida_Senior_Living_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "12.3", "Stockholders Equity": "97.2", "ECR before LimitedLiability": "116", "Property Plant and Equipment": "38.9", "Intangible Assets": "-5.62", "Other Liabilities": "13.9", "Liabilities": "66.4", "Long Term Liabilities": "40.8", "Liabilities, Current": "22.5", "Expenses": "11.1", "Revenues": "33.4", "Net Income": "17.7", "Other Expenses": "-36.0", "Operating Costs and Expenses": "7.52", "Labor Expense": "11.8", "General and Administrative Expense": "15.3", "Cost of Goods and Services Sold": "7.49", "Other Revenues": "33.4", "Other Net Income": "-29.2", "Comprehensive Net Income": "17.9", "Economic Capital Ratio": "109" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001043000_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "60,999", "Assets, Non-Current": "29,016", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "18,299", "General and Administrative Expense": "13,198", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "40,213", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "6,852", "Other Compr. Net Income": "0", "Other Expenses": "228,493", "Other Liabilities": "0", "Other Net Income": "-487", "Other Revenues": "263,502", "Property Plant and Equipment": "365,459", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "462,326", "Liabilities": "40,213", "Expenses": "259,990", "Revenues": "263,502", "Stockholders Equity": "422,113", "Net Income": "3,025", "Comprehensive Net Income": "3,025", "BaseVar": "513,259", "ECR before LimitedLiability": "245%", "Economic Capital Ratio": "270%" } } }, "top_rated": true, "trend": null, "value": 2.6991980891630782, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001043000.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001043000.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001043000.svg" }, { "company_id": "0000352915", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000352915.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000352915.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000352915.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000352915_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000352915_main_keyfigs.svg", "name": "Universal Health Services Inc", "rank": 4, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000352915.svg", "report_text": "The relative strengths and weaknesses of Universal Health Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Universal Health Services Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 86% points.The greatest weakness of Universal Health Services Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 62% points.

The company's Economic Capital Ratio, given in the ranking table, is 269%, being 108% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000352915_2012_Universal_Health_Services_Inc.pdf", "shrinked_graph_json": { "2010": { "Assets": "3.86", "Liabilities": "72.2", "Stockholders Equity": "68.2", "ECR before LimitedLiability": "73.3", "Property Plant and Equipment": "8.34", "Assets, Non-Current": "17.0", "Other Assets": "-9.32", "Other Liabilities": "20.5", "Long Term Liabilities": "56.6", "Other Expenses": "17.7", "Expenses": "-16.1", "Revenues": "-42.2", "Net Income": "-6.14", "Cost of Goods and Services Sold": "13.5", "General and Administrative Expense": "6.28", "Labor Expense": "-34.0", "Operating Costs and Expenses": "-19.9", "Other Revenues": "-42.2", "Comprehensive Net Income": "-4.95", "Other Net Income": "46.7", "Economic Capital Ratio": "75.1" }, "2011": { "Other Liabilities": "18.0", "Liabilities": "84.0", "Stockholders Equity": "67.5", "ECR before LimitedLiability": "115", "Long Term Liabilities": "51.4", "Liabilities, Current": "31.3", "Expenses": "-6.31", "Net Income": "29.5", "Other Expenses": "23.2", "Operating Costs and Expenses": "-29.6", "Labor Expense": "-46.2", "General and Administrative Expense": "24.9", "Cost of Goods and Services Sold": "9.88", "Other Revenues": "-61.7", "Revenues": "-61.7", "Other Assets": "-8.66", "Property Plant and Equipment": "6.09", "Assets, Non-Current": "15.1", "Other Net Income": "86.3", "Comprehensive Net Income": "29.8", "Economic Capital Ratio": "108" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000352915_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "1,331,116", "Assets, Non-Current": "2,943,853", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "223,915", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "2,589,914", "Labor Expense": "2,423,102", "Liabilities, Current": "826,299", "Long Term Liabilities": "0", "Operating Costs and Expenses": "1,738,381", "Other Assets": "-2,589,914", "Other Compr. Net Income": "0", "Other Expenses": "906,992", "Other Liabilities": "0", "Other Net Income": "5,568,185", "Other Revenues": "0", "Property Plant and Equipment": "3,252,967", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "7,527,936", "Liabilities": "826,299", "Expenses": "5,292,390", "Revenues": "0", "Stockholders Equity": "6,701,637", "Net Income": "275,795", "Comprehensive Net Income": "275,795", "BaseVar": "9,607,405", "ECR before LimitedLiability": "239%", "Economic Capital Ratio": "266%" } }, "2011": { "input_variables": { "Assets, Current": "1,364,905", "Assets, Non-Current": "3,012,360", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "295,228", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "2,627,602", "Labor Expense": "3,394,967", "Liabilities, Current": "836,933", "Long Term Liabilities": "0", "Operating Costs and Expenses": "2,207,491", "Other Assets": "-2,627,602", "Other Compr. Net Income": "0", "Other Expenses": "1,153,642", "Other Liabilities": "0", "Other Net Income": "7,500,198", "Other Revenues": "0", "Property Plant and Equipment": "3,287,980", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "7,665,245", "Liabilities": "836,933", "Expenses": "7,051,328", "Revenues": "0", "Stockholders Equity": "6,828,312", "Net Income": "448,870", "Comprehensive Net Income": "448,870", "BaseVar": "11,526,852", "ECR before LimitedLiability": "243%", "Economic Capital Ratio": "269%" } } }, "top_rated": true, "trend": -2.0, "value": 2.689337173868546, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000352915.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000352915.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000352915.svg" }, { "company_id": "0000731012", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000731012.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000731012.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000731012.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000731012_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000731012_main_keyfigs.svg", "name": "Healthcare Services Group Inc", "rank": 5, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000731012.svg", "report_text": "The relative strengths and weaknesses of Healthcare Services Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Healthcare Services Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 103% points.The greatest weakness of Healthcare Services Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 26% points.

The company's Economic Capital Ratio, given in the ranking table, is 262%, being 101% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000731012_2012_Healthcare_Services_Group_Inc.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "49.9", "Assets": "29.0", "Liabilities": "21.3", "Stockholders Equity": "99.0", "ECR before LimitedLiability": "72.3", "Other Assets": "3.90", "Intangible Assets": "-4.32", "Other Liabilities": "11.4", "Liabilities, Current": "-30.1", "Long Term Liabilities": "33.3", "Other Expenses": "9.01", "Expenses": "30.9", "Revenues": "-21.9", "Net Income": "9.88", "Cost of Goods and Services Sold": "7.28", "General and Administrative Expense": "3.37", "Labor Expense": "5.40", "Operating Costs and Expenses": "5.94", "Other Revenues": "-21.9", "Comprehensive Net Income": "10.5", "Economic Capital Ratio": "74.1" }, "2011": { "Other Assets": "3.65", "Assets": "34.8", "Stockholders Equity": "103", "ECR before LimitedLiability": "108", "Assets, Current": "48.3", "Other Liabilities": "8.19", "Liabilities": "16.3", "Long Term Liabilities": "25.2", "Liabilities, Current": "-20.6", "Expenses": "41.3", "Revenues": "-26.3", "Net Income": "25.8", "Other Expenses": "11.0", "Operating Costs and Expenses": "4.45", "Labor Expense": "6.98", "General and Administrative Expense": "11.3", "Cost of Goods and Services Sold": "4.43", "Other Revenues": "-26.3", "Other Net Income": "8.56", "Comprehensive Net Income": "26.0", "Economic Capital Ratio": "101" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000731012_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "221,775", "Assets, Non-Current": "42", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "16,955", "Labor Expense": "0", "Liabilities, Current": "40,531", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "32,506", "Other Compr. Net Income": "0", "Other Expenses": "19,678", "Other Liabilities": "0", "Other Net Income": "54,119", "Other Revenues": "0", "Property Plant and Equipment": "6,656", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "277,934", "Liabilities": "40,531", "Expenses": "19,678", "Revenues": "0", "Stockholders Equity": "237,403", "Net Income": "34,441", "Comprehensive Net Income": "34,441", "BaseVar": "196,131", "ECR before LimitedLiability": "238%", "Economic Capital Ratio": "265%" } }, "2011": { "input_variables": { "Assets, Current": "232,121", "Assets, Non-Current": "40", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "16,955", "Labor Expense": "0", "Liabilities, Current": "45,387", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "30,816", "Other Compr. Net Income": "0", "Other Expenses": "19,656", "Other Liabilities": "0", "Other Net Income": "57,812", "Other Revenues": "0", "Property Plant and Equipment": "9,763", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "289,695", "Liabilities": "45,387", "Expenses": "19,656", "Revenues": "0", "Stockholders Equity": "244,308", "Net Income": "38,156", "Comprehensive Net Income": "38,156", "BaseVar": "206,275", "ECR before LimitedLiability": "234%", "Economic Capital Ratio": "262%" } } }, "top_rated": true, "trend": -2.0, "value": 2.6213510133632467, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000731012.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000731012.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000731012.svg" }, { "company_id": "0001522138", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001522138.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001522138.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001522138_main_keyfigs.svg", "name": "Capella Healthcare Inc", "rank": 6, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001522138.svg", "report_text": "The relative strengths and weaknesses of Capella Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Capella Healthcare Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 76% points.The greatest weakness of Capella Healthcare Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 56% points.

The company's Economic Capital Ratio, given in the ranking table, is 259%, being 98% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001522138_2012_Capella_Healthcare_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "4.46", "Stockholders Equity": "72.1", "ECR before LimitedLiability": "105", "Property Plant and Equipment": "15.7", "Intangible Assets": "-4.43", "Other Liabilities": "16.1", "Liabilities": "75.6", "Long Term Liabilities": "46.6", "Liabilities, Current": "26.1", "Expenses": "-5.86", "Revenues": "-56.0", "Net Income": "18.2", "Other Expenses": "5.64", "Operating Costs and Expenses": "-8.01", "Labor Expense": "-43.0", "General and Administrative Expense": "22.8", "Cost of Goods and Services Sold": "9.01", "Other Revenues": "-56.0", "Other Net Income": "71.5", "Comprehensive Net Income": "18.4", "Economic Capital Ratio": "98.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001522138_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "211,000", "Assets, Non-Current": "29,900", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "33,700", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "117,300", "Labor Expense": "332,100", "Liabilities, Current": "86,100", "Long Term Liabilities": "0", "Operating Costs and Expenses": "103,100", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "208,400", "Other Liabilities": "0", "Other Net Income": "664,000", "Other Revenues": "0", "Property Plant and Equipment": "426,500", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "784,700", "Liabilities": "86,100", "Expenses": "677,300", "Revenues": "0", "Stockholders Equity": "698,600", "Net Income": "-13,300", "Comprehensive Net Income": "-13,300", "BaseVar": "1,106,050", "ECR before LimitedLiability": "230%", "Economic Capital Ratio": "259%" } } }, "top_rated": true, "trend": null, "value": 2.5879221357765143, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001522138.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001522138.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001522138.svg" }, { "company_id": "0001367832", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001367832.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001367832.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001367832_main_keyfigs.svg", "name": "Aurora Diagnostics Holdings LLC", "rank": 7, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001367832.svg", "report_text": "The relative strengths and weaknesses of Aurora Diagnostics Holdings LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Aurora Diagnostics Holdings LLC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 156% points.The greatest weakness of Aurora Diagnostics Holdings LLC is the variable Operating Costs and Expenses, reducing the Economic Capital Ratio by 58% points.

The company's Economic Capital Ratio, given in the ranking table, is 258%, being 97% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001367832_2012_Aurora_Diagnostics_Holdings_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "-20.2", "Assets": "19.6", "Liabilities": "55.6", "Stockholders Equity": "99.0", "ECR before LimitedLiability": "104", "Assets, Non-Current": "156", "Intangible Assets": "63.6", "Other Liabilities": "12.1", "Long Term Liabilities": "35.9", "Liabilities, Current": "14.7", "Expenses": "18.2", "Revenues": "21.0", "Net Income": "8.21", "Other Expenses": "46.7", "Operating Costs and Expenses": "-57.7", "Labor Expense": "10.5", "Cost of Goods and Services Sold": "6.68", "Other Revenues": "21.0", "Other Net Income": "-33.4", "Comprehensive Net Income": "8.41", "Economic Capital Ratio": "97.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001367832_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "56,096", "Assets, Non-Current": "538,561", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "65,547", "Goodwill Impairment Loss": "24,471", "Intangible Assets": "525,243", "Labor Expense": "0", "Liabilities, Current": "59,228", "Long Term Liabilities": "0", "Operating Costs and Expenses": "278,520", "Other Assets": "-525,243", "Other Compr. Net Income": "0", "Other Expenses": "-90,758", "Other Liabilities": "0", "Other Net Income": "-32,580", "Other Revenues": "277,494", "Property Plant and Equipment": "12,306", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "606,963", "Liabilities": "59,228", "Expenses": "277,780", "Revenues": "277,494", "Stockholders Equity": "547,735", "Net Income": "-32,866", "Comprehensive Net Income": "-32,866", "BaseVar": "627,022", "ECR before LimitedLiability": "229%", "Economic Capital Ratio": "258%" } } }, "top_rated": true, "trend": null, "value": 2.5805030425672433, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001367832.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001367832.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001367832.svg" }, { "company_id": "0000744825", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000744825.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000744825.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000744825.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000744825_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000744825_main_keyfigs.svg", "name": "American Shared Hospital Services", "rank": 8, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000744825.svg", "report_text": "The relative strengths and weaknesses of American Shared Hospital Services are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of American Shared Hospital Services compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 100% points.The greatest weakness of American Shared Hospital Services is the variable Other Revenues, reducing the Economic Capital Ratio by 23% points.

The company's Economic Capital Ratio, given in the ranking table, is 256%, being 95% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000744825_2012_American_Shared_Hospital_Services.pdf", "shrinked_graph_json": { "2011": { "Assets": "29.9", "Liabilities": "33.5", "Stockholders Equity": "100", "ECR before LimitedLiability": "102", "Property Plant and Equipment": "43.9", "Intangible Assets": "-5.98", "Other Liabilities": "9.64", "Long Term Liabilities": "29.3", "Expenses": "26.5", "Revenues": "-22.7", "Net Income": "14.5", "Other Expenses": "28.7", "Depreciation, Depletion, Amortization": "-8.66", "Operating Costs and Expenses": "5.36", "Labor Expense": "8.41", "General and Administrative Expense": "6.97", "Cost of Goods and Services Sold": "-19.2", "Other Revenues": "-22.7", "Other Net Income": "9.22", "Comprehensive Net Income": "14.7", "Economic Capital Ratio": "95.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000744825_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "17,615", "Assets, Non-Current": "997", "Cost of Goods and Services Sold": "14,224", "Depreciation, Depletion, Amortization": "6,127", "General and Administrative Expense": "4,041", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "9,944", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "2,656", "Other Compr. Net Income": "0", "Other Expenses": "-3,552", "Other Liabilities": "0", "Other Net Income": "17,237", "Other Revenues": "5,092", "Property Plant and Equipment": "53,267", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "74,535", "Liabilities": "9,944", "Expenses": "20,840", "Revenues": "5,092", "Stockholders Equity": "64,591", "Net Income": "1,489", "Comprehensive Net Income": "1,489", "BaseVar": "63,824", "ECR before LimitedLiability": "225%", "Economic Capital Ratio": "256%" } } }, "top_rated": true, "trend": null, "value": 2.5567332755664025, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000744825.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000744825.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000744825.svg" }, { "company_id": "0001294632", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001294632.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001294632.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001294632_main_keyfigs.svg", "name": "Iasis Healthcare LLC", "rank": 9, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001294632.svg", "report_text": "The relative strengths and weaknesses of Iasis Healthcare LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Iasis Healthcare LLC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 88% points.The greatest weakness of Iasis Healthcare LLC is the variable Other Revenues, reducing the Economic Capital Ratio by 61% points.

The company's Economic Capital Ratio, given in the ranking table, is 252%, being 91% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001294632_2012_Iasis_Healthcare_LLC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "17.0", "Liabilities": "76.7", "Stockholders Equity": "52.9", "ECR before LimitedLiability": "98.1", "Long Term Liabilities": "49.2", "Liabilities, Current": "23.1", "Expenses": "-11.7", "Revenues": "-61.1", "Net Income": "23.7", "Research And Development Expense": "2.99", "Other Expenses": "-21.3", "Operating Costs and Expenses": "-10.2", "Labor Expense": "-23.0", "General and Administrative Expense": "24.7", "Cost of Goods and Services Sold": "9.76", "Other Revenues": "-61.1", "Property Plant and Equipment": "7.81", "Assets, Current": "-4.89", "Other Net Income": "88.2", "Comprehensive Net Income": "24.0", "Economic Capital Ratio": "91.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001294632_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "606,918", "Assets, Non-Current": "63,509", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "104,241", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "808,651", "Labor Expense": "818,742", "Liabilities, Current": "381,802", "Long Term Liabilities": "0", "Operating Costs and Expenses": "431,070", "Other Assets": "32,779", "Other Compr. Net Income": "0", "Other Expenses": "1,388,487", "Other Liabilities": "0", "Other Net Income": "2,781,600", "Other Revenues": "0", "Property Plant and Equipment": "1,167,920", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,679,777", "Liabilities": "381,802", "Expenses": "2,742,540", "Revenues": "0", "Stockholders Equity": "2,297,975", "Net Income": "39,060", "Comprehensive Net Income": "39,060", "BaseVar": "4,292,860", "ECR before LimitedLiability": "220%", "Economic Capital Ratio": "252%" } } }, "top_rated": true, "trend": null, "value": 2.5209392405515, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001294632.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001294632.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001294632.svg" }, { "company_id": "0001125376", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001125376.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001125376.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001125376.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001125376_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001125376_main_keyfigs.svg", "name": "Ensign Group INC", "rank": 10, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001125376.svg", "report_text": "The relative strengths and weaknesses of Ensign Group INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Ensign Group INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 109% points.The greatest weakness of Ensign Group INC is the variable Other Expenses, reducing the Economic Capital Ratio by 94% points.

The company's Economic Capital Ratio, given in the ranking table, is 252%, being 91% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001125376_2012_Ensign_Group_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "18.5", "Liabilities": "80.9", "Stockholders Equity": "36.8", "ECR before LimitedLiability": "97.8", "Long Term Liabilities": "53.0", "Liabilities, Current": "22.8", "Expenses": "-15.7", "Net Income": "33.1", "Other Expenses": "-93.7", "Operating Costs and Expenses": "10.7", "Labor Expense": "16.7", "General and Administrative Expense": "21.3", "Cost of Goods and Services Sold": "10.7", "Other Revenues": "-67.3", "Revenues": "-67.3", "Property Plant and Equipment": "22.0", "Assets, Current": "-5.94", "Intangible Assets": "-10.9", "Other Net Income": "109", "Comprehensive Net Income": "33.1", "Economic Capital Ratio": "91.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001125376_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "140,639", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "23,286", "General and Administrative Expense": "29,766", "Goodwill Impairment Loss": "0", "Intangible Assets": "17,177", "Labor Expense": "0", "Liabilities, Current": "100,387", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "34,661", "Other Compr. Net Income": "-1,308", "Other Expenses": "644,021", "Other Liabilities": "0", "Other Net Income": "744,748", "Other Revenues": "0", "Property Plant and Equipment": "403,862", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "596,339", "Liabilities": "100,387", "Expenses": "697,073", "Revenues": "0", "Stockholders Equity": "495,952", "Net Income": "47,675", "Comprehensive Net Income": "46,367", "BaseVar": "1,069,928", "ECR before LimitedLiability": "220%", "Economic Capital Ratio": "252%" } } }, "top_rated": true, "trend": null, "value": 2.517543536672353, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001125376.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001125376.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001125376.svg" }, { "company_id": "0001022079", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001022079.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001022079.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001022079.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001022079_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001022079_main_keyfigs.svg", "name": "Quest Diagnostics INC", "rank": 11, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001022079.svg", "report_text": "The relative strengths and weaknesses of Quest Diagnostics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Quest Diagnostics INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 61% points.The greatest weakness of Quest Diagnostics INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 52% points.

The company's Economic Capital Ratio, given in the ranking table, is 249%, being 88% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001022079_2012_Quest_Diagnostics_INC.pdf", "shrinked_graph_json": { "2009": { "Assets": "10.8", "Stockholders Equity": "79.5", "ECR before LimitedLiability": "71.5", "Intangible Assets": "9.50", "Liabilities, Current": "10.4", "Liabilities": "52.4", "Long Term Liabilities": "42.0", "Other Liabilities": "4.28", "Other Expenses": "16.3", "Expenses": "7.55", "Revenues": "36.8", "Net Income": "1.97", "General and Administrative Expense": "-16.0", "Cost of Goods and Services Sold": "-12.9", "Labor Expense": "5.30", "Operating Costs and Expenses": "12.5", "Depreciation, Depletion, Amortization": "1.15", "Other Revenues": "36.8", "Comprehensive Net Income": "1.97", "Other Net Income": "-47.2", "Economic Capital Ratio": "71.9" }, "2010": { "Other Liabilities": "21.1", "Liabilities": "69.8", "Assets, Current": "-2.44", "Stockholders Equity": "52.8", "ECR before LimitedLiability": "69.0", "Liabilities, Current": "-4.04", "Long Term Liabilities": "58.1", "Other Expenses": "27.5", "Expenses": "-16.4", "Cost of Goods and Services Sold": "-53.7", "General and Administrative Expense": "-19.4", "Labor Expense": "10.5", "Operating Costs and Expenses": "11.5", "Depreciation, Depletion, Amortization": "1.89", "Other Revenues": "63.7", "Revenues": "63.7", "Property Plant and Equipment": "-4.82", "Intangible Assets": "13.5", "Economic Capital Ratio": "70.8", "Other Compr. Net Income": "1.23", "Other Net Income": "-56.5" }, "2011": { "Assets": "6.63", "Liabilities": "56.5", "Stockholders Equity": "61.0", "ECR before LimitedLiability": "95.1", "Property Plant and Equipment": "-6.00", "Assets, Current": "-5.90", "Intangible Assets": "33.5", "Other Liabilities": "14.1", "Long Term Liabilities": "41.6", "Liabilities, Current": "6.50", "Expenses": "6.49", "Revenues": "48.3", "Net Income": "24.5", "Other Expenses": "26.7", "Operating Costs and Expenses": "8.11", "Labor Expense": "12.7", "Cost of Goods and Services Sold": "-52.2", "Other Revenues": "48.3", "Other Net Income": "-33.4", "Comprehensive Net Income": "24.7", "Economic Capital Ratio": "88.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001022079_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "1,679,425", "Assets, Non-Current": "150,663", "Cost of Goods and Services Sold": "4,321,475", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,747,618", "Goodwill Impairment Loss": "0", "Intangible Assets": "5,907,609", "Labor Expense": "0", "Liabilities, Current": "1,059,212", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "487,513", "Other Liabilities": "0", "Other Net Income": "-132,415", "Other Revenues": "7,455,243", "Property Plant and Equipment": "825,946", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "8,563,643", "Liabilities": "1,059,212", "Expenses": "6,556,606", "Revenues": "7,455,243", "Stockholders Equity": "7,504,431", "Net Income": "766,222", "Comprehensive Net Income": "766,222", "BaseVar": "11,883,560", "ECR before LimitedLiability": "242%", "Economic Capital Ratio": "268%" } }, "2010": { "input_variables": { "Assets, Current": "1,605,417", "Assets, Non-Current": "189,494", "Cost of Goods and Services Sold": "4,317,247", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,707,673", "Goodwill Impairment Loss": "0", "Intangible Assets": "5,898,343", "Labor Expense": "0", "Liabilities, Current": "1,214,268", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "474,001", "Other Liabilities": "0", "Other Net Income": "-112,987", "Other Revenues": "7,368,925", "Property Plant and Equipment": "834,376", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "8,527,630", "Liabilities": "1,214,268", "Expenses": "6,498,921", "Revenues": "7,368,925", "Stockholders Equity": "7,313,362", "Net Income": "757,017", "Comprehensive Net Income": "757,017", "BaseVar": "11,861,366", "ECR before LimitedLiability": "233%", "Economic Capital Ratio": "261%" } }, "2011": { "input_variables": { "Assets, Current": "1,401,260", "Assets, Non-Current": "280,971", "Cost of Goods and Services Sold": "4,395,333", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,814,315", "Goodwill Impairment Loss": "0", "Intangible Assets": "6,831,377", "Labor Expense": "0", "Liabilities, Current": "1,561,159", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "654,794", "Other Liabilities": "0", "Other Net Income": "-140,398", "Other Revenues": "7,510,490", "Property Plant and Equipment": "799,771", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "9,313,379", "Liabilities": "1,561,159", "Expenses": "6,864,442", "Revenues": "7,510,490", "Stockholders Equity": "7,752,220", "Net Income": "505,650", "Comprehensive Net Income": "505,650", "BaseVar": "12,694,934", "ECR before LimitedLiability": "216%", "Economic Capital Ratio": "249%" } } }, "top_rated": true, "trend": -7.0, "value": 2.4914195016417264, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001022079.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001022079.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001022079.svg" }, { "company_id": "0001131324", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001131324.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001131324.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001131324.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001131324_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001131324_main_keyfigs.svg", "name": "Genomic Health INC", "rank": 12, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001131324.svg", "report_text": "The relative strengths and weaknesses of Genomic Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Genomic Health INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 102% points.The greatest weakness of Genomic Health INC is the variable Selling and Marketing Expense, reducing the Economic Capital Ratio by 73% points.

The company's Economic Capital Ratio, given in the ranking table, is 245%, being 84% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001131324_2012_Genomic_Health_INC.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "19.6", "Liabilities": "86.9", "Stockholders Equity": "21.9", "ECR before LimitedLiability": "90.7", "Long Term Liabilities": "56.0", "Liabilities, Current": "25.4", "Selling and Marketing Expense": "-72.7", "Expenses": "-27.0", "Revenues": "102", "Net Income": "32.2", "Research And Development Expense": "-30.4", "Other Expenses": "23.0", "Operating Costs and Expenses": "11.6", "Labor Expense": "18.2", "Cost of Goods and Services Sold": "11.6", "Other Revenues": "102", "Assets, Current": "34.7", "Intangible Assets": "-14.1", "Other Net Income": "-46.0", "Comprehensive Net Income": "32.5", "Economic Capital Ratio": "84.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001131324_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "128,995", "Assets, Non-Current": "4,560", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "40,543", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "26,139", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "34,261", "Other Liabilities": "0", "Other Net Income": "16", "Other Revenues": "206,111", "Property Plant and Equipment": "9,443", "Research And Development Expense": "39,864", "Selling and Marketing Expense": "83,613" }, "output_variables": { "Assets": "142,998", "Liabilities": "26,139", "Expenses": "198,281", "Revenues": "206,111", "Stockholders Equity": "116,859", "Net Income": "7,846", "Comprehensive Net Income": "7,846", "BaseVar": "286,772", "ECR before LimitedLiability": "210%", "Economic Capital Ratio": "245%" } } }, "top_rated": true, "trend": null, "value": 2.4467895806470983, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001131324.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001131324.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001131324.svg" }, { "company_id": "0000860730", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000860730.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000860730.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000860730.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000860730_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000860730_main_keyfigs.svg", "name": "HCA Healthcare Inc", "rank": 13, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000860730.svg", "report_text": "The relative strengths and weaknesses of HCA Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of HCA Healthcare Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 92% points.The greatest weakness of HCA Healthcare Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 37% points.

The company's Economic Capital Ratio, given in the ranking table, is 244%, being 83% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000860730_2012_HCA_Healthcare_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "12.2", "Assets": "48.2", "Stockholders Equity": "92.0", "ECR before LimitedLiability": "89.7", "Property Plant and Equipment": "23.3", "Assets, Current": "6.17", "Intangible Assets": "-5.66", "Expenses": "41.0", "Net Income": "20.6", "Other Expenses": "13.9", "Operating Costs and Expenses": "3.90", "Labor Expense": "6.13", "General and Administrative Expense": "9.95", "Cost of Goods and Services Sold": "3.89", "Other Revenues": "-22.9", "Revenues": "-22.9", "Other Liabilities": "6.85", "Long Term Liabilities": "21.3", "Liabilities, Current": "-36.9", "Comprehensive Net Income": "20.7", "Economic Capital Ratio": "83.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000860730_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "7,233,000", "Assets, Non-Current": "742,000", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "5,554,000", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "6,089,000", "Other Compr. Net Income": "0", "Other Expenses": "719,000", "Other Liabilities": "0", "Other Net Income": "3,561,000", "Other Revenues": "0", "Property Plant and Equipment": "12,834,000", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "26,898,000", "Liabilities": "5,554,000", "Expenses": "719,000", "Revenues": "0", "Stockholders Equity": "21,344,000", "Net Income": "2,842,000", "Comprehensive Net Income": "2,842,000", "BaseVar": "18,366,000", "ECR before LimitedLiability": "208%", "Economic Capital Ratio": "244%" } } }, "top_rated": true, "trend": null, "value": 2.437139857581922, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000860730.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000860730.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000860730.svg" }, { "company_id": "0001138476", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001138476.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001138476.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001138476.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001138476_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001138476_main_keyfigs.svg", "name": "Pacific Health CARE Organization INC", "rank": 14, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001138476.svg", "report_text": "The relative strengths and weaknesses of Pacific Health CARE Organization INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Pacific Health CARE Organization INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 164% points.The greatest weakness of Pacific Health CARE Organization INC is the variable Labor Expense, reducing the Economic Capital Ratio by 103% points.

The company's Economic Capital Ratio, given in the ranking table, is 241%, being 80% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001138476_2012_Pacific_Health_CARE_Organization_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-27.7", "Liabilities": "127", "Stockholders Equity": "-59.4", "ECR before LimitedLiability": "87.1", "Property Plant and Equipment": "-16.9", "Assets, Current": "12.6", "Intangible Assets": "-20.1", "Other Liabilities": "26.6", "Long Term Liabilities": "78.1", "Liabilities, Current": "46.1", "Expenses": "-76.0", "Revenues": "164", "Net Income": "58.9", "Research And Development Expense": "5.31", "Operating Costs and Expenses": "-20.2", "Labor Expense": "-103", "Cost of Goods and Services Sold": "17.3", "Other Revenues": "164", "Other Net Income": "-71.4", "Comprehensive Net Income": "59.4", "Economic Capital Ratio": "80.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001138476_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "980", "Assets, Non-Current": "8.2", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "14", "General and Administrative Expense": "392", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "1,132", "Liabilities, Current": "257", "Long Term Liabilities": "0", "Operating Costs and Expenses": "359", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "735", "Other Liabilities": "7.1", "Other Net Income": "-1.5", "Other Revenues": "2,832", "Property Plant and Equipment": "71", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,059", "Liabilities": "264", "Expenses": "2,632", "Revenues": "2,832", "Stockholders Equity": "796", "Net Income": "198", "Comprehensive Net Income": "198", "BaseVar": "3,394", "ECR before LimitedLiability": "204%", "Economic Capital Ratio": "241%" } } }, "top_rated": true, "trend": null, "value": 2.410551880023038, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001138476.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001138476.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001138476.svg" }, { "company_id": "0000885978", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000885978.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000885978.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000885978.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000885978_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000885978_main_keyfigs.svg", "name": "U S Physical Therapy INC NV", "rank": 15, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000885978.svg", "report_text": "The relative strengths and weaknesses of U S Physical Therapy INC NV are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of U S Physical Therapy INC NV compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 97% points.The greatest weakness of U S Physical Therapy INC NV is the variable Labor Expense, reducing the Economic Capital Ratio by 73% points.

The company's Economic Capital Ratio, given in the ranking table, is 239%, being 78% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000885978_2012_U_S_Physical_Therapy_INC_NV.pdf", "shrinked_graph_json": { "2011": { "Assets": "-11.4", "Stockholders Equity": "8.44", "ECR before LimitedLiability": "84.8", "Property Plant and Equipment": "-10.9", "Intangible Assets": "13.7", "Other Liabilities": "16.8", "Liabilities": "70.2", "Long Term Liabilities": "22.3", "Liabilities, Current": "41.2", "Expenses": "-14.3", "Revenues": "96.8", "Net Income": "43.7", "Other Expenses": "-10.2", "Operating Costs and Expenses": "10.9", "Labor Expense": "-72.9", "General and Administrative Expense": "27.6", "Cost of Goods and Services Sold": "10.9", "Other Revenues": "96.8", "Other Net Income": "-38.7", "Comprehensive Net Income": "44.0", "Economic Capital Ratio": "78.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000885978_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "45,667", "Assets, Non-Current": "2,043", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "102,353", "Labor Expense": "125,117", "Liabilities, Current": "16,324", "Long Term Liabilities": "24,407", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "87,551", "Other Liabilities": "941", "Other Net Income": "5,445", "Other Revenues": "237,006", "Property Plant and Equipment": "13,189", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "163,252", "Liabilities": "41,672", "Expenses": "212,668", "Revenues": "237,006", "Stockholders Equity": "121,580", "Net Income": "29,783", "Comprehensive Net Income": "29,783", "BaseVar": "330,022", "ECR before LimitedLiability": "201%", "Economic Capital Ratio": "239%" } } }, "top_rated": true, "trend": null, "value": 2.3880594702152966, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000885978.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000885978.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000885978.svg" }, { "company_id": "0000893949", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000893949.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000893949.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000893949.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000893949_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000893949_main_keyfigs.svg", "name": "Pediatrix Medical Group Inc", "rank": 16, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000893949.svg", "report_text": "The relative strengths and weaknesses of Pediatrix Medical Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Pediatrix Medical Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 51% points.The greatest weakness of Pediatrix Medical Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 41% points.

The company's Economic Capital Ratio, given in the ranking table, is 234%, being 73% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000893949_2012_Pediatrix_Medical_Group_Inc.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-5.23", "Assets": "6.34", "Liabilities": "22.2", "Stockholders Equity": "29.7", "ECR before LimitedLiability": "28.9", "Property Plant and Equipment": "-10.7", "Intangible Assets": "35.6", "Other Liabilities": "6.46", "Liabilities, Current": "-9.19", "Long Term Liabilities": "24.1", "Other Revenues": "-32.1", "Revenues": "-32.1", "Net Income": "1.69", "Other Expenses": "-26.8", "Comprehensive Net Income": "2.60", "Cost of Goods and Services Sold": "10.7", "General and Administrative Expense": "-2.85", "Labor Expense": "7.92", "Operating Costs and Expenses": "8.72", "Other Net Income": "32.9", "Economic Capital Ratio": "30.7" }, "2011": { "Assets": "11.8", "Stockholders Equity": "51.0", "ECR before LimitedLiability": "79.9", "Property Plant and Equipment": "-8.91", "Intangible Assets": "46.4", "Other Liabilities": "-12.2", "Liabilities": "31.7", "Long Term Liabilities": "27.2", "Liabilities, Current": "16.1", "Expenses": "14.5", "Revenues": "-41.5", "Net Income": "25.8", "Other Expenses": "20.3", "Operating Costs and Expenses": "6.90", "Labor Expense": "-37.5", "General and Administrative Expense": "9.57", "Cost of Goods and Services Sold": "6.88", "Other Revenues": "-41.5", "Other Net Income": "50.0", "Comprehensive Net Income": "26.0", "Economic Capital Ratio": "73.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000893949_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "296,009", "Assets, Non-Current": "70,151", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "154,267", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,601,319", "Labor Expense": "0", "Liabilities, Current": "320,847", "Long Term Liabilities": "195,223", "Operating Costs and Expenses": "0", "Other Assets": "27,393", "Other Compr. Net Income": "0", "Other Expenses": "1,046,035", "Other Liabilities": "74,122", "Other Net Income": "1,402,993", "Other Revenues": "0", "Property Plant and Equipment": "42,774", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,037,646", "Liabilities": "590,192", "Expenses": "1,200,302", "Revenues": "0", "Stockholders Equity": "1,447,454", "Net Income": "202,691", "Comprehensive Net Income": "202,691", "BaseVar": "2,615,566", "ECR before LimitedLiability": "175%", "Economic Capital Ratio": "221%" } }, "2011": { "input_variables": { "Assets, Current": "337,273", "Assets, Non-Current": "83,092", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "25,292", "General and Administrative Expense": "170,356", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,746,762", "Labor Expense": "970,396", "Liabilities, Current": "254,301", "Long Term Liabilities": "83,544", "Operating Costs and Expenses": "0", "Other Assets": "44,991", "Other Compr. Net Income": "0", "Other Expenses": "205,702", "Other Liabilities": "203,787", "Other Net Income": "1,589,743", "Other Revenues": "0", "Property Plant and Equipment": "60,530", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,272,648", "Liabilities": "541,632", "Expenses": "1,371,746", "Revenues": "0", "Stockholders Equity": "1,731,016", "Net Income": "217,997", "Comprehensive Net Income": "217,997", "BaseVar": "2,887,884", "ECR before LimitedLiability": "194%", "Economic Capital Ratio": "234%" } } }, "top_rated": true, "trend": -11.0, "value": 2.3386599881737897, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000893949.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000893949.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000893949.svg" }, { "company_id": "0001124140", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001124140.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001124140.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001124140.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001124140_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001124140_main_keyfigs.svg", "name": "Exact Sciences CORP", "rank": 17, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001124140.svg", "report_text": "The relative strengths and weaknesses of Exact Sciences CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Exact Sciences CORP compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 163% points.The greatest weakness of Exact Sciences CORP is the variable Research And Development Expense, reducing the Economic Capital Ratio by 28% points.

The company's Economic Capital Ratio, given in the ranking table, is 232%, being 71% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001124140_2012_Exact_Sciences_CORP.pdf", "shrinked_graph_json": { "2011": { "Assets": "64.8", "Liabilities": "34.9", "Stockholders Equity": "133", "ECR before LimitedLiability": "77.9", "Property Plant and Equipment": "-5.73", "Assets, Current": "163", "Intangible Assets": "-7.84", "Other Liabilities": "7.68", "Long Term Liabilities": "23.8", "Liabilities, Current": "5.75", "Expenses": "10.5", "Revenues": "-21.0", "Net Income": "-27.5", "Research And Development Expense": "-27.7", "Other Expenses": "19.7", "Operating Costs and Expenses": "4.55", "Labor Expense": "7.14", "Other Revenues": "-21.0", "Other Net Income": "-17.1", "Comprehensive Net Income": "-27.4", "Economic Capital Ratio": "71.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001124140_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "94,395", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "24", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "8,137", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "7,977", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "0", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "4,163", "Property Plant and Equipment": "2,558", "Research And Development Expense": "21,968", "Selling and Marketing Expense": "2,857" }, "output_variables": { "Assets": "96,953", "Liabilities": "7,977", "Expenses": "32,986", "Revenues": "4,163", "Stockholders Equity": "88,976", "Net Income": "-28,823", "Comprehensive Net Income": "-28,823", "BaseVar": "71,040", "ECR before LimitedLiability": "191%", "Economic Capital Ratio": "232%" } } }, "top_rated": true, "trend": null, "value": 2.3190813712638167, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001124140.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001124140.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001124140.svg" }, { "company_id": "0001060009", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001060009.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001060009.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001060009_main_keyfigs.svg", "name": "Kindred Healthcare INC", "rank": 18, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001060009.svg", "report_text": "The relative strengths and weaknesses of Kindred Healthcare INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Kindred Healthcare INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 118% points.The greatest weakness of Kindred Healthcare INC is the variable Labor Expense, reducing the Economic Capital Ratio by 78% points.

The company's Economic Capital Ratio, given in the ranking table, is 231%, being 70% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001060009_2012_Kindred_Healthcare_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-11.3", "Stockholders Equity": "20.8", "ECR before LimitedLiability": "76.7", "Property Plant and Equipment": "-4.34", "Assets, Current": "-6.56", "Other Liabilities": "17.5", "Liabilities": "76.1", "Long Term Liabilities": "51.3", "Liabilities, Current": "16.4", "Expenses": "-25.2", "Revenues": "-66.9", "Net Income": "22.9", "Other Expenses": "20.6", "Operating Costs and Expenses": "-21.1", "Labor Expense": "-78.0", "General and Administrative Expense": "27.4", "Cost of Goods and Services Sold": "10.7", "Other Revenues": "-66.9", "Other Net Income": "118", "Comprehensive Net Income": "23.2", "Economic Capital Ratio": "70.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001060009_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,233,282", "Assets, Non-Current": "198,469", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "165,594", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,531,862", "Labor Expense": "3,255,815", "Liabilities, Current": "848,923", "Long Term Liabilities": "0", "Operating Costs and Expenses": "1,164,480", "Other Assets": "115,839", "Other Compr. Net Income": "0", "Other Expenses": "992,145", "Other Liabilities": "0", "Other Net Income": "5,524,315", "Other Revenues": "0", "Property Plant and Equipment": "1,059,041", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "4,138,493", "Liabilities": "848,923", "Expenses": "5,578,034", "Revenues": "0", "Stockholders Equity": "3,289,570", "Net Income": "-53,719", "Comprehensive Net Income": "-53,719", "BaseVar": "8,044,882", "ECR before LimitedLiability": "189%", "Economic Capital Ratio": "231%" } } }, "top_rated": true, "trend": null, "value": 2.306634443009617, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001060009.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001060009.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001060009.svg" }, { "company_id": "0001047335", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001047335.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001047335.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001047335.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001047335_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001047335_main_keyfigs.svg", "name": "National Healthcare CORP", "rank": 19, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001047335.svg", "report_text": "The relative strengths and weaknesses of National Healthcare CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of National Healthcare CORP compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 67% points.The greatest weakness of National Healthcare CORP is the variable Other Revenues, reducing the Economic Capital Ratio by 46% points.

The company's Economic Capital Ratio, given in the ranking table, is 229%, being 68% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001047335_2012_National_Healthcare_CORP.pdf", "shrinked_graph_json": { "2011": { "Other Liabilities": "13.2", "Liabilities": "42.3", "Stockholders Equity": "36.3", "ECR before LimitedLiability": "74.6", "Long Term Liabilities": "39.5", "Liabilities, Current": "-10.7", "Expenses": "3.27", "Net Income": "25.9", "Other Expenses": "25.9", "Operating Costs and Expenses": "-16.8", "Labor Expense": "-42.5", "General and Administrative Expense": "20.5", "Cost of Goods and Services Sold": "7.99", "Other Revenues": "-45.6", "Revenues": "-45.6", "Property Plant and Equipment": "16.0", "Assets, Current": "5.30", "Intangible Assets": "-12.5", "Other Net Income": "66.7", "Comprehensive Net Income": "26.2", "Economic Capital Ratio": "67.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001047335_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "362,186", "Assets, Non-Current": "73,835", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "28,901", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "20,320", "Labor Expense": "428,672", "Liabilities, Current": "215,907", "Long Term Liabilities": "0", "Operating Costs and Expenses": "198,439", "Other Assets": "-20,320", "Other Compr. Net Income": "0", "Other Expenses": "73,986", "Other Liabilities": "0", "Other Net Income": "773,537", "Other Revenues": "20,533", "Property Plant and Equipment": "429,651", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "865,672", "Liabilities": "215,907", "Expenses": "729,998", "Revenues": "20,533", "Stockholders Equity": "649,765", "Net Income": "64,072", "Comprehensive Net Income": "64,072", "BaseVar": "1,302,824", "ECR before LimitedLiability": "186%", "Economic Capital Ratio": "229%" } } }, "top_rated": false, "trend": null, "value": 2.286111638308291, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001047335.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001047335.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001047335.svg" }, { "company_id": "0001410471", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001410471.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001410471.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001410471_main_keyfigs.svg", "name": "IPC Healthcare Inc", "rank": 20, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001410471.svg", "report_text": "The relative strengths and weaknesses of IPC Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of IPC Healthcare Inc compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 101% points.The greatest weakness of IPC Healthcare Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 76% points.

The company's Economic Capital Ratio, given in the ranking table, is 218%, being 57% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001410471_2012_IPC_Healthcare_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-16.5", "Liabilities": "61.3", "ECR before LimitedLiability": "63.9", "Property Plant and Equipment": "-16.9", "Assets, Current": "-6.09", "Assets, Non-Current": "-4.09", "Intangible Assets": "11.6", "Other Liabilities": "-7.62", "Long Term Liabilities": "49.9", "Liabilities, Current": "21.1", "Expenses": "-18.8", "Net Income": "34.1", "Other Expenses": "-76.2", "Operating Costs and Expenses": "10.6", "Labor Expense": "16.7", "Cost of Goods and Services Sold": "10.6", "Other Revenues": "101", "Revenues": "101", "Other Net Income": "-40.6", "Comprehensive Net Income": "34.4", "Economic Capital Ratio": "57.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001410471_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "107,594", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "3,192", "General and Administrative Expense": "73,259", "Goodwill Impairment Loss": "0", "Intangible Assets": "175,500", "Labor Expense": "0", "Liabilities, Current": "59,459", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "16,708", "Other Compr. Net Income": "0", "Other Expenses": "351,764", "Other Liabilities": "32,803", "Other Net Income": "17", "Other Revenues": "457,467", "Property Plant and Equipment": "5,112", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "304,914", "Liabilities": "92,262", "Expenses": "428,215", "Revenues": "457,467", "Stockholders Equity": "212,652", "Net Income": "29,269", "Comprehensive Net Income": "29,269", "BaseVar": "641,438", "ECR before LimitedLiability": "170%", "Economic Capital Ratio": "218%" } } }, "top_rated": false, "trend": null, "value": 2.1792829931120554, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001410471.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001410471.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001410471.svg" }, { "company_id": "0000704415", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000704415.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000704415.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000704415.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000704415_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000704415_main_keyfigs.svg", "name": "Tivity Health INC", "rank": 21, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000704415.svg", "report_text": "The relative strengths and weaknesses of Tivity Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Tivity Health INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 109% points.The greatest weakness of Tivity Health INC is the variable Other Net Income, reducing the Economic Capital Ratio by 38% points.

The company's Economic Capital Ratio, given in the ranking table, is 217%, being 56% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000704415_2012_Tivity_Health_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "77.8", "Stockholders Equity": "109", "ECR before LimitedLiability": "63.0", "Property Plant and Equipment": "5.87", "Intangible Assets": "55.2", "Other Liabilities": "6.35", "Liabilities": "9.26", "Long Term Liabilities": "20.0", "Liabilities, Current": "-19.8", "Expenses": "43.7", "Revenues": "-22.6", "Net Income": "-16.4", "Other Expenses": "14.8", "Operating Costs and Expenses": "3.92", "Labor Expense": "6.18", "General and Administrative Expense": "10.1", "Cost of Goods and Services Sold": "3.91", "Other Revenues": "-22.6", "Other Net Income": "-38.4", "Comprehensive Net Income": "-16.3", "Economic Capital Ratio": "56.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000704415_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "127,531", "Assets, Non-Current": "10,797", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "428,389", "Labor Expense": "0", "Liabilities, Current": "118,757", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "15,386", "Other Liabilities": "0", "Other Net Income": "-142,307", "Other Revenues": "0", "Property Plant and Equipment": "142,188", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "708,905", "Liabilities": "118,757", "Expenses": "15,386", "Revenues": "0", "Stockholders Equity": "590,148", "Net Income": "-157,693", "Comprehensive Net Income": "-157,693", "BaseVar": "492,678", "ECR before LimitedLiability": "169%", "Economic Capital Ratio": "217%" } } }, "top_rated": false, "trend": null, "value": 2.170467811630787, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000704415.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000704415.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000704415.svg" }, { "company_id": "0000792641", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000792641.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000792641.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000792641_main_keyfigs.svg", "name": "BIO Reference Laboratories INC", "rank": 22, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000792641.svg", "report_text": "The relative strengths and weaknesses of BIO Reference Laboratories INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of BIO Reference Laboratories INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 60% points.The greatest weakness of BIO Reference Laboratories INC is the variable Liabilities, Current, reducing the Economic Capital Ratio by 48% points.

The company's Economic Capital Ratio, given in the ranking table, is 215%, being 54% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000792641_2012_BIO_Reference_Laboratories_INC.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "-6.79", "Assets": "46.1", "Liabilities": "-21.0", "Stockholders Equity": "57.5", "ECR before LimitedLiability": "60.9", "Assets, Current": "59.8", "Assets, Non-Current": "5.84", "Other Liabilities": "6.60", "Long Term Liabilities": "12.9", "Liabilities, Current": "-47.7", "Expenses": "38.2", "Revenues": "-23.7", "Net Income": "22.1", "Other Expenses": "8.07", "Operating Costs and Expenses": "4.11", "Labor Expense": "6.47", "General and Administrative Expense": "10.5", "Other Revenues": "-23.7", "Other Net Income": "7.58", "Comprehensive Net Income": "22.2", "Economic Capital Ratio": "54.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000792641_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "206,780", "Assets, Non-Current": "32,912", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "30,312", "Labor Expense": "0", "Liabilities, Current": "82,514", "Long Term Liabilities": "10,978", "Operating Costs and Expenses": "0", "Other Assets": "-30,312", "Other Compr. Net Income": "0", "Other Expenses": "28,487", "Other Liabilities": "0", "Other Net Income": "64,846", "Other Revenues": "0", "Property Plant and Equipment": "43,567", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "283,259", "Liabilities": "93,492", "Expenses": "28,487", "Revenues": "0", "Stockholders Equity": "189,767", "Net Income": "36,359", "Comprehensive Net Income": "36,359", "BaseVar": "235,042", "ECR before LimitedLiability": "165%", "Economic Capital Ratio": "215%" } } }, "top_rated": false, "trend": null, "value": 2.148689447704913, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000792641.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000792641.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000792641.svg" }, { "company_id": "0000931059", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000931059.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000931059.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000931059.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000931059_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000931059_main_keyfigs.svg", "name": "Rennova Health Inc", "rank": 23, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000931059.svg", "report_text": "The relative strengths and weaknesses of Rennova Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Rennova Health Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 125% points.The greatest weakness of Rennova Health Inc is the variable Other Net Income, reducing the Economic Capital Ratio by 28% points.

The company's Economic Capital Ratio, given in the ranking table, is 212%, being 52% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000931059_2012_Rennova_Health_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "14.7", "Assets": "79.9", "Liabilities": "12.9", "Stockholders Equity": "112", "ECR before LimitedLiability": "58.3", "Property Plant and Equipment": "-7.67", "Assets, Current": "125", "Intangible Assets": "-9.17", "Other Liabilities": "6.52", "Long Term Liabilities": "20.6", "Liabilities, Current": "-16.2", "Expenses": "28.7", "Revenues": "-23.4", "Net Income": "-22.7", "Other Expenses": "18.0", "Labor Expense": "6.45", "General and Administrative Expense": "-8.58", "Other Revenues": "-23.4", "Other Net Income": "-28.3", "Comprehensive Net Income": "-22.7", "Economic Capital Ratio": "51.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000931059_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "9,043", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,883", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "1,792", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "2,046", "Other Compr. Net Income": "-18", "Other Expenses": "0", "Other Liabilities": "0", "Other Net Income": "-1,263", "Other Revenues": "16", "Property Plant and Equipment": "112", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "11,201", "Liabilities": "1,792", "Expenses": "1,883", "Revenues": "16", "Stockholders Equity": "9,409", "Net Income": "-3,130", "Comprehensive Net Income": "-3,148", "BaseVar": "8,086", "ECR before LimitedLiability": "162%", "Economic Capital Ratio": "212%" } } }, "top_rated": false, "trend": null, "value": 2.1235019079011703, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000931059.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000931059.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000931059.svg" }, { "company_id": "0000929994", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000929994.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000929994.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000929994_main_keyfigs.svg", "name": "Assisted Living Concepts INC", "rank": 24, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000929994.svg", "report_text": "The relative strengths and weaknesses of Assisted Living Concepts INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Assisted Living Concepts INC compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 119% points.The greatest weakness of Assisted Living Concepts INC is the variable Other Revenues, reducing the Economic Capital Ratio by 32% points.

The company's Economic Capital Ratio, given in the ranking table, is 206%, being 45% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000929994_2012_Assisted_Living_Concepts_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "23.2", "Stockholders Equity": "39.8", "ECR before LimitedLiability": "51.9", "Property Plant and Equipment": "119", "Assets, Current": "-12.3", "Intangible Assets": "-12.1", "Expenses": "21.1", "Revenues": "-32.3", "Net Income": "18.2", "Other Expenses": "-12.2", "Depreciation, Depletion, Amortization": "-3.00", "Operating Costs and Expenses": "5.66", "Labor Expense": "8.93", "General and Administrative Expense": "11.7", "Cost of Goods and Services Sold": "5.64", "Other Revenues": "-32.3", "Long Term Liabilities": "-15.5", "Liabilities, Current": "17.0", "Other Net Income": "29.5", "Comprehensive Net Income": "18.3", "Economic Capital Ratio": "45.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000929994_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "20,271", "Assets, Non-Current": "2,025", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "23,103", "General and Administrative Expense": "13,361", "Goodwill Impairment Loss": "0", "Intangible Assets": "9,028", "Labor Expense": "0", "Liabilities, Current": "36,005", "Long Term Liabilities": "94,810", "Operating Costs and Expenses": "0", "Other Assets": "1,996", "Other Compr. Net Income": "0", "Other Expenses": "174,596", "Other Liabilities": "25,518", "Other Net Income": "234,464", "Other Revenues": "956", "Property Plant and Equipment": "430,733", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "464,053", "Liabilities": "156,333", "Expenses": "211,060", "Revenues": "956", "Stockholders Equity": "307,720", "Net Income": "24,360", "Comprehensive Net Income": "24,360", "BaseVar": "533,433", "ECR before LimitedLiability": "152%", "Economic Capital Ratio": "206%" } } }, "top_rated": false, "trend": null, "value": 2.0586795369536066, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000929994.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000929994.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000929994.svg" }, { "company_id": "0000019411", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000019411.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000019411.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019411.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019411_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000019411_main_keyfigs.svg", "name": "Magellan Health INC", "rank": 25, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000019411.svg", "report_text": "The relative strengths and weaknesses of Magellan Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Magellan Health INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 119% points.The greatest weakness of Magellan Health INC is the variable Other Expenses, reducing the Economic Capital Ratio by 149% points.

The company's Economic Capital Ratio, given in the ranking table, is 203%, being 42% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000019411_2012_Magellan_Health_INC.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "5.49", "Assets": "-32.3", "Liabilities": "80.2", "Stockholders Equity": "-50.4", "ECR before LimitedLiability": "18.7", "Property Plant and Equipment": "-19.2", "Intangible Assets": "-21.2", "Other Liabilities": "10.5", "Long Term Liabilities": "74.5", "Other Expenses": "-148", "Expenses": "-70.2", "Revenues": "126", "Net Income": "-7.40", "Cost of Goods and Services Sold": "20.5", "General and Administrative Expense": "9.41", "Labor Expense": "15.1", "Operating Costs and Expenses": "16.7", "Other Revenues": "126", "Comprehensive Net Income": "-5.66", "Other Net Income": "-77.3", "Economic Capital Ratio": "20.5" }, "2011": { "Assets": "-33.0", "Liabilities": "76.2", "Stockholders Equity": "-42.6", "ECR before LimitedLiability": "49.1", "Property Plant and Equipment": "-20.6", "Assets, Non-Current": "-5.37", "Intangible Assets": "-10.8", "Long Term Liabilities": "59.0", "Liabilities, Current": "20.5", "Expenses": "-39.9", "Revenues": "119", "Net Income": "40.5", "Other Expenses": "-149", "Operating Costs and Expenses": "13.2", "Labor Expense": "20.9", "General and Administrative Expense": "34.6", "Cost of Goods and Services Sold": "13.1", "Other Revenues": "119", "Other Net Income": "-49.2", "Comprehensive Net Income": "41.0", "Economic Capital Ratio": "42.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000019411_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "858,487", "Assets, Non-Current": "2,396", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "54,682", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "480,936", "Labor Expense": "0", "Liabilities, Current": "390,169", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "95,799", "Other Compr. Net Income": "-105", "Other Expenses": "2,775,899", "Other Liabilities": "120,248", "Other Net Income": "0", "Other Revenues": "2,969,240", "Property Plant and Equipment": "111,814", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,549,432", "Liabilities": "510,417", "Expenses": "2,830,581", "Revenues": "2,969,240", "Stockholders Equity": "1,039,015", "Net Income": "138,659", "Comprehensive Net Income": "138,554", "BaseVar": "3,929,888", "ECR before LimitedLiability": "160%", "Economic Capital Ratio": "211%" } }, "2011": { "input_variables": { "Assets, Current": "732,709", "Assets, Non-Current": "10,952", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "58,623", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "471,528", "Labor Expense": "0", "Liabilities, Current": "369,550", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "7,956", "Other Compr. Net Income": "-159", "Other Expenses": "2,611,154", "Other Liabilities": "126,343", "Other Net Income": "0", "Other Revenues": "2,799,400", "Property Plant and Equipment": "118,022", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,341,167", "Liabilities": "495,893", "Expenses": "2,669,777", "Revenues": "2,799,400", "Stockholders Equity": "845,274", "Net Income": "129,623", "Comprehensive Net Income": "129,464", "BaseVar": "3,653,198", "ECR before LimitedLiability": "148%", "Economic Capital Ratio": "203%" } } }, "top_rated": false, "trend": -18.0, "value": 2.0312523858492453, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000019411.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000019411.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000019411.svg" }, { "company_id": "0000019584", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000019584.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000019584.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019584.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019584_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000019584_main_keyfigs.svg", "name": "Chemed CORP", "rank": 26, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000019584.svg", "report_text": "The relative strengths and weaknesses of Chemed CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Chemed CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 96% points.The greatest weakness of Chemed CORP is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 103% points.

The company's Economic Capital Ratio, given in the ranking table, is 182%, being 22% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000019584_2012_Chemed_CORP.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-12.0", "Assets": "-30.2", "Liabilities": "40.9", "Stockholders Equity": "-43.3", "ECR before LimitedLiability": "-3.98", "Property Plant and Equipment": "-18.7", "Assets, Non-Current": "-3.86", "Other Liabilities": "8.86", "Liabilities, Current": "5.35", "Long Term Liabilities": "28.3", "Other Expenses": "32.6", "Expenses": "-39.6", "Revenues": "102", "Net Income": "-4.16", "Cost of Goods and Services Sold": "-86.6", "General and Administrative Expense": "-14.7", "Labor Expense": "12.6", "Operating Costs and Expenses": "13.9", "Other Revenues": "102", "Comprehensive Net Income": "-2.73", "Other Net Income": "-58.7", "Economic Capital Ratio": "-2.17" }, "2011": { "Assets": "-30.0", "Liabilities": "38.7", "Stockholders Equity": "-38.6", "ECR before LimitedLiability": "28.4", "Property Plant and Equipment": "-20.1", "Assets, Current": "-21.3", "Assets, Non-Current": "-4.98", "Intangible Assets": "17.5", "Long Term Liabilities": "11.4", "Liabilities, Current": "26.5", "Expenses": "-18.8", "Revenues": "95.8", "Net Income": "37.2", "Other Expenses": "39.5", "Operating Costs and Expenses": "11.2", "Labor Expense": "17.8", "Cost of Goods and Services Sold": "-103", "Other Revenues": "95.8", "Other Net Income": "-39.3", "Comprehensive Net Income": "37.6", "Economic Capital Ratio": "21.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000019584_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "196,797", "Assets, Non-Current": "11,015", "Cost of Goods and Services Sold": "906,016", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "201,964", "Goodwill Impairment Loss": "0", "Intangible Assets": "514,753", "Labor Expense": "0", "Liabilities, Current": "149,342", "Long Term Liabilities": "165,834", "Operating Costs and Expenses": "0", "Other Assets": "28,304", "Other Compr. Net Income": "0", "Other Expenses": "93,002", "Other Liabilities": "52,936", "Other Net Income": "2,268", "Other Revenues": "1,280,545", "Property Plant and Equipment": "79,292", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "830,161", "Liabilities": "368,112", "Expenses": "1,200,982", "Revenues": "1,280,545", "Stockholders Equity": "462,049", "Net Income": "81,831", "Comprehensive Net Income": "81,831", "BaseVar": "1,841,034", "ECR before LimitedLiability": "125%", "Economic Capital Ratio": "188%" } }, "2011": { "input_variables": { "Assets, Current": "150,753", "Assets, Non-Current": "11,677", "Cost of Goods and Services Sold": "970,484", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "202,260", "Goodwill Impairment Loss": "0", "Intangible Assets": "518,895", "Labor Expense": "0", "Liabilities, Current": "145,400", "Long Term Liabilities": "176,665", "Operating Costs and Expenses": "0", "Other Assets": "31,629", "Other Compr. Net Income": "0", "Other Expenses": "97,964", "Other Liabilities": "60,156", "Other Net Income": "717", "Other Revenues": "1,355,970", "Property Plant and Equipment": "82,951", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "795,905", "Liabilities": "382,221", "Expenses": "1,270,708", "Revenues": "1,355,970", "Stockholders Equity": "413,684", "Net Income": "85,979", "Comprehensive Net Income": "85,979", "BaseVar": "1,902,760", "ECR before LimitedLiability": "116%", "Economic Capital Ratio": "182%" } } }, "top_rated": false, "trend": -18.0, "value": 1.823798305178335, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000019584.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000019584.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000019584.svg" }, { "company_id": "0001003130", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001003130.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001003130.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001003130_main_keyfigs.svg", "name": "LCA Vision INC", "rank": 27, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001003130.svg", "report_text": "The relative strengths and weaknesses of LCA Vision INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of LCA Vision INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 94% points.The greatest weakness of LCA Vision INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 51% points.

The company's Economic Capital Ratio, given in the ranking table, is 181%, being 20% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001003130_2012_LCA_Vision_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-29.4", "Liabilities": "52.7", "Stockholders Equity": "-24.6", "ECR before LimitedLiability": "27.0", "Property Plant and Equipment": "-17.4", "Assets, Current": "32.7", "Intangible Assets": "-28.6", "Other Liabilities": "16.0", "Long Term Liabilities": "50.0", "Liabilities, Current": "-13.8", "Selling and Marketing Expense": "-30.2", "Expenses": "-30.7", "Revenues": "94.0", "Net Income": "17.1", "Operating Costs and Expenses": "11.5", "Labor Expense": "18.4", "Cost of Goods and Services Sold": "-51.1", "Other Revenues": "94.0", "Other Net Income": "-39.0", "Comprehensive Net Income": "17.4", "Economic Capital Ratio": "20.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001003130_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "52,473", "Assets, Non-Current": "1,652", "Cost of Goods and Services Sold": "43,048", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "13,942", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "25,772", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "1,671", "Other Compr. Net Income": "0", "Other Expenses": "30,601", "Other Liabilities": "0", "Other Net Income": "1,088", "Other Revenues": "102,983", "Property Plant and Equipment": "10,637", "Research And Development Expense": "0", "Selling and Marketing Expense": "22,678" }, "output_variables": { "Assets": "66,433", "Liabilities": "25,772", "Expenses": "110,269", "Revenues": "102,983", "Stockholders Equity": "40,661", "Net Income": "-6,198", "Comprehensive Net Income": "-6,198", "BaseVar": "153,272", "ECR before LimitedLiability": "114%", "Economic Capital Ratio": "181%" } } }, "top_rated": false, "trend": null, "value": 1.81027489696901, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001003130.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001003130.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001003130.svg" }, { "company_id": "0001316645", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001316645.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001316645.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001316645_main_keyfigs.svg", "name": "American Caresource Holdings Inc", "rank": 28, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001316645.svg", "report_text": "The relative strengths and weaknesses of American Caresource Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of American Caresource Holdings Inc compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 122% points.The greatest weakness of American Caresource Holdings Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 192% points.

The company's Economic Capital Ratio, given in the ranking table, is 179%, being 18% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001316645_2012_American_Caresource_Holdings_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-56.7", "Expenses": "-107", "Stockholders Equity": "-63.0", "ECR before LimitedLiability": "25.0", "Property Plant and Equipment": "-33.4", "Assets, Current": "11.6", "Intangible Assets": "-38.8", "Other Liabilities": "25.4", "Liabilities": "94.0", "Long Term Liabilities": "77.6", "Liabilities, Current": "43.2", "Other Expenses": "-192", "Goodwill Impairment Loss": "-20.3", "Operating Costs and Expenses": "19.0", "Labor Expense": "30.6", "General and Administrative Expense": "12.0", "Cost of Goods and Services Sold": "18.9", "Other Revenues": "122", "Revenues": "122", "Economic Capital Ratio": "18.3", "Other Net Income": "-65.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001316645_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "16,197", "Assets, Non-Current": "16", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "792", "General and Administrative Expense": "6,240", "Goodwill Impairment Loss": "4,361", "Intangible Assets": "896", "Labor Expense": "0", "Liabilities, Current": "4,915", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "226", "Other Compr. Net Income": "0", "Other Expenses": "44,789", "Other Liabilities": "0", "Other Net Income": "39", "Other Revenues": "48,906", "Property Plant and Equipment": "1,829", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "19,164", "Liabilities": "4,915", "Expenses": "56,182", "Revenues": "48,906", "Stockholders Equity": "14,249", "Net Income": "-7,237", "Comprehensive Net Income": "-7,237", "BaseVar": "64,603", "ECR before LimitedLiability": "112%", "Economic Capital Ratio": "179%" } } }, "top_rated": false, "trend": null, "value": 1.790133337631494, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001316645.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001316645.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001316645.svg" }, { "company_id": "0001468328", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001468328.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001468328.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001468328.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001468328_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001468328_main_keyfigs.svg", "name": "Addus Homecare Corp", "rank": 29, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001468328.svg", "report_text": "The relative strengths and weaknesses of Addus Homecare Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Addus Homecare Corp compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Addus Homecare Corp is the variable Other Revenues, reducing the Economic Capital Ratio by 33% points.

The company's Economic Capital Ratio, given in the ranking table, is 178%, being 18% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001468328_2012_Addus_Homecare_Corp.pdf", "shrinked_graph_json": { "2011": { "Assets": "20.9", "Liabilities": "-14.3", "Stockholders Equity": "18.6", "ECR before LimitedLiability": "24.4", "Property Plant and Equipment": "-14.9", "Assets, Current": "34.5", "Intangible Assets": "13.1", "Other Liabilities": "8.50", "Liabilities, Current": "-21.2", "Expenses": "18.5", "Revenues": "-32.9", "Net Income": "12.6", "Other Expenses": "29.6", "Goodwill Impairment Loss": "-8.44", "Operating Costs and Expenses": "6.04", "Labor Expense": "9.57", "General and Administrative Expense": "-25.2", "Other Revenues": "-32.9", "Other Net Income": "29.9", "Comprehensive Net Income": "12.8", "Economic Capital Ratio": "17.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001468328_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "88,861", "Assets, Non-Current": "513", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "3,554", "General and Administrative Expense": "66,926", "Goodwill Impairment Loss": "15,989", "Intangible Assets": "58,739", "Labor Expense": "0", "Liabilities, Current": "43,293", "Long Term Liabilities": "24,958", "Operating Costs and Expenses": "0", "Other Assets": "4,089", "Other Compr. Net Income": "0", "Other Expenses": "-2,954", "Other Liabilities": "0", "Other Net Income": "81,534", "Other Revenues": "0", "Property Plant and Equipment": "2,490", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "154,692", "Liabilities": "68,251", "Expenses": "83,515", "Revenues": "0", "Stockholders Equity": "86,441", "Net Income": "-1,981", "Comprehensive Net Income": "-1,981", "BaseVar": "193,996", "ECR before LimitedLiability": "111%", "Economic Capital Ratio": "178%" } } }, "top_rated": false, "trend": null, "value": 1.7843852836230516, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001468328.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001468328.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001468328.svg" }, { "company_id": "0001159281", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001159281.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001159281.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001159281.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001159281_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001159281_main_keyfigs.svg", "name": "Alerislife Inc", "rank": 30, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001159281.svg", "report_text": "The relative strengths and weaknesses of Alerislife Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Alerislife Inc compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 98% points.The greatest weakness of Alerislife Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 66% points.

The company's Economic Capital Ratio, given in the ranking table, is 176%, being 15% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001159281_2012_Alerislife_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-43.7", "Stockholders Equity": "-65.5", "ECR before LimitedLiability": "21.9", "Assets, Current": "-25.4", "Intangible Assets": "-33.2", "Other Liabilities": "18.3", "Liabilities": "55.5", "Long Term Liabilities": "26.0", "Liabilities, Current": "14.1", "Expenses": "-35.3", "Revenues": "97.8", "Net Income": "44.5", "Other Expenses": "-34.9", "Operating Costs and Expenses": "13.6", "Labor Expense": "-60.7", "General and Administrative Expense": "26.3", "Cost of Goods and Services Sold": "13.5", "Other Revenues": "97.8", "Other Net Income": "-46.0", "Comprehensive Net Income": "44.9", "Economic Capital Ratio": "15.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001159281_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "141,516", "Assets, Non-Current": "56,419", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "21,127", "General and Administrative Expense": "57,540", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "536,386", "Liabilities, Current": "189,331", "Long Term Liabilities": "113,952", "Operating Costs and Expenses": "0", "Other Assets": "32,477", "Other Compr. Net Income": "0", "Other Expenses": "603,985", "Other Liabilities": "0", "Other Net Income": "5,551", "Other Revenues": "1,281,764", "Property Plant and Equipment": "353,065", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "583,477", "Liabilities": "303,283", "Expenses": "1,219,038", "Revenues": "1,281,764", "Stockholders Equity": "280,194", "Net Income": "68,277", "Comprehensive Net Income": "68,277", "BaseVar": "1,696,556", "ECR before LimitedLiability": "107%", "Economic Capital Ratio": "176%" } } }, "top_rated": false, "trend": null, "value": 1.7593120157660085, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001159281.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001159281.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001159281.svg" }, { "company_id": "0001301611", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001301611.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001301611.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001301611.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001301611_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001301611_main_keyfigs.svg", "name": "Legacy Lifepoint Health INC", "rank": 31, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001301611.svg", "report_text": "The relative strengths and weaknesses of Legacy Lifepoint Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Legacy Lifepoint Health INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Legacy Lifepoint Health INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 37% points.

The company's Economic Capital Ratio, given in the ranking table, is 164%, being 3.3% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001301611_2012_Legacy_Lifepoint_Health_INC.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-7.71", "Assets": "-6.84", "Liabilities": "-13.4", "Stockholders Equity": "-19.9", "ECR before LimitedLiability": "-27.6", "Property Plant and Equipment": "13.3", "Intangible Assets": "-5.11", "Liabilities, Current": "11.6", "Long Term Liabilities": "-24.7", "Other Expenses": "4.68", "Expenses": "-4.10", "Revenues": "-32.2", "Net Income": "-5.67", "Cost of Goods and Services Sold": "12.0", "General and Administrative Expense": "5.44", "Labor Expense": "-19.3", "Operating Costs and Expenses": "-4.06", "Other Revenues": "-32.2", "Comprehensive Net Income": "-4.69", "Other Net Income": "34.7", "Economic Capital Ratio": "-25.8" }, "2011": { "Assets": "8.03", "Liabilities": "-22.3", "Stockholders Equity": "-5.36", "ECR before LimitedLiability": "10.0", "Property Plant and Equipment": "18.2", "Assets, Current": "-10.6", "Intangible Assets": "9.97", "Other Liabilities": "-7.76", "Long Term Liabilities": "-37.0", "Liabilities, Current": "20.0", "Expenses": "18.0", "Revenues": "-36.3", "Net Income": "19.7", "Other Expenses": "16.4", "Operating Costs and Expenses": "-7.73", "Labor Expense": "-18.0", "General and Administrative Expense": "18.0", "Cost of Goods and Services Sold": "6.83", "Other Revenues": "-36.3", "Other Net Income": "43.8", "Comprehensive Net Income": "20.0", "Economic Capital Ratio": "3.34" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001301611_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "823,100", "Assets, Non-Current": "9,700", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "148,500", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,623,800", "Labor Expense": "1,270,300", "Liabilities, Current": "324,300", "Long Term Liabilities": "1,570,500", "Operating Costs and Expenses": "605,200", "Other Assets": "27,200", "Other Compr. Net Income": "0", "Other Expenses": "1,079,700", "Other Liabilities": "351,000", "Other Net Income": "3,262,300", "Other Revenues": "0", "Property Plant and Equipment": "1,668,600", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "4,152,400", "Liabilities": "2,245,800", "Expenses": "3,103,700", "Revenues": "0", "Stockholders Equity": "1,906,600", "Net Income": "158,600", "Comprehensive Net Income": "158,600", "BaseVar": "6,382,100", "ECR before LimitedLiability": "91%", "Economic Capital Ratio": "165%" } }, "2011": { "input_variables": { "Assets, Current": "840,000", "Assets, Non-Current": "19,800", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "165,800", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,658,200", "Labor Expense": "1,364,700", "Liabilities, Current": "372,800", "Long Term Liabilities": "1,595,400", "Operating Costs and Expenses": "682,400", "Other Assets": "21,700", "Other Compr. Net Income": "1,200", "Other Expenses": "647,700", "Other Liabilities": "416,100", "Other Net Income": "3,025,900", "Other Revenues": "0", "Property Plant and Equipment": "1,830,400", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "4,370,100", "Liabilities": "2,384,300", "Expenses": "2,860,600", "Revenues": "0", "Stockholders Equity": "1,985,800", "Net Income": "165,300", "Comprehensive Net Income": "166,500", "BaseVar": "6,321,050", "ECR before LimitedLiability": "90%", "Economic Capital Ratio": "164%" } } }, "top_rated": false, "trend": -21.0, "value": 1.6402088381208357, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001301611.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001301611.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001301611.svg" }, { "company_id": "0000882235", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000882235.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000882235.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000882235_main_keyfigs.svg", "name": "Lincare Holdings INC", "rank": 32, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000882235.svg", "report_text": "The relative strengths and weaknesses of Lincare Holdings INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Lincare Holdings INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Lincare Holdings INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 49% points.

The company's Economic Capital Ratio, given in the ranking table, is 162%, being 1.2% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000882235_2012_Lincare_Holdings_INC.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-5.56", "Assets": "-5.76", "Liabilities": "-8.99", "Stockholders Equity": "-15.7", "ECR before LimitedLiability": "-17.9", "Property Plant and Equipment": "-8.38", "Assets, Non-Current": "-3.42", "Intangible Assets": "16.6", "Other Liabilities": "-80.6", "Liabilities, Current": "10.3", "Long Term Liabilities": "41.5", "Other Revenues": "45.8", "Revenues": "45.8", "Operating Costs and Expenses": "-8.51", "Economic Capital Ratio": "-16.1", "Other Expenses": "22.5", "Cost of Goods and Services Sold": "-8.84", "General and Administrative Expense": "-9.57", "Labor Expense": "8.59", "Other Net Income": "-40.2", "Depreciation, Depletion, Amortization": "-3.72" }, "2011": { "Other Liabilities": "-49.4", "Liabilities": "-18.8", "Stockholders Equity": "-17.6", "ECR before LimitedLiability": "7.91", "Long Term Liabilities": "32.0", "Liabilities, Current": "-7.41", "Expenses": "16.3", "Net Income": "26.1", "Other Expenses": "27.9", "Operating Costs and Expenses": "-10.9", "Labor Expense": "12.1", "General and Administrative Expense": "4.01", "Cost of Goods and Services Sold": "-17.2", "Other Revenues": "41.6", "Revenues": "41.6", "Property Plant and Equipment": "-9.92", "Assets, Current": "-15.7", "Assets, Non-Current": "-3.45", "Intangible Assets": "44.6", "Other Net Income": "-27.7", "Comprehensive Net Income": "26.4", "Economic Capital Ratio": "1.23" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000882235_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "443,298", "Assets, Non-Current": "7,690", "Cost of Goods and Services Sold": "453,905", "Depreciation, Depletion, Amortization": "116,783", "General and Administrative Expense": "333,094", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,258,065", "Labor Expense": "0", "Liabilities, Current": "174,750", "Long Term Liabilities": "0", "Operating Costs and Expenses": "399,393", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "148,768", "Other Liabilities": "875,332", "Other Net Income": "-35,688", "Other Revenues": "1,669,205", "Property Plant and Equipment": "338,778", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,047,831", "Liabilities": "1,050,082", "Expenses": "1,451,943", "Revenues": "1,669,205", "Stockholders Equity": "997,749", "Net Income": "181,574", "Comprehensive Net Income": "181,574", "BaseVar": "3,127,374", "ECR before LimitedLiability": "105%", "Economic Capital Ratio": "175%" } }, "2011": { "input_variables": { "Assets, Current": "342,194", "Assets, Non-Current": "34,776", "Cost of Goods and Services Sold": "579,509", "Depreciation, Depletion, Amortization": "125,504", "General and Administrative Expense": "349,488", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,389,965", "Labor Expense": "0", "Liabilities, Current": "566,643", "Long Term Liabilities": "0", "Operating Costs and Expenses": "427,958", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "150,032", "Other Liabilities": "665,103", "Other Net Income": "-37,718", "Other Revenues": "1,847,520", "Property Plant and Equipment": "350,725", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,117,660", "Liabilities": "1,231,746", "Expenses": "1,632,491", "Revenues": "1,847,520", "Stockholders Equity": "885,914", "Net Income": "177,311", "Comprehensive Net Income": "177,311", "BaseVar": "3,433,568", "ECR before LimitedLiability": "87%", "Economic Capital Ratio": "162%" } } }, "top_rated": false, "trend": -23.0, "value": 1.6191734879328643, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000882235.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000882235.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000882235.svg" }, { "company_id": "0000920148", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000920148.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000920148.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000920148.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000920148_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000920148_main_keyfigs.svg", "name": "Laboratory Corp OF America Holdings", "rank": 33, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000920148.svg", "report_text": "The relative strengths and weaknesses of Laboratory Corp OF America Holdings are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Laboratory Corp OF America Holdings compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Laboratory Corp OF America Holdings is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 39% points.

The company's Economic Capital Ratio, given in the ranking table, is 161%, being 0.29% points above the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000920148_2012_Laboratory_Corp_OF_America_Holdings.pdf", "shrinked_graph_json": { "2009": { "Assets": "9.99", "Stockholders Equity": "-10.7", "ECR before LimitedLiability": "-28.7", "Intangible Assets": "11.8", "Assets, Current": "-3.40", "Liabilities, Current": "-26.2", "Liabilities": "-35.2", "Long Term Liabilities": "-10.7", "Other Liabilities": "2.65", "Other Expenses": "13.2", "Expenses": "15.1", "Revenues": "25.4", "Net Income": "2.19", "General and Administrative Expense": "-8.43", "Cost of Goods and Services Sold": "-5.80", "Labor Expense": "4.56", "Operating Costs and Expenses": "11.0", "Other Revenues": "25.4", "Comprehensive Net Income": "2.19", "Other Net Income": "-34.9", "Economic Capital Ratio": "-28.3" }, "2010": { "Assets, Current": "-9.24", "Assets": "-8.24", "Liabilities": "-22.2", "Stockholders Equity": "-27.7", "ECR before LimitedLiability": "-32.2", "Property Plant and Equipment": "-15.0", "Assets, Non-Current": "-2.71", "Intangible Assets": "27.6", "Other Liabilities": "13.1", "Liabilities, Current": "-23.8", "Long Term Liabilities": "-12.2", "Other Revenues": "44.6", "Revenues": "44.6", "Operating Costs and Expenses": "9.70", "Economic Capital Ratio": "-30.4", "Other Expenses": "23.9", "Cost of Goods and Services Sold": "-29.9", "General and Administrative Expense": "-9.80", "Labor Expense": "8.79", "Other Net Income": "-39.2", "Depreciation, Depletion, Amortization": "1.54" }, "2011": { "Assets": "-4.73", "Liabilities": "-18.2", "Stockholders Equity": "-19.9", "ECR before LimitedLiability": "6.97", "Property Plant and Equipment": "-15.7", "Assets, Current": "-15.2", "Assets, Non-Current": "-3.66", "Intangible Assets": "52.3", "Other Liabilities": "10.2", "Long Term Liabilities": "-33.2", "Liabilities, Current": "3.16", "Expenses": "13.6", "Revenues": "44.0", "Net Income": "26.8", "Other Expenses": "26.0", "Operating Costs and Expenses": "7.74", "Labor Expense": "12.3", "Cost of Goods and Services Sold": "-38.9", "Other Revenues": "44.0", "Other Net Income": "-26.6", "Comprehensive Net Income": "27.1", "Economic Capital Ratio": "0.292" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000920148_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "935,600", "Assets, Non-Current": "90,700", "Cost of Goods and Services Sold": "2,723,800", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "958,900", "Goodwill Impairment Loss": "0", "Intangible Assets": "3,239,300", "Labor Expense": "0", "Liabilities, Current": "1,596,100", "Long Term Liabilities": "1,135,600", "Operating Costs and Expenses": "0", "Other Assets": "71,400", "Other Compr. Net Income": "0", "Other Expenses": "405,100", "Other Liabilities": "0", "Other Net Income": "-51,300", "Other Revenues": "4,694,700", "Property Plant and Equipment": "500,800", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "4,837,800", "Liabilities": "2,731,700", "Expenses": "4,087,800", "Revenues": "4,694,700", "Stockholders Equity": "2,106,100", "Net Income": "555,600", "Comprehensive Net Income": "555,600", "BaseVar": "8,201,650", "ECR before LimitedLiability": "95%", "Economic Capital Ratio": "168%" } }, "2010": { "input_variables": { "Assets, Current": "1,143,800", "Assets, Non-Current": "103,200", "Cost of Goods and Services Sold": "2,906,100", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,034,300", "Goodwill Impairment Loss": "0", "Intangible Assets": "4,275,400", "Labor Expense": "0", "Liabilities, Current": "1,722,800", "Long Term Liabilities": "1,978,100", "Operating Costs and Expenses": "0", "Other Assets": "78,500", "Other Compr. Net Income": "0", "Other Expenses": "416,700", "Other Liabilities": "0", "Other Net Income": "-51,200", "Other Revenues": "5,003,900", "Property Plant and Equipment": "586,900", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "6,187,800", "Liabilities": "3,700,900", "Expenses": "4,357,100", "Revenues": "5,003,900", "Stockholders Equity": "2,486,900", "Net Income": "595,600", "Comprehensive Net Income": "595,600", "BaseVar": "9,650,450", "ECR before LimitedLiability": "85%", "Economic Capital Ratio": "160%" } }, "2011": { "input_variables": { "Assets, Current": "1,084,800", "Assets, Non-Current": "94,200", "Cost of Goods and Services Sold": "3,267,600", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,159,600", "Goodwill Impairment Loss": "0", "Intangible Assets": "4,302,500", "Labor Expense": "0", "Liabilities, Current": "1,300,100", "Long Term Liabilities": "2,312,800", "Operating Costs and Expenses": "0", "Other Assets": "76,800", "Other Compr. Net Income": "0", "Other Expenses": "587,200", "Other Liabilities": "0", "Other Net Income": "5,200", "Other Revenues": "5,542,300", "Property Plant and Equipment": "578,300", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "6,136,600", "Liabilities": "3,612,900", "Expenses": "5,014,400", "Revenues": "5,542,300", "Stockholders Equity": "2,523,700", "Net Income": "533,100", "Comprehensive Net Income": "533,100", "BaseVar": "10,155,700", "ECR before LimitedLiability": "86%", "Economic Capital Ratio": "161%" } } }, "top_rated": false, "trend": -22.0, "value": 1.6097638589052883, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000920148.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000920148.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000920148.svg" }, { "company_id": "0001383183", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001383183.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001383183.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001383183_main_keyfigs.svg", "name": "Combimatrix Corp", "rank": 34, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001383183.svg", "report_text": "The relative strengths and weaknesses of Combimatrix Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Combimatrix Corp compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 99% points.The greatest weakness of Combimatrix Corp is the variable Net Income, reducing the Economic Capital Ratio by 76% points.

The company's Economic Capital Ratio, given in the ranking table, is 155%, being 5.3% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001383183_2012_Combimatrix_Corp.pdf", "shrinked_graph_json": { "2011": { "Assets": "8.29", "Liabilities": "66.3", "Stockholders Equity": "68.2", "Economic Capital Ratio": "-5.25", "Property Plant and Equipment": "-22.1", "Assets, Current": "98.6", "Intangible Assets": "-29.2", "Other Liabilities": "8.30", "Long Term Liabilities": "40.5", "Liabilities, Current": "20.7", "Selling and Marketing Expense": "-33.5", "Expenses": "-55.1", "Revenues": "8.26", "Net Income": "-76.0", "Research And Development Expense": "-15.6", "Operating Costs and Expenses": "9.98", "Labor Expense": "15.9", "General and Administrative Expense": "-48.4", "Cost of Goods and Services Sold": "9.95", "Other Revenues": "8.26", "Other Net Income": "-30.0", "Comprehensive Net Income": "-75.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001383183_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "8,582", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "5,567", "Goodwill Impairment Loss": "0", "Intangible Assets": "132", "Labor Expense": "0", "Liabilities, Current": "1,119", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "127", "Other Compr. Net Income": "0", "Other Expenses": "2,808", "Other Liabilities": "179", "Other Net Income": "299", "Other Revenues": "4,558", "Property Plant and Equipment": "607", "Research And Development Expense": "1,366", "Selling and Marketing Expense": "2,715" }, "output_variables": { "Assets": "9,448", "Liabilities": "1,298", "Expenses": "12,456", "Revenues": "4,558", "Stockholders Equity": "8,150", "Net Income": "-7,599", "Comprehensive Net Income": "-7,599", "BaseVar": "14,030", "ECR before LimitedLiability": "79%", "Economic Capital Ratio": "155%" } } }, "top_rated": false, "trend": null, "value": 1.5543334790194332, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001383183.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001383183.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001383183.svg" }, { "company_id": "0000722723", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000722723.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000722723.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000722723.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000722723_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000722723_main_keyfigs.svg", "name": "Hanger INC", "rank": 35, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000722723.svg", "report_text": "The relative strengths and weaknesses of Hanger INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Hanger INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Hanger INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 53% points.

The company's Economic Capital Ratio, given in the ranking table, is 152%, being 8.5% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000722723_2012_Hanger_INC.pdf", "shrinked_graph_json": { "2011": { "Liabilities": "-26.5", "Stockholders Equity": "-21.6", "Economic Capital Ratio": "-8.49", "Long Term Liabilities": "-53.2", "Liabilities, Current": "23.3", "Expenses": "15.9", "Revenues": "36.7", "Net Income": "22.7", "Research And Development Expense": "2.28", "Other Expenses": "5.43", "Operating Costs and Expenses": "-7.21", "Labor Expense": "-14.6", "General and Administrative Expense": "20.1", "Cost of Goods and Services Sold": "7.59", "Other Revenues": "36.7", "Property Plant and Equipment": "-16.2", "Assets, Current": "-5.31", "Assets, Non-Current": "-4.51", "Intangible Assets": "36.7", "Other Net Income": "-26.1", "Comprehensive Net Income": "23.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000722723_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "333,471", "Assets, Non-Current": "8,394", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "30,969", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "664,378", "Labor Expense": "322,765", "Liabilities, Current": "91,742", "Long Term Liabilities": "532,786", "Operating Costs and Expenses": "178,335", "Other Assets": "17,485", "Other Compr. Net Income": "0", "Other Expenses": "331,451", "Other Liabilities": "74,309", "Other Net Income": "0", "Other Revenues": "918,539", "Property Plant and Equipment": "104,772", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,128,500", "Liabilities": "698,837", "Expenses": "863,520", "Revenues": "918,539", "Stockholders Equity": "429,663", "Net Income": "55,019", "Comprehensive Net Income": "55,019", "BaseVar": "1,804,698", "ECR before LimitedLiability": "74%", "Economic Capital Ratio": "152%" } } }, "top_rated": false, "trend": null, "value": 1.5218939043700366, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000722723.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000722723.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000722723.svg" }, { "company_id": "0000948072", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000948072.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000948072.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000948072.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000948072_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000948072_main_keyfigs.svg", "name": "Birner Dental Management Services INC", "rank": 36, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000948072.svg", "report_text": "The relative strengths and weaknesses of Birner Dental Management Services INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Birner Dental Management Services INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 97% points.The greatest weakness of Birner Dental Management Services INC is the variable Labor Expense, reducing the Economic Capital Ratio by 112% points.

The company's Economic Capital Ratio, given in the ranking table, is 151%, being 9.9% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000948072_2012_Birner_Dental_Management_Services_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-67.8", "Liabilities": "63.4", "Stockholders Equity": "-111", "Economic Capital Ratio": "-9.86", "Property Plant and Equipment": "-29.4", "Assets, Current": "-41.2", "Assets, Non-Current": "-11.5", "Intangible Assets": "-18.5", "Long Term Liabilities": "39.5", "Liabilities, Current": "39.2", "Selling and Marketing Expense": "-7.38", "Expenses": "-59.0", "Revenues": "96.7", "Net Income": "51.7", "Other Expenses": "34.9", "Labor Expense": "-112", "General and Administrative Expense": "21.0", "Cost of Goods and Services Sold": "17.9", "Other Revenues": "96.7", "Other Net Income": "-54.5", "Comprehensive Net Income": "52.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000948072_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "4,616", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "2,506", "General and Administrative Expense": "5,706", "Goodwill Impairment Loss": "0", "Intangible Assets": "11,096", "Labor Expense": "35,647", "Liabilities, Current": "5,931", "Long Term Liabilities": "4,251", "Operating Costs and Expenses": "5,606", "Other Assets": "321", "Other Compr. Net Income": "5.2", "Other Expenses": "10,204", "Other Liabilities": "3,814", "Other Net Income": "830", "Other Revenues": "63,121", "Property Plant and Equipment": "5,790", "Research And Development Expense": "0", "Selling and Marketing Expense": "2,667" }, "output_variables": { "Assets": "21,822", "Liabilities": "13,996", "Expenses": "62,335", "Revenues": "63,121", "Stockholders Equity": "7,826", "Net Income": "1,615", "Comprehensive Net Income": "1,620", "BaseVar": "81,055", "ECR before LimitedLiability": "72%", "Economic Capital Ratio": "151%" } } }, "top_rated": false, "trend": null, "value": 1.5082041854853183, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000948072.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000948072.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000948072.svg" }, { "company_id": "0000862692", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000862692.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000862692.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000862692.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000862692_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000862692_main_keyfigs.svg", "name": "CRYO CELL International INC", "rank": 37, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000862692.svg", "report_text": "The relative strengths and weaknesses of CRYO CELL International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of CRYO CELL International INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 53% points.The greatest weakness of CRYO CELL International INC is the variable Liabilities, Current, reducing the Economic Capital Ratio by 60% points.

The company's Economic Capital Ratio, given in the ranking table, is 151%, being 10% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000862692_2012_CRYO_CELL_International_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-10.8", "Other Liabilities": "11.1", "Stockholders Equity": "-19.2", "Economic Capital Ratio": "-10.2", "Property Plant and Equipment": "-20.3", "Assets, Current": "52.8", "Assets, Non-Current": "17.3", "Intangible Assets": "-28.4", "Expenses": "7.05", "Revenues": "46.8", "Net Income": "9.19", "Other Expenses": "10.7", "Operating Costs and Expenses": "8.82", "Labor Expense": "14.1", "General and Administrative Expense": "-38.1", "Cost of Goods and Services Sold": "8.79", "Other Revenues": "46.8", "Long Term Liabilities": "35.5", "Liabilities, Current": "-60.4", "Other Net Income": "-37.3", "Comprehensive Net Income": "9.46" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000862692_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "14,053", "Assets, Non-Current": "3,873", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "361", "General and Administrative Expense": "12,413", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "10,563", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "5,409", "Other Liabilities": "0", "Other Net Income": "-1,647", "Other Revenues": "17,918", "Property Plant and Equipment": "1,540", "Research And Development Expense": "184", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "19,467", "Liabilities": "10,563", "Expenses": "18,367", "Revenues": "17,918", "Stockholders Equity": "8,903", "Net Income": "-2,096", "Comprehensive Net Income": "-2,096", "BaseVar": "33,981", "ECR before LimitedLiability": "72%", "Economic Capital Ratio": "151%" } } }, "top_rated": false, "trend": null, "value": 1.5052305699174793, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000862692.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000862692.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000862692.svg" }, { "company_id": "0001101723", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001101723.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001101723.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001101723_main_keyfigs.svg", "name": "United Surgical Partners International INC", "rank": 38, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001101723.svg", "report_text": "The relative strengths and weaknesses of United Surgical Partners International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of United Surgical Partners International INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 59% points.The greatest weakness of United Surgical Partners International INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 61% points.

The company's Economic Capital Ratio, given in the ranking table, is 146%, being 15% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001101723_2012_United_Surgical_Partners_International_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "46.3", "Liabilities": "-60.2", "ECR before LimitedLiability": "-8.16", "Property Plant and Equipment": "-8.82", "Assets, Current": "-16.0", "Assets, Non-Current": "19.7", "Intangible Assets": "58.8", "Other Liabilities": "-5.37", "Long Term Liabilities": "-60.7", "Liabilities, Current": "5.71", "Expenses": "38.6", "Net Income": "12.8", "Other Expenses": "16.6", "Goodwill Impairment Loss": "-3.10", "General and Administrative Expense": "11.8", "Cost of Goods and Services Sold": "5.18", "Other Revenues": "-27.5", "Revenues": "-27.5", "Other Net Income": "6.24", "Comprehensive Net Income": "13.1", "Economic Capital Ratio": "-14.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001101723_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "155,328", "Assets, Non-Current": "466,364", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "29,462", "General and Administrative Expense": "43,710", "Goodwill Impairment Loss": "107,028", "Intangible Assets": "1,536,485", "Labor Expense": "165,083", "Liabilities, Current": "277,237", "Long Term Liabilities": "1,073,776", "Operating Costs and Expenses": "98,246", "Other Assets": "0", "Other Compr. Net Income": "3,318", "Other Expenses": "164,407", "Other Liabilities": "167,946", "Other Net Income": "627,021", "Other Revenues": "0", "Property Plant and Equipment": "235,321", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,393,498", "Liabilities": "1,518,959", "Expenses": "607,936", "Revenues": "0", "Stockholders Equity": "874,539", "Net Income": "19,085", "Comprehensive Net Income": "22,403", "BaseVar": "2,575,366", "ECR before LimitedLiability": "66%", "Economic Capital Ratio": "146%" } } }, "top_rated": false, "trend": null, "value": 1.4584535219065151, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001101723.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001101723.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001101723.svg" }, { "company_id": "0001498021", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001498021.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001498021.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001498021_main_keyfigs.svg", "name": "Examworks Group Inc", "rank": 39, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001498021.svg", "report_text": "The relative strengths and weaknesses of Examworks Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Examworks Group Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 59% points.The greatest weakness of Examworks Group Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 68% points.

The company's Economic Capital Ratio, given in the ranking table, is 146%, being 15% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001498021_2012_Examworks_Group_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "8.75", "Liabilities": "-34.9", "Stockholders Equity": "-15.8", "ECR before LimitedLiability": "-8.34", "Property Plant and Equipment": "-21.4", "Assets, Current": "-6.52", "Intangible Assets": "58.6", "Other Liabilities": "-68.4", "Long Term Liabilities": "16.7", "Liabilities, Current": "9.89", "Expenses": "22.6", "Revenues": "22.6", "Net Income": "15.2", "Other Expenses": "33.8", "Operating Costs and Expenses": "7.12", "Labor Expense": "11.3", "Cost of Goods and Services Sold": "-31.2", "Other Revenues": "22.6", "Other Net Income": "-26.7", "Comprehensive Net Income": "15.0", "Economic Capital Ratio": "-15.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001498021_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "159,797", "Assets, Non-Current": "438", "Cost of Goods and Services Sold": "262,242", "Depreciation, Depletion, Amortization": "47,439", "General and Administrative Expense": "84,133", "Goodwill Impairment Loss": "0", "Intangible Assets": "446,428", "Labor Expense": "0", "Liabilities, Current": "90,113", "Long Term Liabilities": "46,040", "Operating Costs and Expenses": "0", "Other Assets": "11,458", "Other Compr. Net Income": "-2,645", "Other Expenses": "-4,082", "Other Liabilities": "252,962", "Other Net Income": "-16,461", "Other Revenues": "397,860", "Property Plant and Equipment": "8,918", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "627,039", "Liabilities": "389,115", "Expenses": "389,732", "Revenues": "397,860", "Stockholders Equity": "237,924", "Net Income": "-8,333", "Comprehensive Net Income": "-10,978", "BaseVar": "911,426", "ECR before LimitedLiability": "66%", "Economic Capital Ratio": "146%" } } }, "top_rated": false, "trend": null, "value": 1.4566760326405754, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001498021.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001498021.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001498021.svg" }, { "company_id": "0000896262", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000896262.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000896262.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000896262.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000896262_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000896262_main_keyfigs.svg", "name": "Amedisys INC", "rank": 40, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000896262.svg", "report_text": "The relative strengths and weaknesses of Amedisys INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Amedisys INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 76% points.The greatest weakness of Amedisys INC is the variable Other Revenues, reducing the Economic Capital Ratio by 74% points.

The company's Economic Capital Ratio, given in the ranking table, is 143%, being 18% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000896262_2012_Amedisys_INC.pdf", "shrinked_graph_json": { "2009": { "Liabilities, Current": "3.61", "Liabilities": "11.3", "Stockholders Equity": "6.14", "ECR before LimitedLiability": "8.16", "Long Term Liabilities": "9.40", "Other Liabilities": "-1.69", "Other Expenses": "-60.9", "Expenses": "-3.17", "Net Income": "1.31", "General and Administrative Expense": "11.3", "Cost of Goods and Services Sold": "57.3", "Labor Expense": "-21.5", "Operating Costs and Expenses": "12.9", "Other Revenues": "-81.2", "Revenues": "-81.2", "Intangible Assets": "7.32", "Assets, Current": "-4.89", "Property Plant and Equipment": "-1.71", "Comprehensive Net Income": "1.31", "Other Net Income": "91.4", "Economic Capital Ratio": "8.57" }, "2010": { "Assets, Current": "-7.22", "Assets": "-16.2", "Liabilities": "47.8", "Stockholders Equity": "-9.62", "ECR before LimitedLiability": "19.8", "Property Plant and Equipment": "-12.4", "Assets, Non-Current": "-2.37", "Intangible Assets": "7.23", "Other Liabilities": "11.5", "Long Term Liabilities": "36.7", "Other Expenses": "-50.4", "Expenses": "-31.3", "Revenues": "-45.4", "Net Income": "-3.37", "Cost of Goods and Services Sold": "15.2", "General and Administrative Expense": "6.96", "Labor Expense": "-16.3", "Operating Costs and Expenses": "12.3", "Other Revenues": "-45.4", "Other Net Income": "76.5", "Economic Capital Ratio": "21.7" }, "2011": { "Assets": "-52.4", "Stockholders Equity": "-43.3", "Economic Capital Ratio": "-17.8", "Property Plant and Equipment": "-28.5", "Assets, Current": "-30.1", "Other Liabilities": "18.4", "Liabilities": "55.7", "Long Term Liabilities": "33.6", "Liabilities, Current": "20.5", "Expenses": "-62.9", "Revenues": "-74.1", "Net Income": "-16.2", "Other Expenses": "-51.6", "Goodwill Impairment Loss": "-65.1", "Operating Costs and Expenses": "15.4", "Labor Expense": "-19.8", "General and Administrative Expense": "41.8", "Cost of Goods and Services Sold": "15.3", "Other Revenues": "-74.1", "Other Net Income": "75.6", "Comprehensive Net Income": "-15.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000896262_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "218,036", "Assets, Non-Current": "17,865", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "28,312", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "844,531", "Labor Expense": "327,738", "Liabilities, Current": "229,306", "Long Term Liabilities": "177,311", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,012,832", "Other Liabilities": "29,399", "Other Net Income": "1,505,105", "Other Revenues": "0", "Property Plant and Equipment": "91,919", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,172,351", "Liabilities": "436,016", "Expenses": "1,368,882", "Revenues": "0", "Stockholders Equity": "736,335", "Net Income": "136,223", "Comprehensive Net Income": "136,223", "BaseVar": "2,241,177", "ECR before LimitedLiability": "150%", "Economic Capital Ratio": "205%" } }, "2010": { "input_variables": { "Assets, Current": "293,930", "Assets, Non-Current": "22,536", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "34,589", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "844,805", "Labor Expense": "357,502", "Liabilities, Current": "216,304", "Long Term Liabilities": "151,520", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,121,027", "Other Liabilities": "52,286", "Other Net Income": "1,626,391", "Other Revenues": "0", "Property Plant and Equipment": "138,554", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,299,825", "Liabilities": "420,110", "Expenses": "1,513,118", "Revenues": "0", "Stockholders Equity": "879,715", "Net Income": "113,273", "Comprehensive Net Income": "113,273", "BaseVar": "2,429,722", "ECR before LimitedLiability": "162%", "Economic Capital Ratio": "212%" } }, "2011": { "input_variables": { "Assets, Current": "232,016", "Assets, Non-Current": "24,322", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "579,955", "Intangible Assets": "384,762", "Labor Expense": "333,190", "Liabilities, Current": "221,734", "Long Term Liabilities": "116,403", "Operating Costs and Expenses": "0", "Other Assets": "68,649", "Other Compr. Net Income": "0", "Other Expenses": "924,653", "Other Liabilities": "0", "Other Net Income": "1,455,456", "Other Revenues": "0", "Property Plant and Equipment": "148,536", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "858,285", "Liabilities": "338,137", "Expenses": "1,837,798", "Revenues": "0", "Stockholders Equity": "520,148", "Net Income": "-382,342", "Comprehensive Net Income": "-382,342", "BaseVar": "2,244,838", "ECR before LimitedLiability": "62%", "Economic Capital Ratio": "143%" } } }, "top_rated": false, "trend": -34.0, "value": 1.4285584837403504, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000896262.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000896262.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000896262.svg" }, { "company_id": "0000927066", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000927066.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000927066.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000927066.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000927066_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000927066_main_keyfigs.svg", "name": "Davita INC", "rank": 41, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000927066.svg", "report_text": "The relative strengths and weaknesses of Davita INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Davita INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Davita INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 58% points.

The company's Economic Capital Ratio, given in the ranking table, is 142%, being 19% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000927066_2012_Davita_INC.pdf", "shrinked_graph_json": { "2009": { "Assets": "17.8", "Stockholders Equity": "-20.5", "ECR before LimitedLiability": "-50.7", "Assets, Current": "9.43", "Property Plant and Equipment": "6.46", "Liabilities, Current": "6.74", "Liabilities": "-56.3", "Long Term Liabilities": "-57.8", "Other Liabilities": "-5.71", "Other Expenses": "12.6", "Expenses": "20.6", "Revenues": "-56.5", "Net Income": "-2.14", "General and Administrative Expense": "2.71", "Cost of Goods and Services Sold": "49.5", "Labor Expense": "4.46", "Operating Costs and Expenses": "-38.9", "Other Revenues": "-56.5", "Comprehensive Net Income": "-2.14", "Other Net Income": "45.1", "Economic Capital Ratio": "-50.3" }, "2010": { "Assets, Current": "2.37", "Assets": "-13.2", "Liabilities": "-36.4", "Stockholders Equity": "-43.0", "ECR before LimitedLiability": "-53.1", "Property Plant and Equipment": "-14.1", "Assets, Non-Current": "-4.65", "Intangible Assets": "6.02", "Other Liabilities": "4.18", "Liabilities, Current": "6.13", "Long Term Liabilities": "-48.4", "Other Revenues": "-33.4", "Revenues": "-33.4", "Net Income": "-4.20", "Other Expenses": "24.1", "Comprehensive Net Income": "-3.16", "Cost of Goods and Services Sold": "12.8", "Labor Expense": "9.39", "Operating Costs and Expenses": "-38.6", "Other Net Income": "33.7", "Economic Capital Ratio": "-51.3" }, "2011": { "Liabilities": "-38.6", "Stockholders Equity": "-30.3", "ECR before LimitedLiability": "-12.4", "Long Term Liabilities": "-58.4", "Liabilities, Current": "15.0", "Expenses": "20.4", "Net Income": "24.5", "Other Expenses": "26.7", "Operating Costs and Expenses": "-38.7", "Labor Expense": "12.2", "General and Administrative Expense": "12.3", "Cost of Goods and Services Sold": "7.62", "Other Revenues": "-39.2", "Revenues": "-39.2", "Property Plant and Equipment": "-11.5", "Assets, Current": "-9.38", "Assets, Non-Current": "-5.16", "Intangible Assets": "36.5", "Other Net Income": "51.7", "Comprehensive Net Income": "24.7", "Economic Capital Ratio": "-19.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000927066_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "2,302,521", "Assets, Non-Current": "32,615", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "228,986", "General and Administrative Expense": "531,531", "Goodwill Impairment Loss": "0", "Intangible Assets": "4,087,928", "Labor Expense": "0", "Liabilities, Current": "1,046,941", "Long Term Liabilities": "3,619,909", "Operating Costs and Expenses": "4,248,668", "Other Assets": "30,247", "Other Compr. Net Income": "0", "Other Expenses": "623,564", "Other Liabilities": "365,502", "Other Net Income": "6,108,800", "Other Revenues": "3,708", "Property Plant and Equipment": "1,104,925", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "7,558,236", "Liabilities": "5,032,352", "Expenses": "5,632,749", "Revenues": "3,708", "Stockholders Equity": "2,525,884", "Net Income": "479,759", "Comprehensive Net Income": "479,759", "BaseVar": "12,167,922", "ECR before LimitedLiability": "66%", "Economic Capital Ratio": "146%" } }, "2010": { "input_variables": { "Assets, Current": "2,622,854", "Assets, Non-Current": "32,054", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "234,378", "General and Administrative Expense": "579,000", "Goodwill Impairment Loss": "0", "Intangible Assets": "4,253,942", "Labor Expense": "0", "Liabilities, Current": "924,345", "Long Term Liabilities": "4,323,140", "Operating Costs and Expenses": "4,474,735", "Other Assets": "34,766", "Other Compr. Net Income": "0", "Other Expenses": "678,479", "Other Liabilities": "446,753", "Other Net Income": "6,447,391", "Other Revenues": "3,420", "Property Plant and Equipment": "1,170,808", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "8,114,424", "Liabilities": "5,694,238", "Expenses": "5,966,592", "Revenues": "3,420", "Stockholders Equity": "2,420,186", "Net Income": "484,219", "Comprehensive Net Income": "484,219", "BaseVar": "13,113,032", "ECR before LimitedLiability": "58%", "Economic Capital Ratio": "139%" } }, "2011": { "input_variables": { "Assets, Current": "2,281,608", "Assets, Non-Current": "34,231", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "266,628", "General and Administrative Expense": "691,243", "Goodwill Impairment Loss": "24,000", "Intangible Assets": "5,106,467", "Labor Expense": "0", "Liabilities, Current": "1,153,116", "Long Term Liabilities": "4,549,630", "Operating Costs and Expenses": "4,680,772", "Other Assets": "37,215", "Other Compr. Net Income": "0", "Other Expenses": "745,623", "Other Liabilities": "443,085", "Other Net Income": "6,978,679", "Other Revenues": "2,982", "Property Plant and Equipment": "1,432,651", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "8,892,172", "Liabilities": "6,145,831", "Expenses": "6,408,266", "Revenues": "2,982", "Stockholders Equity": "2,746,341", "Net Income": "573,395", "Comprehensive Net Income": "573,395", "BaseVar": "14,213,965", "ECR before LimitedLiability": "61%", "Economic Capital Ratio": "142%" } } }, "top_rated": false, "trend": -28.0, "value": 1.4160504173010207, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000927066.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000927066.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000927066.svg" }, { "company_id": "0000320017", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000320017.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000320017.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000320017.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000320017_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000320017_main_keyfigs.svg", "name": "Lisata Therapeutics INC", "rank": 42, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000320017.svg", "report_text": "The relative strengths and weaknesses of Lisata Therapeutics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Lisata Therapeutics INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Lisata Therapeutics INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 30% points.

The company's Economic Capital Ratio, given in the ranking table, is 140%, being 20% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000320017_2012_Lisata_Therapeutics_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "17.3", "Stockholders Equity": "12.2", "ECR before LimitedLiability": "-13.7", "Property Plant and Equipment": "10.7", "Intangible Assets": "13.3", "Other Liabilities": "9.47", "Liabilities": "-8.98", "Long Term Liabilities": "-10.5", "Liabilities, Current": "-8.21", "Other Revenues": "9.29", "Revenues": "9.29", "Net Income": "-21.7", "Comprehensive Net Income": "-21.5", "Other Net Income": "-27.4", "Other Expenses": "35.9", "Goodwill Impairment Loss": "-11.8", "Operating Costs and Expenses": "7.75", "Labor Expense": "12.3", "General and Administrative Expense": "-9.88", "Cost of Goods and Services Sold": "-30.1", "Economic Capital Ratio": "-20.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000320017_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "38,610", "Assets, Non-Current": "5,936", "Cost of Goods and Services Sold": "55,974", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "41,845", "Goodwill Impairment Loss": "19,433", "Intangible Assets": "56,546", "Labor Expense": "0", "Liabilities, Current": "36,445", "Long Term Liabilities": "33,938", "Operating Costs and Expenses": "0", "Other Assets": "4,872", "Other Compr. Net Income": "0", "Other Expenses": "393", "Other Liabilities": "0", "Other Net Income": "-1,653", "Other Revenues": "73,718", "Property Plant and Equipment": "49,363", "Research And Development Expense": "11,003", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "155,328", "Liabilities": "70,384", "Expenses": "128,648", "Revenues": "73,718", "Stockholders Equity": "84,944", "Net Income": "-56,583", "Comprehensive Net Income": "-56,583", "BaseVar": "214,865", "ECR before LimitedLiability": "59%", "Economic Capital Ratio": "140%" } } }, "top_rated": false, "trend": null, "value": 1.4033866072242027, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000320017.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000320017.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000320017.svg" }, { "company_id": "0000776325", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000776325.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000776325.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000776325_main_keyfigs.svg", "name": "RES CARE INC KY", "rank": 43, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000776325.svg", "report_text": "The relative strengths and weaknesses of RES CARE INC KY are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of RES CARE INC KY compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 56% points.The greatest weakness of RES CARE INC KY is the variable Stockholders Equity, reducing the Economic Capital Ratio by 64% points.

The company's Economic Capital Ratio, given in the ranking table, is 139%, being 21% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000776325_2012_RES_CARE_INC_KY.pdf", "shrinked_graph_json": { "2011": { "Assets": "-41.0", "Stockholders Equity": "-63.6", "Long Term Liabilities": "-23.1", "ECR before LimitedLiability": "-14.7", "Property Plant and Equipment": "-28.8", "Assets, Current": "-21.2", "Assets, Non-Current": "-5.60", "Intangible Assets": "14.3", "Expenses": "-9.75", "Revenues": "56.1", "Net Income": "33.4", "Other Expenses": "-62.5", "Operating Costs and Expenses": "11.7", "Labor Expense": "18.8", "General and Administrative Expense": "7.61", "Cost of Goods and Services Sold": "11.7", "Other Revenues": "56.1", "Liabilities, Current": "25.5", "Other Net Income": "-41.1", "Comprehensive Net Income": "33.8", "Economic Capital Ratio": "-21.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000776325_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "297,056", "Assets, Non-Current": "27,658", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "229,254", "Goodwill Impairment Loss": "0", "Intangible Assets": "582,651", "Labor Expense": "0", "Liabilities, Current": "174,337", "Long Term Liabilities": "420,054", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,266,186", "Other Liabilities": "98,912", "Other Net Income": "-30,903", "Other Revenues": "1,579,335", "Property Plant and Equipment": "84,893", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "992,258", "Liabilities": "693,303", "Expenses": "1,495,440", "Revenues": "1,579,335", "Stockholders Equity": "298,955", "Net Income": "52,992", "Comprehensive Net Income": "52,992", "BaseVar": "2,395,620", "ECR before LimitedLiability": "58%", "Economic Capital Ratio": "139%" } } }, "top_rated": false, "trend": null, "value": 1.3931369389701436, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000776325.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000776325.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000776325.svg" }, { "company_id": "0001035688", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001035688.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001035688.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001035688_main_keyfigs.svg", "name": "Select Medical CORP", "rank": 44, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001035688.svg", "report_text": "The relative strengths and weaknesses of Select Medical CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Select Medical CORP compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Select Medical CORP is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 55% points.

The company's Economic Capital Ratio, given in the ranking table, is 139%, being 21% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001035688_2012_Select_Medical_CORP.pdf", "shrinked_graph_json": { "2011": { "Assets": "-15.7", "Liabilities": "-26.4", "Stockholders Equity": "-40.0", "ECR before LimitedLiability": "-14.7", "Property Plant and Equipment": "-13.3", "Assets, Current": "-21.0", "Intangible Assets": "36.6", "Long Term Liabilities": "-55.2", "Liabilities, Current": "18.6", "Expenses": "9.70", "Revenues": "-44.8", "Net Income": "25.0", "Other Expenses": "-44.3", "Operating Costs and Expenses": "8.86", "Labor Expense": "14.1", "General and Administrative Expense": "21.1", "Cost of Goods and Services Sold": "8.82", "Other Revenues": "-44.8", "Other Net Income": "52.7", "Comprehensive Net Income": "25.3", "Economic Capital Ratio": "-21.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001035688_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "483,410", "Assets, Non-Current": "72,128", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "71,517", "General and Administrative Expense": "62,354", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,703,839", "Labor Expense": "0", "Liabilities, Current": "383,938", "Long Term Liabilities": "1,450,855", "Operating Costs and Expenses": "0", "Other Assets": "2,742", "Other Compr. Net Income": "0", "Other Expenses": "2,530,101", "Other Liabilities": "82,028", "Other Net Income": "2,776,734", "Other Revenues": "0", "Property Plant and Equipment": "510,028", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,772,147", "Liabilities": "1,916,821", "Expenses": "2,663,972", "Revenues": "0", "Stockholders Equity": "855,326", "Net Income": "112,762", "Comprehensive Net Income": "112,762", "BaseVar": "5,064,837", "ECR before LimitedLiability": "58%", "Economic Capital Ratio": "139%" } } }, "top_rated": false, "trend": null, "value": 1.3930279569121042, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001035688.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001035688.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001035688.svg" }, { "company_id": "0001320414", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001320414.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001320414.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001320414.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001320414_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001320414_main_keyfigs.svg", "name": "Select Medical Holdings Corp", "rank": 44, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001320414.svg", "report_text": "The relative strengths and weaknesses of Select Medical Holdings Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Select Medical Holdings Corp compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Select Medical Holdings Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 55% points.

The company's Economic Capital Ratio, given in the ranking table, is 139%, being 21% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001320414_2012_Select_Medical_Holdings_Corp.pdf", "shrinked_graph_json": { "2011": { "Assets": "-15.7", "Liabilities": "-26.4", "Stockholders Equity": "-40.0", "ECR before LimitedLiability": "-14.7", "Property Plant and Equipment": "-13.3", "Assets, Current": "-21.0", "Intangible Assets": "36.6", "Long Term Liabilities": "-55.2", "Liabilities, Current": "18.6", "Expenses": "9.70", "Revenues": "-44.8", "Net Income": "25.0", "Other Expenses": "-44.3", "Operating Costs and Expenses": "8.86", "Labor Expense": "14.1", "General and Administrative Expense": "21.1", "Cost of Goods and Services Sold": "8.82", "Other Revenues": "-44.8", "Other Net Income": "52.7", "Comprehensive Net Income": "25.3", "Economic Capital Ratio": "-21.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001320414_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "483,410", "Assets, Non-Current": "72,128", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "71,517", "General and Administrative Expense": "62,354", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,703,839", "Labor Expense": "0", "Liabilities, Current": "383,938", "Long Term Liabilities": "1,450,855", "Operating Costs and Expenses": "0", "Other Assets": "2,742", "Other Compr. Net Income": "0", "Other Expenses": "2,530,101", "Other Liabilities": "82,028", "Other Net Income": "2,776,734", "Other Revenues": "0", "Property Plant and Equipment": "510,028", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,772,147", "Liabilities": "1,916,821", "Expenses": "2,663,972", "Revenues": "0", "Stockholders Equity": "855,326", "Net Income": "112,762", "Comprehensive Net Income": "112,762", "BaseVar": "5,064,837", "ECR before LimitedLiability": "58%", "Economic Capital Ratio": "139%" } } }, "top_rated": false, "trend": null, "value": 1.3930279569121042, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001320414.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001320414.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001320414.svg" }, { "company_id": "0001014739", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001014739.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001014739.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001014739.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001014739_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001014739_main_keyfigs.svg", "name": "Option Care Health Inc", "rank": 46, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001014739.svg", "report_text": "The relative strengths and weaknesses of Option Care Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Option Care Health Inc compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 81% points.The greatest weakness of Option Care Health Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 175% points.

The company's Economic Capital Ratio, given in the ranking table, is 138%, being 23% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001014739_2012_Option_Care_Health_Inc.pdf", "shrinked_graph_json": { "2009": { "Other Assets": "4.70", "Assets": "-57.7", "Liabilities": "107", "Stockholders Equity": "-159", "Economic Capital Ratio": "-1.96", "Intangible Assets": "-55.1", "Property Plant and Equipment": "-14.2", "Liabilities, Current": "25.4", "Long Term Liabilities": "88.0", "Other Liabilities": "7.32", "Other Expenses": "31.8", "Expenses": "-132", "Revenues": "156", "Net Income": "-8.53", "General and Administrative Expense": "30.6", "Cost of Goods and Services Sold": "-288", "Labor Expense": "14.2", "Operating Costs and Expenses": "35.0", "Depreciation, Depletion, Amortization": "3.03", "Other Revenues": "156", "Comprehensive Net Income": "-8.53", "Other Net Income": "-120" }, "2011": { "Assets": "-70.2", "Liabilities": "50.7", "Stockholders Equity": "-106", "ECR before LimitedLiability": "-15.9", "Property Plant and Equipment": "-43.5", "Assets, Current": "-29.7", "Intangible Assets": "-16.6", "Other Liabilities": "18.2", "Liabilities, Current": "26.3", "Expenses": "-54.1", "Revenues": "81.4", "Net Income": "43.5", "Other Expenses": "33.4", "Operating Costs and Expenses": "17.6", "Labor Expense": "28.4", "General and Administrative Expense": "48.2", "Cost of Goods and Services Sold": "-175", "Other Revenues": "81.4", "Other Net Income": "-55.5", "Comprehensive Net Income": "44.1", "Economic Capital Ratio": "-22.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001014739_strength_weakness.svg", "table_records": { "2009": { "input_variables": { "Assets, Current": "219,281", "Assets, Non-Current": "1,194", "Cost of Goods and Services Sold": "1,171,703", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "24,498", "Labor Expense": "0", "Liabilities, Current": "128,203", "Long Term Liabilities": "787", "Operating Costs and Expenses": "0", "Other Assets": "26,793", "Other Compr. Net Income": "0", "Other Expenses": "103,723", "Other Liabilities": "2,437", "Other Net Income": "0", "Other Revenues": "1,329,525", "Property Plant and Equipment": "15,454", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "287,220", "Liabilities": "131,427", "Expenses": "1,275,426", "Revenues": "1,329,525", "Stockholders Equity": "155,793", "Net Income": "54,099", "Comprehensive Net Income": "54,099", "BaseVar": "1,511,799", "ECR before LimitedLiability": "134%", "Economic Capital Ratio": "194%" } }, "2011": { "input_variables": { "Assets, Current": "292,469", "Assets, Non-Current": "1,830", "Cost of Goods and Services Sold": "1,505,723", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "349,367", "Labor Expense": "0", "Liabilities, Current": "220,774", "Long Term Liabilities": "230,754", "Operating Costs and Expenses": "0", "Other Assets": "3,992", "Other Compr. Net Income": "0", "Other Expenses": "304,431", "Other Liabilities": "10,295", "Other Net Income": "0", "Other Revenues": "1,818,026", "Property Plant and Equipment": "29,444", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "677,102", "Liabilities": "461,823", "Expenses": "1,810,154", "Revenues": "1,818,026", "Stockholders Equity": "215,279", "Net Income": "7,872", "Comprehensive Net Income": "7,872", "BaseVar": "2,383,552", "ECR before LimitedLiability": "56%", "Economic Capital Ratio": "138%" } } }, "top_rated": false, "trend": null, "value": 1.380843667582125, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001014739.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001014739.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001014739.svg" }, { "company_id": "0000785161", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000785161.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000785161.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000785161.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000785161_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000785161_main_keyfigs.svg", "name": "Encompass Health Corp", "rank": 47, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000785161.svg", "report_text": "The relative strengths and weaknesses of Encompass Health Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Encompass Health Corp compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 49% points.The greatest weakness of Encompass Health Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 72% points.

The company's Economic Capital Ratio, given in the ranking table, is 136%, being 25% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000785161_2012_Encompass_Health_Corp.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-10.5", "Assets": "-8.75", "Liabilities": "-60.9", "Stockholders Equity": "-51.3", "ECR before LimitedLiability": "-45.9", "Other Assets": "33.0", "Intangible Assets": "-20.3", "Other Liabilities": "3.47", "Long Term Liabilities": "-64.7", "Other Expenses": "10.6", "Expenses": "24.6", "Revenues": "-29.4", "Net Income": "26.5", "Cost of Goods and Services Sold": "11.1", "Labor Expense": "8.14", "Operating Costs and Expenses": "-5.68", "Depreciation, Depletion, Amortization": "-1.30", "Other Revenues": "-29.4", "Comprehensive Net Income": "25.9", "Other Net Income": "35.6", "Economic Capital Ratio": "-44.1" }, "2011": { "Other Assets": "35.7", "Assets": "-10.1", "Liabilities": "-39.6", "Stockholders Equity": "-41.1", "ECR before LimitedLiability": "-17.9", "Assets, Current": "-19.6", "Intangible Assets": "-12.6", "Other Liabilities": "9.91", "Long Term Liabilities": "-72.2", "Liabilities, Current": "16.2", "Expenses": "20.8", "Revenues": "-41.9", "Net Income": "31.0", "Other Expenses": "-14.4", "Labor Expense": "13.1", "General and Administrative Expense": "16.9", "Cost of Goods and Services Sold": "8.22", "Other Revenues": "-41.9", "Other Net Income": "49.0", "Comprehensive Net Income": "29.0", "Economic Capital Ratio": "-24.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000785161_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "406,200", "Assets, Non-Current": "90,400", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "76,400", "General and Administrative Expense": "106,200", "Goodwill Impairment Loss": "0", "Intangible Assets": "480,100", "Labor Expense": "0", "Liabilities, Current": "359,300", "Long Term Liabilities": "1,496,800", "Operating Costs and Expenses": "407,700", "Other Assets": "710,000", "Other Compr. Net Income": "-40,300", "Other Expenses": "457,600", "Other Liabilities": "130,800", "Other Net Income": "1,987,700", "Other Revenues": "0", "Property Plant and Equipment": "685,400", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,372,100", "Liabilities": "1,986,900", "Expenses": "1,047,900", "Revenues": "0", "Stockholders Equity": "385,200", "Net Income": "939,800", "Comprehensive Net Income": "899,500", "BaseVar": "3,717,450", "ECR before LimitedLiability": "67%", "Economic Capital Ratio": "147%" } }, "2011": { "input_variables": { "Assets, Current": "391,000", "Assets, Non-Current": "99,300", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "78,800", "General and Administrative Expense": "110,500", "Goodwill Impairment Loss": "0", "Intangible Assets": "479,400", "Labor Expense": "0", "Liabilities, Current": "313,200", "Long Term Liabilities": "1,369,000", "Operating Costs and Expenses": "386,800", "Other Assets": "637,100", "Other Compr. Net Income": "-46,600", "Other Expenses": "1,220,900", "Other Liabilities": "0", "Other Net Income": "2,051,600", "Other Revenues": "0", "Property Plant and Equipment": "664,400", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,271,200", "Liabilities": "1,682,200", "Expenses": "1,797,000", "Revenues": "0", "Stockholders Equity": "589,000", "Net Income": "254,600", "Comprehensive Net Income": "208,000", "BaseVar": "3,924,300", "ECR before LimitedLiability": "54%", "Economic Capital Ratio": "136%" } } }, "top_rated": false, "trend": -35.0, "value": 1.3607874760962173, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000785161.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000785161.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000785161.svg" }, { "company_id": "0001360474", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001360474.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001360474.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001360474_main_keyfigs.svg", "name": "CRC Health LLC", "rank": 48, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001360474.svg", "report_text": "The relative strengths and weaknesses of CRC Health LLC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of CRC Health LLC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 48% points.The greatest weakness of CRC Health LLC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 77% points.

The company's Economic Capital Ratio, given in the ranking table, is 127%, being 34% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001360474_2012_CRC_Health_LLC.pdf", "shrinked_graph_json": { "2011": { "Assets": "29.8", "Liabilities": "-67.6", "Stockholders Equity": "-23.1", "ECR before LimitedLiability": "-26.9", "Property Plant and Equipment": "-10.6", "Assets, Current": "-21.5", "Intangible Assets": "48.3", "Other Liabilities": "-11.6", "Long Term Liabilities": "-77.4", "Liabilities, Current": "18.5", "Expenses": "36.9", "Revenues": "-32.1", "Net Income": "14.5", "Other Expenses": "25.6", "Operating Costs and Expenses": "-6.43", "Labor Expense": "-9.74", "General and Administrative Expense": "16.2", "Other Revenues": "-32.1", "Other Net Income": "14.9", "Comprehensive Net Income": "14.9", "Economic Capital Ratio": "-33.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001360474_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "65,859", "Assets, Non-Current": "21,119", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "19,730", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "825,139", "Labor Expense": "208,472", "Liabilities, Current": "59,206", "Long Term Liabilities": "594,629", "Operating Costs and Expenses": "134,486", "Other Assets": "0", "Other Compr. Net Income": "2,106", "Other Expenses": "26,863", "Other Liabilities": "120,168", "Other Net Income": "392,091", "Other Revenues": "0", "Property Plant and Equipment": "126,840", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,038,957", "Liabilities": "774,003", "Expenses": "389,551", "Revenues": "0", "Stockholders Equity": "264,954", "Net Income": "2,540", "Comprehensive Net Income": "4,646", "BaseVar": "1,298,354", "ECR before LimitedLiability": "43%", "Economic Capital Ratio": "127%" } } }, "top_rated": false, "trend": null, "value": 1.270584907774503, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001360474.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001360474.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001360474.svg" }, { "company_id": "0000919956", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000919956.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000919956.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000919956.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000919956_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000919956_main_keyfigs.svg", "name": "Diversicare Healthcare Services Inc", "rank": 49, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000919956.svg", "report_text": "The relative strengths and weaknesses of Diversicare Healthcare Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Diversicare Healthcare Services Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 83% points.The greatest weakness of Diversicare Healthcare Services Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 129% points.

The company's Economic Capital Ratio, given in the ranking table, is 124%, being 36% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000919956_2012_Diversicare_Healthcare_Services_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-76.5", "Liabilities": "37.0", "Stockholders Equity": "-114", "ECR before LimitedLiability": "-29.6", "Property Plant and Equipment": "-22.2", "Assets, Current": "-36.0", "Intangible Assets": "-53.8", "Other Liabilities": "20.1", "Liabilities, Current": "36.5", "Expenses": "-52.1", "Revenues": "-83.1", "Net Income": "37.0", "Other Expenses": "-129", "Operating Costs and Expenses": "18.0", "Labor Expense": "29.1", "General and Administrative Expense": "24.4", "Cost of Goods and Services Sold": "18.0", "Other Revenues": "-83.1", "Other Net Income": "83.1", "Comprehensive Net Income": "37.0", "Economic Capital Ratio": "-36.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000919956_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "45,320", "Assets, Non-Current": "24,346", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "6,592", "General and Administrative Expense": "25,589", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "29,885", "Long Term Liabilities": "58,972", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "-945", "Other Expenses": "278,683", "Other Liabilities": "0", "Other Net Income": "312,231", "Other Revenues": "0", "Property Plant and Equipment": "47,078", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "116,744", "Liabilities": "88,857", "Expenses": "310,864", "Revenues": "0", "Stockholders Equity": "27,887", "Net Income": "1,367", "Comprehensive Net Income": "422", "BaseVar": "414,820", "ECR before LimitedLiability": "40%", "Economic Capital Ratio": "124%" } } }, "top_rated": false, "trend": null, "value": 1.2436626831911848, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000919956.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000919956.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000919956.svg" }, { "company_id": "0000895665", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000895665.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000895665.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000895665.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000895665_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000895665_main_keyfigs.svg", "name": "Clearday Inc", "rank": 50, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000895665.svg", "report_text": "The relative strengths and weaknesses of Clearday Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Clearday Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Clearday Inc is the variable Net Income, reducing the Economic Capital Ratio by 110% points.

The company's Economic Capital Ratio, given in the ranking table, is 123%, being 38% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000895665_2012_Clearday_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "28.2", "Liabilities": "36.8", "Stockholders Equity": "42.3", "ECR before LimitedLiability": "-30.9", "Assets, Current": "43.9", "Intangible Assets": "-25.3", "Long Term Liabilities": "35.7", "Liabilities, Current": "24.9", "Expenses": "-69.0", "Revenues": "-14.6", "Net Income": "-110", "Research And Development Expense": "-52.8", "Other Expenses": "-18.2", "Operating Costs and Expenses": "10.7", "Labor Expense": "17.1", "General and Administrative Expense": "-43.0", "Cost of Goods and Services Sold": "10.7", "Other Revenues": "-14.6", "Other Net Income": "-35.3", "Comprehensive Net Income": "-110", "Economic Capital Ratio": "-37.5" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000895665_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "8,307", "Assets, Non-Current": "362", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "6,322", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,409", "Labor Expense": "0", "Liabilities, Current": "1,146", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "5,526", "Other Liabilities": "628", "Other Net Income": "22", "Other Revenues": "3,768", "Property Plant and Equipment": "2,871", "Research And Development Expense": "5,325", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "12,949", "Liabilities": "1,774", "Expenses": "17,173", "Revenues": "3,768", "Stockholders Equity": "11,175", "Net Income": "-13,383", "Comprehensive Net Income": "-13,383", "BaseVar": "17,843", "ECR before LimitedLiability": "38%", "Economic Capital Ratio": "123%" } } }, "top_rated": false, "trend": null, "value": 1.23135252298004, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000895665.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000895665.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000895665.svg" }, { "company_id": "0001332349", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001332349.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001332349.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001332349.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001332349_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001332349_main_keyfigs.svg", "name": "Brookdale Senior Living Inc", "rank": 51, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001332349.svg", "report_text": "The relative strengths and weaknesses of Brookdale Senior Living Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Brookdale Senior Living Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Brookdale Senior Living Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 67% points.

The company's Economic Capital Ratio, given in the ranking table, is 122%, being 39% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001332349_2012_Brookdale_Senior_Living_Inc.pdf", "shrinked_graph_json": { "2010": { "Liabilities": "-60.8", "Stockholders Equity": "-40.8", "ECR before LimitedLiability": "-70.3", "Long Term Liabilities": "-58.8", "Other Expenses": "-29.0", "Expenses": "13.3", "Revenues": "16.7", "Net Income": "-9.61", "Cost of Goods and Services Sold": "11.3", "General and Administrative Expense": "8.07", "Labor Expense": "8.30", "Operating Costs and Expenses": "9.17", "Depreciation, Depletion, Amortization": "7.93", "Other Revenues": "16.7", "Assets, Current": "-19.9", "Property Plant and Equipment": "47.3", "Other Assets": "4.64", "Intangible Assets": "-35.7", "Comprehensive Net Income": "-8.71", "Other Net Income": "-35.9", "Economic Capital Ratio": "-68.5" }, "2011": { "Assets": "11.2", "Liabilities": "-59.9", "Stockholders Equity": "-34.3", "ECR before LimitedLiability": "-32.4", "Property Plant and Equipment": "46.7", "Assets, Current": "-26.1", "Intangible Assets": "-26.3", "Long Term Liabilities": "-67.0", "Liabilities, Current": "9.76", "Expenses": "28.8", "Revenues": "14.4", "Net Income": "15.1", "Other Expenses": "-14.5", "Operating Costs and Expenses": "7.21", "Labor Expense": "11.5", "General and Administrative Expense": "15.5", "Cost of Goods and Services Sold": "7.19", "Other Revenues": "14.4", "Other Net Income": "-25.0", "Comprehensive Net Income": "15.4", "Economic Capital Ratio": "-39.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001332349_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "328,109", "Assets, Non-Current": "98,973", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "-292,341", "General and Administrative Expense": "-131,709", "Goodwill Impairment Loss": "0", "Intangible Assets": "109,693", "Labor Expense": "0", "Liabilities, Current": "606,358", "Long Term Liabilities": "2,527,885", "Operating Costs and Expenses": "0", "Other Assets": "256,853", "Other Compr. Net Income": "0", "Other Expenses": "2,681,492", "Other Liabilities": "336,230", "Other Net Income": "-4,723", "Other Revenues": "2,213,264", "Property Plant and Equipment": "3,736,842", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "4,530,470", "Liabilities": "3,470,473", "Expenses": "2,257,442", "Revenues": "2,213,264", "Stockholders Equity": "1,059,997", "Net Income": "-48,901", "Comprehensive Net Income": "-48,901", "BaseVar": "6,238,186", "ECR before LimitedLiability": "37%", "Economic Capital Ratio": "122%" } }, "2011": { "input_variables": { "Assets, Current": "280,875", "Assets, Non-Current": "109,934", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "268,506", "General and Administrative Expense": "148,327", "Goodwill Impairment Loss": "0", "Intangible Assets": "109,553", "Labor Expense": "0", "Liabilities, Current": "620,950", "Long Term Liabilities": "2,458,497", "Operating Costs and Expenses": "0", "Other Assets": "271,635", "Other Compr. Net Income": "0", "Other Expenses": "2,091,545", "Other Liabilities": "346,406", "Other Net Income": "-17,715", "Other Revenues": "2,457,918", "Property Plant and Equipment": "3,694,064", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "4,466,061", "Liabilities": "3,425,853", "Expenses": "2,508,378", "Revenues": "2,457,918", "Stockholders Equity": "1,040,208", "Net Income": "-68,175", "Comprehensive Net Income": "-68,175", "BaseVar": "6,437,962", "ECR before LimitedLiability": "36%", "Economic Capital Ratio": "122%" } } }, "top_rated": false, "trend": -37.0, "value": 1.2155478051231854, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001332349.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001332349.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001332349.svg" }, { "company_id": "0001300524", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001300524.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001300524.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001300524.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001300524_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001300524_main_keyfigs.svg", "name": "American International Holdings CORP", "rank": 52, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001300524.svg", "report_text": "The relative strengths and weaknesses of American International Holdings CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of American International Holdings CORP compared to the market average is the variable General and Administrative Expense, increasing the Economic Capital Ratio by 64% points.The greatest weakness of American International Holdings CORP is the variable Other Expenses, reducing the Economic Capital Ratio by 342% points.

The company's Economic Capital Ratio, given in the ranking table, is 120%, being 40% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001300524_2012_American_International_Holdings_CORP.pdf", "shrinked_graph_json": { "2011": { "Assets": "-67.2", "Stockholders Equity": "-94.5", "ECR before LimitedLiability": "-33.7", "Property Plant and Equipment": "-22.5", "Intangible Assets": "-50.5", "Other Liabilities": "17.5", "Liabilities": "23.9", "Long Term Liabilities": "33.5", "Liabilities, Current": "-54.7", "Expenses": "-39.4", "Revenues": "52.7", "Net Income": "29.9", "Other Expenses": "-342", "Operating Costs and Expenses": "15.8", "Labor Expense": "25.4", "General and Administrative Expense": "64.1", "Cost of Goods and Services Sold": "48.3", "Other Revenues": "52.7", "Other Net Income": "-50.7", "Comprehensive Net Income": "30.4", "Economic Capital Ratio": "-40.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001300524_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "3,577", "Assets, Non-Current": "6.5", "Cost of Goods and Services Sold": "-5,276", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "-6,270", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "3,880", "Long Term Liabilities": "50", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "23,150", "Other Liabilities": "0", "Other Net Income": "-41", "Other Revenues": "11,293", "Property Plant and Equipment": "1,701", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "5,285", "Liabilities": "3,929", "Expenses": "11,603", "Revenues": "11,293", "Stockholders Equity": "1,356", "Net Income": "-351", "Comprehensive Net Income": "-351", "BaseVar": "16,076", "ECR before LimitedLiability": "35%", "Economic Capital Ratio": "120%" } } }, "top_rated": false, "trend": null, "value": 1.2028258922027333, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001300524.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001300524.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001300524.svg" }, { "company_id": "0001108109", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001108109.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001108109.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001108109.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001108109_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001108109_main_keyfigs.svg", "name": "Community Health System Inc", "rank": 53, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001108109.svg", "report_text": "The relative strengths and weaknesses of Community Health System Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Community Health System Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 32% points.The greatest weakness of Community Health System Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 75% points.

The company's Economic Capital Ratio, given in the ranking table, is 118%, being 43% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001108109_2012_Community_Health_System_Inc.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-15.7", "Assets": "-26.4", "Liabilities": "-46.3", "Stockholders Equity": "-65.0", "ECR before LimitedLiability": "-75.6", "Property Plant and Equipment": "17.0", "Intangible Assets": "-24.9", "Other Liabilities": "7.40", "Liabilities, Current": "8.63", "Long Term Liabilities": "-65.4", "Other Expenses": "5.75", "Expenses": "-4.46", "Revenues": "-37.7", "Net Income": "-8.79", "Cost of Goods and Services Sold": "14.6", "General and Administrative Expense": "6.62", "Labor Expense": "-23.1", "Other Revenues": "-37.7", "Comprehensive Net Income": "-7.62", "Other Net Income": "29.6", "Economic Capital Ratio": "-73.8" }, "2011": { "Assets": "-15.5", "Liabilities": "-48.0", "Stockholders Equity": "-53.2", "ECR before LimitedLiability": "-36.3", "Property Plant and Equipment": "20.0", "Assets, Current": "-22.1", "Intangible Assets": "-8.06", "Long Term Liabilities": "-74.8", "Liabilities, Current": "18.9", "Expenses": "16.7", "Revenues": "-44.7", "Net Income": "22.7", "Other Expenses": "9.44", "Operating Costs and Expenses": "-7.31", "Labor Expense": "-21.1", "General and Administrative Expense": "23.6", "Cost of Goods and Services Sold": "8.87", "Other Revenues": "-44.7", "Other Net Income": "31.9", "Comprehensive Net Income": "23.0", "Economic Capital Ratio": "-43.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001108109_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "2,871,193", "Assets, Non-Current": "1,169,559", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "609,839", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "4,199,905", "Labor Expense": "5,237,971", "Liabilities, Current": "1,642,040", "Long Term Liabilities": "9,810,057", "Operating Costs and Expenses": "2,406,596", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "4,429,085", "Other Liabilities": "608,177", "Other Net Income": "13,031,932", "Other Revenues": "0", "Property Plant and Equipment": "6,457,466", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "14,698,123", "Liabilities": "12,060,274", "Expenses": "12,683,491", "Revenues": "0", "Stockholders Equity": "2,637,849", "Net Income": "348,441", "Comprehensive Net Income": "348,441", "BaseVar": "26,236,910", "ECR before LimitedLiability": "31%", "Economic Capital Ratio": "117%" } }, "2011": { "input_variables": { "Assets, Current": "2,846,089", "Assets, Non-Current": "1,241,930", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "652,674", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "4,264,845", "Labor Expense": "5,577,925", "Liabilities, Current": "1,911,139", "Long Term Liabilities": "9,732,788", "Operating Costs and Expenses": "2,515,638", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "4,527,509", "Other Liabilities": "704,725", "Other Net Income": "13,551,369", "Other Revenues": "0", "Property Plant and Equipment": "6,855,976", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "15,208,840", "Liabilities": "12,348,652", "Expenses": "13,273,746", "Revenues": "0", "Stockholders Equity": "2,860,188", "Net Income": "277,623", "Comprehensive Net Income": "277,623", "BaseVar": "27,191,304", "ECR before LimitedLiability": "32%", "Economic Capital Ratio": "118%" } } }, "top_rated": false, "trend": -38.0, "value": 1.1770636709203548, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001108109.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001108109.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001108109.svg" }, { "company_id": "0001520697", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001520697.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001520697.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001520697.svg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001520697_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001520697_main_keyfigs.svg", "name": "Acadia Healthcare Company Inc", "rank": 54, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001520697.svg", "report_text": "The relative strengths and weaknesses of Acadia Healthcare Company Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Acadia Healthcare Company Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 27% points.The greatest weakness of Acadia Healthcare Company Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 92% points.

The company's Economic Capital Ratio, given in the ranking table, is 115%, being 46% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001520697_2012_Acadia_Healthcare_Company_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "10.4", "Liabilities": "-59.3", "Stockholders Equity": "-35.9", "ECR before LimitedLiability": "-39.3", "Property Plant and Equipment": "-6.63", "Assets, Current": "-5.93", "Intangible Assets": "27.3", "Other Liabilities": "8.41", "Long Term Liabilities": "-91.9", "Liabilities, Current": "16.5", "Expenses": "24.6", "Revenues": "-38.4", "Net Income": "8.39", "Other Expenses": "15.0", "Labor Expense": "-25.4", "General and Administrative Expense": "19.8", "Cost of Goods and Services Sold": "7.48", "Other Revenues": "-38.4", "Other Net Income": "27.2", "Comprehensive Net Income": "8.62", "Economic Capital Ratio": "-46.0" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001520697_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "112,605", "Assets, Non-Current": "16,366", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "4,288", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "195,047", "Labor Expense": "156,561", "Liabilities, Current": "40,668", "Long Term Liabilities": "275,963", "Operating Costs and Expenses": "20,472", "Other Assets": "6,006", "Other Compr. Net Income": "0", "Other Expenses": "72,925", "Other Liabilities": "0", "Other Net Income": "219,354", "Other Revenues": "0", "Property Plant and Equipment": "82,972", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "412,996", "Liabilities": "316,631", "Expenses": "254,246", "Revenues": "0", "Stockholders Equity": "96,365", "Net Income": "-34,892", "Comprehensive Net Income": "-34,892", "BaseVar": "601,614", "ECR before LimitedLiability": "29%", "Economic Capital Ratio": "115%" } } }, "top_rated": false, "trend": null, "value": 1.146964666447542, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001520697.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001520697.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001520697.svg" }, { "company_id": "0000096793", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000096793.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000096793.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000096793.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000096793_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000096793_main_keyfigs.svg", "name": "Sunlink Health Systems INC", "rank": 55, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000096793.svg", "report_text": "The relative strengths and weaknesses of Sunlink Health Systems INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Sunlink Health Systems INC compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Sunlink Health Systems INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 79% points.

The company's Economic Capital Ratio, given in the ranking table, is 113%, being 48% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000096793_2012_Sunlink_Health_Systems_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-58.7", "Other Liabilities": "15.5", "Stockholders Equity": "-79.0", "ECR before LimitedLiability": "-41.0", "Property Plant and Equipment": "-11.6", "Assets, Current": "-13.2", "Assets, Non-Current": "-10.9", "Intangible Assets": "-45.3", "Expenses": "-32.2", "Revenues": "37.0", "Net Income": "12.7", "Other Expenses": "-10.6", "Goodwill Impairment Loss": "-11.9", "Operating Costs and Expenses": "-20.5", "Labor Expense": "-46.3", "General and Administrative Expense": "25.8", "Cost of Goods and Services Sold": "14.2", "Other Revenues": "37.0", "Other Net Income": "-46.5", "Comprehensive Net Income": "13.2", "Economic Capital Ratio": "-47.7" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000096793_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "43,365", "Assets, Non-Current": "346", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "13,347", "Intangible Assets": "4,869", "Labor Expense": "63,846", "Liabilities, Current": "31,332", "Long Term Liabilities": "34,430", "Operating Costs and Expenses": "30,754", "Other Assets": "9,566", "Other Compr. Net Income": "0", "Other Expenses": "62,408", "Other Liabilities": "0", "Other Net Income": "-682", "Other Revenues": "154,380", "Property Plant and Equipment": "33,684", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "91,830", "Liabilities": "65,762", "Expenses": "170,355", "Revenues": "154,380", "Stockholders Equity": "26,068", "Net Income": "-16,657", "Comprehensive Net Income": "-16,657", "BaseVar": "241,504", "ECR before LimitedLiability": "27%", "Economic Capital Ratio": "113%" } } }, "top_rated": false, "trend": null, "value": 1.1297977556991805, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000096793.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000096793.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000096793.svg" }, { "company_id": "0001001604", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001001604.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001001604.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001001604_main_keyfigs.svg", "name": "Emeritus CORP WA", "rank": 56, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001001604.svg", "report_text": "The relative strengths and weaknesses of Emeritus CORP WA are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Emeritus CORP WA compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 33% points.The greatest weakness of Emeritus CORP WA is the variable Liabilities, reducing the Economic Capital Ratio by 83% points.

The company's Economic Capital Ratio, given in the ranking table, is 100%, being 61% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001001604_2012_Emeritus_CORP_WA.pdf", "shrinked_graph_json": { "2010": { "Assets, Current": "-19.8", "Assets": "9.69", "Liabilities": "-79.4", "Stockholders Equity": "-51.0", "ECR before LimitedLiability": "-87.1", "Property Plant and Equipment": "36.5", "Other Assets": "4.37", "Intangible Assets": "-37.6", "Other Liabilities": "-33.9", "Liabilities, Current": "5.36", "Long Term Liabilities": "-47.1", "Expenses": "18.0", "Revenues": "7.32", "Net Income": "-10.6", "Cost of Goods and Services Sold": "11.1", "Labor Expense": "8.14", "Operating Costs and Expenses": "8.98", "Other Revenues": "7.32", "Comprehensive Net Income": "-9.69", "Other Net Income": "-39.1", "Economic Capital Ratio": "-85.3" }, "2011": { "Assets": "12.4", "Liabilities": "-82.5", "Stockholders Equity": "-49.8", "ECR before LimitedLiability": "-54.2", "Property Plant and Equipment": "32.9", "Assets, Current": "-28.6", "Assets, Non-Current": "-4.99", "Intangible Assets": "-27.2", "Other Liabilities": "-32.9", "Long Term Liabilities": "-62.2", "Liabilities, Current": "12.4", "Expenses": "13.9", "Revenues": "4.79", "Net Income": "12.4", "Operating Costs and Expenses": "7.18", "Labor Expense": "11.4", "General and Administrative Expense": "12.4", "Cost of Goods and Services Sold": "7.15", "Other Net Income": "-28.9", "Comprehensive Net Income": "12.4", "Economic Capital Ratio": "-60.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001001604_strength_weakness.svg", "table_records": { "2010": { "input_variables": { "Assets, Current": "216,649", "Assets, Non-Current": "23,969", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "86,697", "General and Administrative Expense": "74,480", "Goodwill Impairment Loss": "0", "Intangible Assets": "75,820", "Labor Expense": "0", "Liabilities, Current": "234,377", "Long Term Liabilities": "1,305,757", "Operating Costs and Expenses": "0", "Other Assets": "133,798", "Other Compr. Net Income": "0", "Other Expenses": "786,855", "Other Liabilities": "722,152", "Other Net Income": "-116,875", "Other Revenues": "1,007,065", "Property Plant and Equipment": "2,163,556", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,613,792", "Liabilities": "2,262,286", "Expenses": "948,032", "Revenues": "1,007,065", "Stockholders Equity": "351,506", "Net Income": "-57,842", "Comprehensive Net Income": "-57,842", "BaseVar": "3,474,025", "ECR before LimitedLiability": "19%", "Economic Capital Ratio": "105%" } }, "2011": { "input_variables": { "Assets, Current": "174,162", "Assets, Non-Current": "29,288", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "122,372", "General and Administrative Expense": "88,767", "Goodwill Impairment Loss": "0", "Intangible Assets": "118,725", "Labor Expense": "0", "Liabilities, Current": "274,241", "Long Term Liabilities": "1,528,710", "Operating Costs and Expenses": "0", "Other Assets": "132,728", "Other Compr. Net Income": "0", "Other Expenses": "982,963", "Other Liabilities": "724,641", "Other Net Income": "-132,931", "Other Revenues": "1,254,770", "Property Plant and Equipment": "2,355,425", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,810,328", "Liabilities": "2,527,592", "Expenses": "1,194,102", "Revenues": "1,254,770", "Stockholders Equity": "282,736", "Net Income": "-72,263", "Comprehensive Net Income": "-72,263", "BaseVar": "3,959,862", "ECR before LimitedLiability": "13%", "Economic Capital Ratio": "100%" } } }, "top_rated": false, "trend": -40.0, "value": 0.9981152131125516, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001001604.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001001604.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001001604.svg" }, { "company_id": "0001272597", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001272597.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001272597.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001272597_main_keyfigs.svg", "name": "Foundation Healthcare Inc", "rank": 57, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001272597.svg", "report_text": "The relative strengths and weaknesses of Foundation Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Foundation Healthcare Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 5.5% points.The greatest weakness of Foundation Healthcare Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 74% points.

The company's Economic Capital Ratio, given in the ranking table, is 91%, being 70% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001272597_2012_Foundation_Healthcare_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "-3.44", "Assets": "-7.24", "Liabilities": "-59.0", "Stockholders Equity": "-54.6", "Property Plant and Equipment": "-24.4", "Assets, Non-Current": "-6.77", "Intangible Assets": "5.51", "Other Liabilities": "3.44", "Long Term Liabilities": "-74.3", "Expenses": "3.68", "Revenues": "3.73", "Net Income": "-3.38", "Other Expenses": "5.30", "Operating Costs and Expenses": "3.44", "Labor Expense": "3.59", "General and Administrative Expense": "-28.5", "Cost of Goods and Services Sold": "-17.1", "Other Revenues": "3.73", "ECR before LimitedLiability": "-63.2", "Other Net Income": "-34.1", "Economic Capital Ratio": "-69.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001272597_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "9,771", "Assets, Non-Current": "280", "Cost of Goods and Services Sold": "6,880", "Depreciation, Depletion, Amortization": "1,111", "General and Administrative Expense": "13,744", "Goodwill Impairment Loss": "0", "Intangible Assets": "14,944", "Labor Expense": "0", "Liabilities, Current": "5,839", "Long Term Liabilities": "17,321", "Operating Costs and Expenses": "0", "Other Assets": "54", "Other Compr. Net Income": "0", "Other Expenses": "910", "Other Liabilities": "0", "Other Net Income": "-992", "Other Revenues": "17,510", "Property Plant and Equipment": "2,936", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "27,985", "Liabilities": "23,160", "Expenses": "22,645", "Revenues": "17,510", "Stockholders Equity": "4,825", "Net Income": "-6,126", "Comprehensive Net Income": "-6,126", "BaseVar": "46,146", "ECR before LimitedLiability": "3.4%", "Economic Capital Ratio": "91%" } } }, "top_rated": false, "trend": null, "value": 0.908295793003718, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001272597.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001272597.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001272597.svg" }, { "company_id": "0001383960", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001383960.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001383960.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001383960_main_keyfigs.svg", "name": "University General Health System INC", "rank": 58, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001383960.svg", "report_text": "The relative strengths and weaknesses of University General Health System INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of University General Health System INC compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 9.0% points.The greatest weakness of University General Health System INC is the variable Liabilities, reducing the Economic Capital Ratio by 82% points.

The company's Economic Capital Ratio, given in the ranking table, is 87%, being 73% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001383960_2012_University_General_Health_System_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-4.31", "Liabilities": "-82.0", "Stockholders Equity": "-68.7", "Property Plant and Equipment": "8.98", "Assets, Current": "-26.0", "Assets, Non-Current": "-2.55", "Intangible Assets": "-18.6", "Other Liabilities": "-32.0", "Long Term Liabilities": "0.653", "Liabilities, Current": "-63.3", "Expenses": "1.89", "Revenues": "0.678", "Net Income": "0.658", "Other Expenses": "-4.77", "Depreciation, Depletion, Amortization": "-1.04", "Labor Expense": "0.427", "Other Revenues": "0.678", "ECR before LimitedLiability": "-66.6", "Other Net Income": "-26.3", "Comprehensive Net Income": "0.675", "Economic Capital Ratio": "-73.2" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001383960_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "15,293", "Assets, Non-Current": "2,235", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "7,337", "General and Administrative Expense": "18,079", "Goodwill Impairment Loss": "0", "Intangible Assets": "18,299", "Labor Expense": "0", "Liabilities, Current": "73,794", "Long Term Liabilities": "8,459", "Operating Costs and Expenses": "0", "Other Assets": "1,827", "Other Compr. Net Income": "0", "Other Expenses": "49,980", "Other Liabilities": "32,822", "Other Net Income": "0", "Other Revenues": "73,007", "Property Plant and Equipment": "77,013", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "114,668", "Liabilities": "115,075", "Expenses": "75,395", "Revenues": "73,007", "Stockholders Equity": "-407", "Net Income": "-2,388", "Comprehensive Net Income": "-2,388", "BaseVar": "189,073", "ECR before LimitedLiability": "-2.6%", "Economic Capital Ratio": "87%" } } }, "top_rated": false, "trend": null, "value": 0.874371446521448, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001383960.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001383960.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001383960.svg" }, { "company_id": "0001051488", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001051488.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001051488.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001051488_main_keyfigs.svg", "name": "Integrated Healthcare Holdings Inc", "rank": 59, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001051488.svg", "report_text": "The relative strengths and weaknesses of Integrated Healthcare Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Integrated Healthcare Holdings Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Integrated Healthcare Holdings Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 141% points.

The company's Economic Capital Ratio, given in the ranking table, is 87%, being 73% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001051488_2012_Integrated_Healthcare_Holdings_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-91.2", "Other Liabilities": "-25.9", "Stockholders Equity": "-141", "Property Plant and Equipment": "-29.4", "Assets, Current": "-17.7", "Assets, Non-Current": "-12.1", "Intangible Assets": "-62.1", "Expenses": "-34.0", "Revenues": "-80.2", "Net Income": "5.59", "Other Expenses": "8.92", "Operating Costs and Expenses": "-68.7", "Labor Expense": "-83.5", "General and Administrative Expense": "4.21", "Other Revenues": "-80.2", "ECR before LimitedLiability": "-66.6", "Long Term Liabilities": "4.98", "Liabilities, Current": "-34.2", "Other Net Income": "48.1", "Comprehensive Net Income": "5.69", "Economic Capital Ratio": "-73.3" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001051488_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "97,206", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "4,165", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "211,636", "Liabilities, Current": "118,459", "Long Term Liabilities": "0", "Operating Costs and Expenses": "162,600", "Other Assets": "445", "Other Compr. Net Income": "0", "Other Expenses": "14,000", "Other Liabilities": "52,004", "Other Net Income": "412,966", "Other Revenues": "0", "Property Plant and Equipment": "54,251", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "151,902", "Liabilities": "170,463", "Expenses": "392,401", "Revenues": "0", "Stockholders Equity": "-18,561", "Net Income": "20,565", "Comprehensive Net Income": "20,565", "BaseVar": "563,866", "ECR before LimitedLiability": "-3.9%", "Economic Capital Ratio": "87%" } } }, "top_rated": false, "trend": null, "value": 0.8742115661871077, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001051488.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001051488.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001051488.svg" }, { "company_id": "0001503518", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001503518.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001503518.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001503518_main_keyfigs.svg", "name": "21st Century Oncology Holdings Inc", "rank": 60, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001503518.svg", "report_text": "The relative strengths and weaknesses of 21st Century Oncology Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of 21st Century Oncology Holdings Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 6.1% points.The greatest weakness of 21st Century Oncology Holdings Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 79% points.

The company's Economic Capital Ratio, given in the ranking table, is 87%, being 73% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001503518_2012_21st_Century_Oncology_Holdings_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-6.76", "Liabilities": "-43.5", "Stockholders Equity": "-50.1", "Property Plant and Equipment": "-1.46", "Assets, Current": "-27.6", "Intangible Assets": "6.12", "Other Liabilities": "0.245", "Long Term Liabilities": "-79.1", "Liabilities, Current": "1.43", "Other Revenues": "-41.8", "Revenues": "-41.8", "Net Income": "-8.20", "ECR before LimitedLiability": "-66.7", "Comprehensive Net Income": "-8.50", "Other Net Income": "3.48", "Other Expenses": "-4.49", "Operating Costs and Expenses": "0.246", "Labor Expense": "-12.2", "General and Administrative Expense": "0.928", "Cost of Goods and Services Sold": "0.468", "Economic Capital Ratio": "-73.4" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001503518_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "116,304", "Assets, Non-Current": "33,218", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "54,084", "General and Administrative Expense": "81,688", "Goodwill Impairment Loss": "0", "Intangible Assets": "598,940", "Labor Expense": "326,782", "Liabilities, Current": "96,375", "Long Term Liabilities": "687,747", "Operating Costs and Expenses": "33,992", "Other Assets": "13,719", "Other Compr. Net Income": "-5,395", "Other Expenses": "498,054", "Other Liabilities": "24,448", "Other Net Income": "644,717", "Other Revenues": "0", "Property Plant and Equipment": "236,411", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "998,592", "Liabilities": "808,570", "Expenses": "994,600", "Revenues": "0", "Stockholders Equity": "190,022", "Net Income": "-349,883", "Comprehensive Net Income": "-355,278", "BaseVar": "1,725,937", "ECR before LimitedLiability": "-8.8%", "Economic Capital Ratio": "87%" } } }, "top_rated": false, "trend": null, "value": 0.8730774211596454, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001503518.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001503518.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001503518.svg" }, { "company_id": "0001351051", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001351051.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001351051.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001351051.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001351051_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001351051_main_keyfigs.svg", "name": "Genesis Healthcare Inc", "rank": 61, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001351051.svg", "report_text": "The relative strengths and weaknesses of Genesis Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Genesis Healthcare Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 9.6% points.The greatest weakness of Genesis Healthcare Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 78% points.

The company's Economic Capital Ratio, given in the ranking table, is 87%, being 74% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001351051_2012_Genesis_Healthcare_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-44.8", "Liabilities": "-18.5", "Stockholders Equity": "-78.2", "Property Plant and Equipment": "2.10", "Assets, Current": "-27.4", "Intangible Assets": "-27.0", "Other Liabilities": "0.845", "Long Term Liabilities": "-67.3", "Liabilities, Current": "2.30", "Expenses": "-0.351", "ECR before LimitedLiability": "-66.9", "Other Expenses": "-41.2", "Goodwill Impairment Loss": "-23.8", "Operating Costs and Expenses": "0.899", "Labor Expense": "1.66", "General and Administrative Expense": "2.78", "Cost of Goods and Services Sold": "0.894", "Other Revenues": "9.59", "Revenues": "9.59", "Economic Capital Ratio": "-73.6", "Other Net Income": "-35.1" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001351051_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "143,331", "Assets, Non-Current": "32,119", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "25,730", "Goodwill Impairment Loss": "270,478", "Intangible Assets": "106,712", "Labor Expense": "0", "Liabilities, Current": "98,378", "Long Term Liabilities": "519,409", "Operating Costs and Expenses": "0", "Other Assets": "37,336", "Other Compr. Net Income": "0", "Other Expenses": "739,935", "Other Liabilities": "0", "Other Net Income": "-36,824", "Other Revenues": "869,701", "Property Plant and Equipment": "375,502", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "695,000", "Liabilities": "617,787", "Expenses": "1,036,143", "Revenues": "869,701", "Stockholders Equity": "77,213", "Net Income": "-203,266", "Comprehensive Net Income": "-203,266", "BaseVar": "1,627,728", "ECR before LimitedLiability": "-14%", "Economic Capital Ratio": "87%" } } }, "top_rated": false, "trend": null, "value": 0.8709793004209045, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001351051.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001351051.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001351051.svg" }, { "company_id": "0000817135", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000817135.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000817135.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000817135_main_keyfigs.svg", "name": "Alliance Healthcare Services Inc", "rank": 62, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000817135.svg", "report_text": "The relative strengths and weaknesses of Alliance Healthcare Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Alliance Healthcare Services Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 3.2% points.The greatest weakness of Alliance Healthcare Services Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 63% points.

The company's Economic Capital Ratio, given in the ranking table, is 84%, being 77% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000817135_2012_Alliance_Healthcare_Services_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-3.11", "Expenses": "2.33", "Stockholders Equity": "-63.0", "ECR before LimitedLiability": "-69.8", "Property Plant and Equipment": "2.88", "Assets, Current": "-3.03", "Assets, Non-Current": "-0.778", "Intangible Assets": "-1.52", "Other Liabilities": "-3.22", "Liabilities": "-48.1", "Long Term Liabilities": "-19.4", "Liabilities, Current": "2.06", "Other Expenses": "-3.28", "Operating Costs and Expenses": "1.48", "Labor Expense": "2.45", "General and Administrative Expense": "2.10", "Cost of Goods and Services Sold": "1.48", "Other Revenues": "3.19", "Revenues": "3.19", "Economic Capital Ratio": "-76.5", "Other Net Income": "-3.10" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000817135_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "135,740", "Assets, Non-Current": "19,270", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "77,140", "Goodwill Impairment Loss": "0", "Intangible Assets": "199,517", "Labor Expense": "0", "Liabilities, Current": "105,564", "Long Term Liabilities": "431,330", "Operating Costs and Expenses": "0", "Other Assets": "17,268", "Other Compr. Net Income": "0", "Other Expenses": "575,131", "Other Liabilities": "231,111", "Other Net Income": "3,516", "Other Revenues": "493,651", "Property Plant and Equipment": "291,299", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "663,094", "Liabilities": "768,005", "Expenses": "652,271", "Revenues": "493,651", "Stockholders Equity": "-104,911", "Net Income": "-155,104", "Comprehensive Net Income": "-155,104", "BaseVar": "1,290,268", "ECR before LimitedLiability": "-43%", "Economic Capital Ratio": "84%" } } }, "top_rated": false, "trend": null, "value": 0.8415789458655887, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000817135.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000817135.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000817135.svg" }, { "company_id": "0000882289", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000882289.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000882289.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000882289_main_keyfigs.svg", "name": "Apria Healthcare Group INC", "rank": 63, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000882289.svg", "report_text": "The relative strengths and weaknesses of Apria Healthcare Group INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Apria Healthcare Group INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Apria Healthcare Group INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 80% points.

The company's Economic Capital Ratio, given in the ranking table, is 82%, being 79% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000882289_2012_Apria_Healthcare_Group_INC.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "3.79", "Assets": "-42.6", "Liabilities": "-4.21", "Stockholders Equity": "-79.9", "ECR before LimitedLiability": "-72.1", "Property Plant and Equipment": "-9.68", "Assets, Current": "-5.35", "Assets, Non-Current": "-2.42", "Long Term Liabilities": "-5.51", "Liabilities, Current": "4.19", "Expenses": "-5.01", "Revenues": "-26.2", "Net Income": "-2.86", "Operating Costs and Expenses": "2.88", "Labor Expense": "4.76", "General and Administrative Expense": "-5.29", "Cost of Goods and Services Sold": "-5.47", "Other Revenues": "-26.2", "Other Net Income": "29.0", "Comprehensive Net Income": "-2.80", "Economic Capital Ratio": "-78.8" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000882289_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "451,767", "Assets, Non-Current": "8,997", "Cost of Goods and Services Sold": "980,333", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,225,400", "Goodwill Impairment Loss": "0", "Intangible Assets": "744,091", "Labor Expense": "0", "Liabilities, Current": "310,853", "Long Term Liabilities": "1,068,550", "Operating Costs and Expenses": "0", "Other Assets": "211,405", "Other Compr. Net Income": "0", "Other Expenses": "843,660", "Other Liabilities": "200,225", "Other Net Income": "2,302,069", "Other Revenues": "0", "Property Plant and Equipment": "83,768", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "1,500,028", "Liabilities": "1,579,628", "Expenses": "3,049,393", "Revenues": "0", "Stockholders Equity": "-79,600", "Net Income": "-747,324", "Comprehensive Net Income": "-747,324", "BaseVar": "4,215,559", "ECR before LimitedLiability": "-56%", "Economic Capital Ratio": "82%" } } }, "top_rated": false, "trend": null, "value": 0.819187707109243, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000882289.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000882289.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000882289.svg" }, { "company_id": "0001289496", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001289496.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001289496.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001289496.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001289496_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001289496_main_keyfigs.svg", "name": "CBA Florida Inc", "rank": 64, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001289496.svg", "report_text": "The relative strengths and weaknesses of CBA Florida Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of CBA Florida Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 58% points.The greatest weakness of CBA Florida Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 44% points.

The company's Economic Capital Ratio, given in the ranking table, is 73%, being 88% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001289496_2012_CBA_Florida_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "57.8", "Assets": "-13.4", "Liabilities": "-11.3", "Stockholders Equity": "-44.0", "ECR before LimitedLiability": "-81.0", "Property Plant and Equipment": "-10.8", "Assets, Current": "-12.4", "Assets, Non-Current": "-3.63", "Intangible Assets": "-12.8", "Liabilities, Current": "-11.6", "Expenses": "-7.42", "Revenues": "3.22", "Net Income": "-11.4", "Operating Costs and Expenses": "3.19", "Labor Expense": "5.11", "General and Administrative Expense": "-13.4", "Cost of Goods and Services Sold": "3.18", "Other Revenues": "3.22", "Other Net Income": "-8.12", "Comprehensive Net Income": "-11.3", "Economic Capital Ratio": "-87.6" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001289496_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "832", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "7,609", "Goodwill Impairment Loss": "0", "Intangible Assets": "244", "Labor Expense": "0", "Liabilities, Current": "5,691", "Long Term Liabilities": "1,478", "Operating Costs and Expenses": "0", "Other Assets": "5,539", "Other Compr. Net Income": "0", "Other Expenses": "4,569", "Other Liabilities": "1,061", "Other Net Income": "539", "Other Revenues": "5,668", "Property Plant and Equipment": "735", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "7,350", "Liabilities": "8,229", "Expenses": "12,179", "Revenues": "5,668", "Stockholders Equity": "-879", "Net Income": "-5,972", "Comprehensive Net Income": "-5,972", "BaseVar": "16,982", "ECR before LimitedLiability": "-93%", "Economic Capital Ratio": "73%" } } }, "top_rated": false, "trend": null, "value": 0.7303722971450302, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001289496.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001289496.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001289496.svg" }, { "company_id": "0001416876", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001416876.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001416876.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001416876_main_keyfigs.svg", "name": "First Choice Healthcare Solutions Inc", "rank": 65, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001416876.svg", "report_text": "The relative strengths and weaknesses of First Choice Healthcare Solutions Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of First Choice Healthcare Solutions Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 27% points.The greatest weakness of First Choice Healthcare Solutions Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 37% points.

The company's Economic Capital Ratio, given in the ranking table, is 68%, being 93% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001416876_2012_First_Choice_Healthcare_Solutions_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-5.99", "Liabilities": "-17.4", "Stockholders Equity": "-19.5", "ECR before LimitedLiability": "-86.2", "Property Plant and Equipment": "27.4", "Assets, Current": "-4.70", "Intangible Assets": "-14.2", "Long Term Liabilities": "-36.8", "Liabilities, Current": "4.84", "Expenses": "-3.04", "Revenues": "-8.14", "Net Income": "-16.9", "Other Expenses": "-14.7", "Operating Costs and Expenses": "2.58", "Labor Expense": "4.10", "General and Administrative Expense": "3.18", "Cost of Goods and Services Sold": "2.57", "Other Revenues": "-8.14", "Other Net Income": "-9.42", "Comprehensive Net Income": "-16.9", "Economic Capital Ratio": "-92.9" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001416876_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "2,006", "Assets, Non-Current": "229", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "796", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "315", "Long Term Liabilities": "7,483", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "6,825", "Other Liabilities": "0", "Other Net Income": "-245", "Other Revenues": "1,305", "Property Plant and Equipment": "4,537", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "6,772", "Liabilities": "7,798", "Expenses": "7,621", "Revenues": "1,305", "Stockholders Equity": "-1,026", "Net Income": "-6,561", "Comprehensive Net Income": "-6,561", "BaseVar": "11,871", "ECR before LimitedLiability": "-110%", "Economic Capital Ratio": "68%" } } }, "top_rated": false, "trend": null, "value": 0.6783149183475812, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001416876.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001416876.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001416876.svg" }, { "company_id": "0001449934", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001449934.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001449934.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001449934_main_keyfigs.svg", "name": "Cannlabs Inc", "rank": 66, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001449934.svg", "report_text": "The relative strengths and weaknesses of Cannlabs Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Cannlabs Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 39% points.The greatest weakness of Cannlabs Inc is the variable Net Income, reducing the Economic Capital Ratio by 66% points.

The company's Economic Capital Ratio, given in the ranking table, is 53%, being 108% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001449934_2012_Cannlabs_Inc.pdf", "shrinked_graph_json": { "2011": { "Assets": "-17.1", "Stockholders Equity": "-17.9", "Long Term Liabilities": "5.58", "ECR before LimitedLiability": "-101", "Property Plant and Equipment": "39.0", "Assets, Current": "-12.6", "Assets, Non-Current": "-5.66", "Intangible Assets": "-25.1", "Expenses": "-29.8", "Revenues": "-14.4", "Net Income": "-65.7", "Other Expenses": "16.2", "Depreciation, Depletion, Amortization": "-14.1", "Operating Costs and Expenses": "3.95", "Labor Expense": "6.20", "General and Administrative Expense": "-39.9", "Other Revenues": "-14.4", "Liabilities, Current": "-14.0", "Other Net Income": "-13.6", "Comprehensive Net Income": "-65.4", "Economic Capital Ratio": "-108" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001449934_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "23", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "34", "General and Administrative Expense": "138", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "58", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1.5", "Other Liabilities": "0", "Other Net Income": "1.3", "Other Revenues": "16", "Property Plant and Equipment": "64", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "87", "Liabilities": "58", "Expenses": "173", "Revenues": "16", "Stockholders Equity": "30", "Net Income": "-155", "Comprehensive Net Income": "-155", "BaseVar": "168", "ECR before LimitedLiability": "-155%", "Economic Capital Ratio": "53%" } } }, "top_rated": false, "trend": null, "value": 0.531587583081125, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001449934.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001449934.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001449934.svg" }, { "company_id": "0000022872", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000022872.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000022872.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000022872.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000022872_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000022872_main_keyfigs.svg", "name": "Advanzeon Solutions Inc", "rank": 67, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000022872.svg", "report_text": "The relative strengths and weaknesses of Advanzeon Solutions Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Advanzeon Solutions Inc compared to the market average is the variable Revenues, increasing the Economic Capital Ratio by 43% points.The greatest weakness of Advanzeon Solutions Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 157% points.

The company's Economic Capital Ratio, given in the ranking table, is 51%, being 110% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000022872_2012_Advanzeon_Solutions_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "-4.81", "Assets": "-97.9", "Stockholders Equity": "-157", "Long Term Liabilities": "6.47", "ECR before LimitedLiability": "-103", "Property Plant and Equipment": "-33.7", "Assets, Current": "-35.2", "Assets, Non-Current": "-9.31", "Intangible Assets": "-20.6", "Expenses": "-32.1", "Revenues": "43.1", "Net Income": "-3.65", "Other Expenses": "-85.9", "Operating Costs and Expenses": "7.30", "Labor Expense": "11.4", "Cost of Goods and Services Sold": "7.27", "Other Revenues": "43.1", "Liabilities, Current": "-17.6", "Other Net Income": "-25.1", "Comprehensive Net Income": "-3.42", "Economic Capital Ratio": "-110" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000022872_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "2,365", "Assets, Non-Current": "381", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "839", "General and Administrative Expense": "11,291", "Goodwill Impairment Loss": "0", "Intangible Assets": "12,178", "Labor Expense": "0", "Liabilities, Current": "27,895", "Long Term Liabilities": "3,903", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "73,187", "Other Liabilities": "0", "Other Net Income": "19", "Other Revenues": "71,210", "Property Plant and Equipment": "392", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "15,316", "Liabilities": "31,798", "Expenses": "85,317", "Revenues": "71,210", "Stockholders Equity": "-16,482", "Net Income": "-14,088", "Comprehensive Net Income": "-14,088", "BaseVar": "101,830", "ECR before LimitedLiability": "-161%", "Economic Capital Ratio": "51%" } } }, "top_rated": false, "trend": null, "value": 0.5090134661033191, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000022872.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000022872.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000022872.svg" }, { "company_id": "0000941020", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0000941020.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0000941020.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000941020_main_keyfigs.svg", "name": "Genelink INC", "rank": 68, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0000941020.svg", "report_text": "The relative strengths and weaknesses of Genelink INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Genelink INC compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 19% points.The greatest weakness of Genelink INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 71% points.

The company's Economic Capital Ratio, given in the ranking table, is 48%, being 113% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0000941020_2012_Genelink_INC.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "13.2", "Assets": "-39.2", "Liabilities": "-9.15", "Stockholders Equity": "-71.1", "ECR before LimitedLiability": "-106", "Property Plant and Equipment": "-27.2", "Assets, Current": "-7.59", "Assets, Non-Current": "-6.63", "Intangible Assets": "-31.1", "Liabilities, Current": "-5.92", "Expenses": "-22.3", "Revenues": "16.5", "Net Income": "-24.9", "Other Expenses": "18.6", "Labor Expense": "7.53", "General and Administrative Expense": "-37.9", "Cost of Goods and Services Sold": "-11.9", "Other Revenues": "16.5", "Other Net Income": "-20.1", "Comprehensive Net Income": "-24.7", "Economic Capital Ratio": "-113" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0000941020_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,859", "Assets, Non-Current": "29", "Cost of Goods and Services Sold": "1,735", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "6,247", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "2,296", "Long Term Liabilities": "965", "Operating Costs and Expenses": "0", "Other Assets": "723", "Other Compr. Net Income": "0", "Other Expenses": "135", "Other Liabilities": "1,000", "Other Net Income": "-264", "Other Revenues": "4,685", "Property Plant and Equipment": "168", "Research And Development Expense": "134", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "2,780", "Liabilities": "4,261", "Expenses": "8,251", "Revenues": "4,685", "Stockholders Equity": "-1,481", "Net Income": "-3,830", "Comprehensive Net Income": "-3,830", "BaseVar": "10,120", "ECR before LimitedLiability": "-170%", "Economic Capital Ratio": "48%" } } }, "top_rated": false, "trend": null, "value": 0.47987332953013734, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0000941020.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0000941020.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0000941020.svg" }, { "company_id": "0001294157", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001294157.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001294157.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001294157_main_keyfigs.svg", "name": "DR Tattoff INC", "rank": 69, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001294157.svg", "report_text": "The relative strengths and weaknesses of DR Tattoff INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of DR Tattoff INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 23% points.The greatest weakness of DR Tattoff INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 54% points.

The company's Economic Capital Ratio, given in the ranking table, is 46%, being 115% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001294157_2012_DR_Tattoff_INC.pdf", "shrinked_graph_json": { "2011": { "Assets": "-52.0", "Stockholders Equity": "-54.5", "ECR before LimitedLiability": "-108", "Assets, Current": "-29.8", "Assets, Non-Current": "-5.70", "Intangible Assets": "-36.3", "Selling and Marketing Expense": "-11.0", "Expenses": "-38.5", "Revenues": "22.7", "Net Income": "-36.9", "Other Expenses": "-9.77", "Operating Costs and Expenses": "5.97", "Labor Expense": "9.27", "General and Administrative Expense": "-39.0", "Cost of Goods and Services Sold": "5.95", "Other Revenues": "22.7", "Long Term Liabilities": "5.31", "Liabilities, Current": "-6.53", "Other Net Income": "-22.3", "Comprehensive Net Income": "-36.8", "Economic Capital Ratio": "-115" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001294157_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "440", "Assets, Non-Current": "70", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "235", "General and Administrative Expense": "2,750", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "1,179", "Long Term Liabilities": "155", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "1,610", "Other Liabilities": "206", "Other Net Income": "-3.2", "Other Revenues": "2,666", "Property Plant and Equipment": "929", "Research And Development Expense": "0", "Selling and Marketing Expense": "541" }, "output_variables": { "Assets": "1,439", "Liabilities": "1,540", "Expenses": "5,137", "Revenues": "2,666", "Stockholders Equity": "-101", "Net Income": "-2,474", "Comprehensive Net Income": "-2,474", "BaseVar": "5,392", "ECR before LimitedLiability": "-176%", "Economic Capital Ratio": "46%" } } }, "top_rated": false, "trend": null, "value": 0.4592154786185406, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001294157.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001294157.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001294157.svg" }, { "company_id": "0001507881", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001507881.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001507881.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001507881_main_keyfigs.svg", "name": "USMD Holdings Inc", "rank": 70, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001507881.svg", "report_text": "The relative strengths and weaknesses of USMD Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of USMD Holdings Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 34% points.The greatest weakness of USMD Holdings Inc is the variable Net Income, reducing the Economic Capital Ratio by 44% points.

The company's Economic Capital Ratio, given in the ranking table, is 40%, being 121% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001507881_2012_USMD_Holdings_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "33.9", "Assets": "-18.8", "Liabilities": "-11.7", "Stockholders Equity": "-37.0", "ECR before LimitedLiability": "-114", "Property Plant and Equipment": "-22.6", "Assets, Non-Current": "-4.80", "Intangible Assets": "-24.8", "Long Term Liabilities": "3.01", "Liabilities, Current": "-22.6", "Expenses": "-21.2", "Revenues": "-17.7", "Net Income": "-44.0", "Other Expenses": "-7.18", "Operating Costs and Expenses": "-32.5", "Labor Expense": "4.59", "General and Administrative Expense": "7.36", "Other Revenues": "-17.7", "Other Net Income": "-11.4", "Comprehensive Net Income": "-44.0", "Economic Capital Ratio": "-121" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001507881_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "44", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "0", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "125", "Long Term Liabilities": "0", "Operating Costs and Expenses": "125", "Other Assets": "62", "Other Compr. Net Income": "0", "Other Expenses": "72", "Other Liabilities": "0", "Other Net Income": "0", "Other Revenues": "0", "Property Plant and Equipment": "0", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "106", "Liabilities": "125", "Expenses": "197", "Revenues": "0", "Stockholders Equity": "-19", "Net Income": "-197", "Comprehensive Net Income": "-197", "BaseVar": "214", "ECR before LimitedLiability": "-194%", "Economic Capital Ratio": "40%" } } }, "top_rated": false, "trend": null, "value": 0.3982255013400304, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001507881.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001507881.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001507881.svg" }, { "company_id": "0001468679", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001468679.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001468679.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001468679.png", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001468679_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001468679_main_keyfigs.svg", "name": "American Cryostem Corp", "rank": 71, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001468679.svg", "report_text": "The relative strengths and weaknesses of American Cryostem Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of American Cryostem Corp compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 31% points.The greatest weakness of American Cryostem Corp is the variable Net Income, reducing the Economic Capital Ratio by 157% points.

The company's Economic Capital Ratio, given in the ranking table, is 40%, being 121% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001468679_2012_American_Cryostem_Corp.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "19.0", "Assets": "-16.6", "Liabilities": "5.28", "Stockholders Equity": "8.97", "ECR before LimitedLiability": "-114", "Property Plant and Equipment": "31.3", "Assets, Current": "-19.5", "Assets, Non-Current": "-7.34", "Intangible Assets": "-34.3", "Expenses": "-55.4", "Revenues": "-26.6", "Net Income": "-157", "Research And Development Expense": "-15.4", "Other Expenses": "27.3", "Operating Costs and Expenses": "4.49", "Labor Expense": "6.97", "General and Administrative Expense": "-155", "Other Revenues": "-26.6", "Other Net Income": "-17.2", "Comprehensive Net Income": "-157", "Economic Capital Ratio": "-121" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001468679_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "125", "Assets, Non-Current": "0", "Cost of Goods and Services Sold": "1.4", "Depreciation, Depletion, Amortization": "0", "General and Administrative Expense": "1,294", "Goodwill Impairment Loss": "0", "Intangible Assets": "0", "Labor Expense": "0", "Liabilities, Current": "145", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "102", "Other Compr. Net Income": "0", "Other Expenses": "-172", "Other Liabilities": "0", "Other Net Income": "5.1", "Other Revenues": "5.0", "Property Plant and Equipment": "334", "Research And Development Expense": "177", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "561", "Liabilities": "145", "Expenses": "1,301", "Revenues": "5.0", "Stockholders Equity": "416", "Net Income": "-1,290", "Comprehensive Net Income": "-1,290", "BaseVar": "1,009", "ECR before LimitedLiability": "-195%", "Economic Capital Ratio": "40%" } } }, "top_rated": false, "trend": null, "value": 0.39785718485003, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001468679.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001468679.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001468679.svg" }, { "company_id": "0001136174", "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution_0001136174.svg", "graph_url": "https://www.realrate-archive.com/us_health_services/2011/graphs/IME_0001136174.svg", "logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001136174.jpg", "logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001136174_256x256.png", "main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001136174_main_keyfigs.svg", "name": "Ontrak Inc", "rank": 72, "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_0001136174.svg", "report_text": "The relative strengths and weaknesses of Ontrak Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.

The greatest strength of Ontrak Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 16% points.The greatest weakness of Ontrak Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 59% points.

The company's Economic Capital Ratio, given in the ranking table, is 24%, being 137% points below the market average of 161%.", "report_url": "https://www.realrate-archive.com/us_health_services/2011/report/0001136174_2012_Ontrak_Inc.pdf", "shrinked_graph_json": { "2011": { "Other Assets": "-1.74", "Assets": "-33.3", "Liabilities": "-8.09", "Stockholders Equity": "-59.0", "ECR before LimitedLiability": "-130", "Property Plant and Equipment": "-20.0", "Assets, Current": "-10.3", "Other Liabilities": "-5.71", "Liabilities, Current": "-2.18", "Expenses": "-11.7", "Revenues": "-12.5", "Net Income": "-37.4", "Other Expenses": "16.0", "Operating Costs and Expenses": "2.08", "Labor Expense": "3.22", "General and Administrative Expense": "-52.4", "Cost of Goods and Services Sold": "2.07", "Other Revenues": "-12.5", "Other Net Income": "-8.86", "Comprehensive Net Income": "-37.3", "Economic Capital Ratio": "-137" } }, "strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2011/plot_over_time/0001136174_strength_weakness.svg", "table_records": { "2011": { "input_variables": { "Assets, Current": "1,359", "Assets, Non-Current": "212", "Cost of Goods and Services Sold": "0", "Depreciation, Depletion, Amortization": "349", "General and Administrative Expense": "11,145", "Goodwill Impairment Loss": "0", "Intangible Assets": "1,920", "Labor Expense": "0", "Liabilities, Current": "3,530", "Long Term Liabilities": "0", "Operating Costs and Expenses": "0", "Other Assets": "0", "Other Compr. Net Income": "0", "Other Expenses": "-3,145", "Other Liabilities": "4,546", "Other Net Income": "-41", "Other Revenues": "271", "Property Plant and Equipment": "89", "Research And Development Expense": "0", "Selling and Marketing Expense": "0" }, "output_variables": { "Assets": "3,580", "Liabilities": "8,076", "Expenses": "8,349", "Revenues": "271", "Stockholders Equity": "-4,496", "Net Income": "-8,119", "Comprehensive Net Income": "-8,119", "BaseVar": "10,158", "ECR before LimitedLiability": "-251%", "Economic Capital Ratio": "24%" } } }, "top_rated": false, "trend": null, "value": 0.23526471517702854, "company_index": "https://www.realrate-archive.com/us_health_services/2011/industry_indexes/0001136174.svg", "analysing_equity": "https://www.realrate-archive.com/us_health_services/2011/analytics/equity/0001136174.svg", "analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2011/analytics/profit_loss/0001136174.svg" } ], "feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2011/feature_distribution/feature_distribution.svg", "final_var_label": "Economic Capital Ratio", "industry_box": [ [ "Revenues", "32.7 B" ], [ "Assets", "129 B" ], [ "Expenses", "89.3 B" ], [ "Stockholders Equity", "69.9 B" ] ], "industry_id": "us_health_services", "industry_label": "Health Services", "num_companies": 72, "num_top_companies": 18, "ecr_records": { "2009": { "0001022079": { "rank": 1, "ecr": "268" }, "0000896262": { "rank": 2, "ecr": "205" }, "0001014739": { "rank": 3, "ecr": "194" }, "0000920148": { "rank": 4, "ecr": "168" }, "0000927066": { "rank": 5, "ecr": "146" } }, "2010": { "0000895930": { "rank": 1, "ecr": "295" }, "0000352915": { "rank": 2, "ecr": "266" }, "0000731012": { "rank": 3, "ecr": "265" }, "0001022079": { "rank": 4, "ecr": "261" }, "0000893949": { "rank": 5, "ecr": "221" }, "0000896262": { "rank": 6, "ecr": "212" }, "0000019411": { "rank": 7, "ecr": "211" }, "0000019584": { "rank": 8, "ecr": "188" }, "0000882235": { "rank": 9, "ecr": "175" }, "0001301611": { "rank": 10, "ecr": "165" }, "0000920148": { "rank": 11, "ecr": "160" }, "0000785161": { "rank": 12, "ecr": "147" }, "0000927066": { "rank": 13, "ecr": "139" }, "0001332349": { "rank": 14, "ecr": "122" }, "0001108109": { "rank": 15, "ecr": "117" }, "0001001604": { "rank": 16, "ecr": "105" } }, "2011": { "0000895930": { "rank": 1, "ecr": "292" }, "0001091312": { "rank": 2, "ecr": "275" }, "0001043000": { "rank": 3, "ecr": "270" }, "0000352915": { "rank": 4, "ecr": "269" }, "0000731012": { "rank": 5, "ecr": "262" }, "0001522138": { "rank": 6, "ecr": "259" }, "0001367832": { "rank": 7, "ecr": "258" }, "0000744825": { "rank": 8, "ecr": "256" }, "0001294632": { "rank": 9, "ecr": "252" }, "0001125376": { "rank": 10, "ecr": "252" }, "0001022079": { "rank": 11, "ecr": "249" }, "0001131324": { "rank": 12, "ecr": "245" }, "0000860730": { "rank": 13, "ecr": "244" }, "0001138476": { "rank": 14, "ecr": "241" }, "0000885978": { "rank": 15, "ecr": "239" }, "0000893949": { "rank": 16, "ecr": "234" }, "0001124140": { "rank": 17, "ecr": "232" }, "0001060009": { "rank": 18, "ecr": "231" }, "0001047335": { "rank": 19, "ecr": "229" }, "0001410471": { "rank": 20, "ecr": "218" }, "0000704415": { "rank": 21, "ecr": "217" }, "0000792641": { "rank": 22, "ecr": "215" }, "0000931059": { "rank": 23, "ecr": "212" }, "0000929994": { "rank": 24, "ecr": "206" }, "0000019411": { "rank": 25, "ecr": "203" }, "0000019584": { "rank": 26, "ecr": "182" }, "0001003130": { "rank": 27, "ecr": "181" }, "0001316645": { "rank": 28, "ecr": "179" }, "0001468328": { "rank": 29, "ecr": "178" }, "0001159281": { "rank": 30, "ecr": "176" }, "0001301611": { "rank": 31, "ecr": "164" }, "0000882235": { "rank": 32, "ecr": "162" }, "0000920148": { "rank": 33, "ecr": "161" }, "0001383183": { "rank": 34, "ecr": "155" }, "0000722723": { "rank": 35, "ecr": "152" }, "0000948072": { "rank": 36, "ecr": "151" }, "0000862692": { "rank": 37, "ecr": "151" }, "0001101723": { "rank": 38, "ecr": "146" }, "0001498021": { "rank": 39, "ecr": "146" }, "0000896262": { "rank": 40, "ecr": "143" }, "0000927066": { "rank": 41, "ecr": "142" }, "0000320017": { "rank": 42, "ecr": "140" }, "0000776325": { "rank": 43, "ecr": "139" }, "0001035688": { "rank": 44, "ecr": "139" }, "0001320414": { "rank": 44, "ecr": "139" }, "0001014739": { "rank": 46, "ecr": "138" }, "0000785161": { "rank": 47, "ecr": "136" }, "0001360474": { "rank": 48, "ecr": "127" }, "0000919956": { "rank": 49, "ecr": "124" }, "0000895665": { "rank": 50, "ecr": "123" }, "0001332349": { "rank": 51, "ecr": "122" }, "0001300524": { "rank": 52, "ecr": "120" }, "0001108109": { "rank": 53, "ecr": "118" }, "0001520697": { "rank": 54, "ecr": "115" }, "0000096793": { "rank": 55, "ecr": "113" }, "0001001604": { "rank": 56, "ecr": "100" }, "0001272597": { "rank": 57, "ecr": "91" }, "0001383960": { "rank": 58, "ecr": "87" }, "0001051488": { "rank": 59, "ecr": "87" }, "0001503518": { "rank": 60, "ecr": "87" }, "0001351051": { "rank": 61, "ecr": "87" }, "0000817135": { "rank": 62, "ecr": "84" }, "0000882289": { "rank": 63, "ecr": "82" }, "0001289496": { "rank": 64, "ecr": "73" }, "0001416876": { "rank": 65, "ecr": "68" }, "0001449934": { "rank": 66, "ecr": "53" }, "0000022872": { "rank": 67, "ecr": "51" }, "0000941020": { "rank": 68, "ecr": "48" }, "0001294157": { "rank": 69, "ecr": "46" }, "0001507881": { "rank": 70, "ecr": "40" }, "0001468679": { "rank": 71, "ecr": "40" }, "0001136174": { "rank": 72, "ecr": "24" } } }, "rating_box": [ [ "Top rated", "18 of 72" ], [ "Best, worst rating", "292 %, 23.5 %" ], [ "New companies", "56" ] ], "regression_plot": "https://www.realrate-archive.com/us_health_services/2011/backtesting_correlation/regression_2011.svg", "scentences": [ "Amsurg CORP climbed 0 positions from 1 to 1 due to its excellent Stockholders Equity.", "Emeritus CORP WA lost 40 positions from 16 to 56 due to its bad Liabilities.", "Symbion INC TN entered the 2012 ranking at rank 2, making it the best newcomer." ], "url_segment": "2012-us-health-services", "year": 2012, "feature_importance": "https://www.realrate-archive.com/us_health_services/2011/feature_importance/feature_importance.svg", "obs_ecr": { "0000920148": { "2011": { "obs_EconomicCapitalRatio": 1.663923414286983 }, "2012": { "obs_EconomicCapitalRatio": 1.4407170672094647 }, "2013": { "obs_EconomicCapitalRatio": 1.323792718489346 }, "2014": { "obs_EconomicCapitalRatio": 1.470242712096841 }, "2015": { "obs_EconomicCapitalRatio": 1.0214010482206495 }, "2016": { "obs_EconomicCapitalRatio": 1.0954224043543792 }, "2017": { "obs_EconomicCapitalRatio": 1.1879221981344004 }, "2018": { "obs_EconomicCapitalRatio": 0.9477895219666614 }, "2019": { "obs_EconomicCapitalRatio": 1.0949627880974482 }, "2021": { "obs_EconomicCapitalRatio": 1.8399468745460335 }, "2022": { "obs_EconomicCapitalRatio": 1.3068086669177197 }, "2023": { "obs_EconomicCapitalRatio": 1.4492522183616858 }, "2024": { "obs_EconomicCapitalRatio": 1.3176610991160915 }, "2025": { "obs_EconomicCapitalRatio": 1.487123295160136 } }, "0001022079": { "2011": { "obs_EconomicCapitalRatio": 1.267911138352765 }, "2012": { "obs_EconomicCapitalRatio": 1.3862017229025643 }, "2013": { "obs_EconomicCapitalRatio": 1.2031665213960887 }, "2014": { "obs_EconomicCapitalRatio": 1.3396669994127473 }, "2015": { "obs_EconomicCapitalRatio": 1.4903768348790714 }, "2016": { "obs_EconomicCapitalRatio": 1.9095314518428617 }, "2017": { "obs_EconomicCapitalRatio": 1.9713217210734026 }, "2018": { "obs_EconomicCapitalRatio": 1.542844211769263 }, "2019": { "obs_EconomicCapitalRatio": 1.7072037694942166 }, "2020": { "obs_EconomicCapitalRatio": 1.8434784506594455 }, "2021": { "obs_EconomicCapitalRatio": 2.4801222638557205 }, "2022": { "obs_EconomicCapitalRatio": 2.303864240107965 }, "2023": { "obs_EconomicCapitalRatio": 1.846925205369018 }, "2024": { "obs_EconomicCapitalRatio": 1.810747224018149 }, "2025": { "obs_EconomicCapitalRatio": 2.0966621477837926 } }, "0001014739": { "2011": { "obs_EconomicCapitalRatio": 0.5455058467503717 }, "2018": { "obs_EconomicCapitalRatio": 0.754424645512964 }, "2019": { "obs_EconomicCapitalRatio": 1.1945159127889264 }, "2020": { "obs_EconomicCapitalRatio": 1.3372488526870943 }, "2021": { "obs_EconomicCapitalRatio": 2.287045484201052 }, "2022": { "obs_EconomicCapitalRatio": 2.2629706450273175 }, "2023": { "obs_EconomicCapitalRatio": 2.369798550093667 }, "2024": { "obs_EconomicCapitalRatio": 1.431722453146353 }, "2025": { "obs_EconomicCapitalRatio": 1.840512605157507 } }, "0000927066": { "2011": { "obs_EconomicCapitalRatio": 0.9398495018958859 }, "2012": { "obs_EconomicCapitalRatio": 0.7666044539176664 }, "2013": { "obs_EconomicCapitalRatio": 0.9312599987060045 }, "2014": { "obs_EconomicCapitalRatio": 1.0994201795059793 }, "2015": { "obs_EconomicCapitalRatio": 0.9688014559679293 }, "2016": { "obs_EconomicCapitalRatio": 0.8477409793726618 }, "2017": { "obs_EconomicCapitalRatio": 0.824189439126132 }, "2018": { "obs_EconomicCapitalRatio": 0.5103927085716712 }, "2019": { "obs_EconomicCapitalRatio": 0.6180542558126978 }, "2020": { "obs_EconomicCapitalRatio": 0.8322454933184945 }, "2021": { "obs_EconomicCapitalRatio": 0.7116567354875124 }, "2022": { "obs_EconomicCapitalRatio": 0.41763359468294975 }, "2023": { "obs_EconomicCapitalRatio": 0.6154642053257157 }, "2024": { "obs_EconomicCapitalRatio": 0.7615486641660242 }, "2025": { "obs_EconomicCapitalRatio": 0.4785719594527293 } }, "0000731012": { "2011": { "obs_EconomicCapitalRatio": 5.269267575857689 }, "2012": { "obs_EconomicCapitalRatio": 5.962718744523781 }, "2013": { "obs_EconomicCapitalRatio": 5.857390336910617 }, "2014": { "obs_EconomicCapitalRatio": 6.010654031230302 }, "2015": { "obs_EconomicCapitalRatio": 7.220294551700417 }, "2016": { "obs_EconomicCapitalRatio": 7.592293402247349 }, "2017": { "obs_EconomicCapitalRatio": 7.648779377528277 }, "2018": { "obs_EconomicCapitalRatio": 5.948743829553438 }, "2019": { "obs_EconomicCapitalRatio": 3.6760348928352986 }, "2020": { "obs_EconomicCapitalRatio": 3.9099437641971453 }, "2021": { "obs_EconomicCapitalRatio": 2.5108136581327076 }, "2022": { "obs_EconomicCapitalRatio": 2.0121273406342404 }, "2023": { "obs_EconomicCapitalRatio": 1.503981335283937 }, "2024": { "obs_EconomicCapitalRatio": 1.6965676535663106 }, "2025": { "obs_EconomicCapitalRatio": 2.8638609322827606 } }, "0001332349": { "2011": { "obs_EconomicCapitalRatio": 0.5097293760371813 }, "2012": { "obs_EconomicCapitalRatio": 0.7321295047182582 }, "2013": { "obs_EconomicCapitalRatio": 0.7994065409175654 }, "2014": { "obs_EconomicCapitalRatio": 0.7310943113449674 }, "2015": { "obs_EconomicCapitalRatio": 0.3861457207385632 }, "2016": { "obs_EconomicCapitalRatio": 0.29096091336542823 }, "2017": { "obs_EconomicCapitalRatio": 0.26366034864469273 }, "2018": { "obs_EconomicCapitalRatio": 0.21789711902103157 }, "2019": { "obs_EconomicCapitalRatio": 0.1903375612099341 }, "2020": { "obs_EconomicCapitalRatio": 0.12286042900676535 }, "2021": { "obs_EconomicCapitalRatio": 0.15643986114831185 }, "2022": { "obs_EconomicCapitalRatio": 0.09034196093382922 }, "2023": { "obs_EconomicCapitalRatio": 0.20082534077007566 }, "2024": { "obs_EconomicCapitalRatio": 0.16215618529739215 }, "2025": { "obs_EconomicCapitalRatio": 0.42924858957859935 } }, "0000785161": { "2011": { "obs_EconomicCapitalRatio": 0.6799239972910698 }, "2020": { "obs_EconomicCapitalRatio": 1.4182305505026696 }, "2021": { "obs_EconomicCapitalRatio": 1.0814619308963784 }, "2022": { "obs_EconomicCapitalRatio": 1.2168672567310501 }, "2023": { "obs_EconomicCapitalRatio": 1.3276977177956595 }, "2024": { "obs_EconomicCapitalRatio": 1.8380528311696858 }, "2025": { "obs_EconomicCapitalRatio": 1.9742320708117875 } }, "0000893949": { "2011": { "obs_EconomicCapitalRatio": 2.4472442147004276 }, "2012": { "obs_EconomicCapitalRatio": 2.324430027116807 }, "2013": { "obs_EconomicCapitalRatio": 1.4153980642767163 }, "2014": { "obs_EconomicCapitalRatio": 2.705255141805469 }, "2015": { "obs_EconomicCapitalRatio": 2.0403070361793634 }, "2016": { "obs_EconomicCapitalRatio": 1.5757900099368114 }, "2017": { "obs_EconomicCapitalRatio": 1.1407480403624084 }, "2018": { "obs_EconomicCapitalRatio": 0.6705050146055793 }, "2020": { "obs_EconomicCapitalRatio": 0.6921913773195393 }, "2021": { "obs_EconomicCapitalRatio": 1.0300015663795175 }, "2022": { "obs_EconomicCapitalRatio": 0.6489855323488252 } }, "0000352915": { "2011": { "obs_EconomicCapitalRatio": 0.0553602404895168 }, "2012": { "obs_EconomicCapitalRatio": 0.0667388364815138 }, "2013": { "obs_EconomicCapitalRatio": 0.10746186223320742 }, "2014": { "obs_EconomicCapitalRatio": 0.1377020365266119 }, "2015": { "obs_EconomicCapitalRatio": 0.14053215356654963 }, "2016": { "obs_EconomicCapitalRatio": 0.11621934942230021 }, "2017": { "obs_EconomicCapitalRatio": 0.114780744950106 }, "2018": { "obs_EconomicCapitalRatio": 0.11647085422878821 }, "2019": { "obs_EconomicCapitalRatio": 0.13844490306808155 }, "2020": { "obs_EconomicCapitalRatio": 0.10967403520573908 }, "2021": { "obs_EconomicCapitalRatio": 0.10964465033831926 }, "2022": { "obs_EconomicCapitalRatio": 0.11838136871728291 } }, "0001108109": { "2011": { "obs_EconomicCapitalRatio": 0.11115589636411495 }, "2018": { "obs_EconomicCapitalRatio": 0.020711060055743875 }, "2019": { "obs_EconomicCapitalRatio": 0.02087391002128378 }, "2020": { "obs_EconomicCapitalRatio": 0.055024335706864366 }, "2021": { "obs_EconomicCapitalRatio": 0.11238728706954826 }, "2022": { "obs_EconomicCapitalRatio": 0.03480717712086575 } }, "0000019584": { "2011": { "obs_EconomicCapitalRatio": 1.6007792741509022 }, "2012": { "obs_EconomicCapitalRatio": 1.9490756925806219 }, "2013": { "obs_EconomicCapitalRatio": 1.914488847567999 }, "2014": { "obs_EconomicCapitalRatio": 2.7276355806390216 }, "2015": { "obs_EconomicCapitalRatio": 4.108866362531992 }, "2016": { "obs_EconomicCapitalRatio": 4.056449959720801 }, "2017": { "obs_EconomicCapitalRatio": 5.771321991229426 }, "2018": { "obs_EconomicCapitalRatio": 6.4038316847246515 }, "2019": { "obs_EconomicCapitalRatio": 7.58709219872699 }, "2020": { "obs_EconomicCapitalRatio": 8.473284302050429 }, "2021": { "obs_EconomicCapitalRatio": 7.75419875738273 }, "2022": { "obs_EconomicCapitalRatio": 7.217090228251971 }, "2023": { "obs_EconomicCapitalRatio": 7.848784782008866 }, "2024": { "obs_EconomicCapitalRatio": 7.020418240239263 }, "2025": { "obs_EconomicCapitalRatio": 5.834267895037539 } }, "0000885978": { "2011": { "obs_EconomicCapitalRatio": 1.8249280503248755 }, "2012": { "obs_EconomicCapitalRatio": 2.5724402670747026 }, "2013": { "obs_EconomicCapitalRatio": 2.440280256916831 }, "2014": { "obs_EconomicCapitalRatio": 2.7841283878931624 }, "2015": { "obs_EconomicCapitalRatio": 3.1734064882953517 }, "2016": { "obs_EconomicCapitalRatio": 3.0246117738545863 }, "2017": { "obs_EconomicCapitalRatio": 3.0139939481056994 }, "2018": { "obs_EconomicCapitalRatio": 4.338573763941583 }, "2019": { "obs_EconomicCapitalRatio": 3.5619391851687783 }, "2020": { "obs_EconomicCapitalRatio": 3.608060136945878 }, "2021": { "obs_EconomicCapitalRatio": 2.2035870209619968 }, "2022": { "obs_EconomicCapitalRatio": 1.6051840413020122 }, "2023": { "obs_EconomicCapitalRatio": 1.9917917705186083 } }, "0001043000": { "2011": { "obs_EconomicCapitalRatio": 0.8293232149926116 }, "2012": { "obs_EconomicCapitalRatio": 1.4742528917925262 }, "2013": { "obs_EconomicCapitalRatio": 1.7089349147012525 }, "2014": { "obs_EconomicCapitalRatio": 1.4658517655187218 }, "2015": { "obs_EconomicCapitalRatio": 1.1163300237064913 }, "2016": { "obs_EconomicCapitalRatio": 0.8011463796423269 }, "2017": { "obs_EconomicCapitalRatio": 0.6657619630661099 }, "2018": { "obs_EconomicCapitalRatio": 0.3499332196919161 }, "2019": { "obs_EconomicCapitalRatio": 0.1435327336460731 }, "2020": { "obs_EconomicCapitalRatio": 0.7691184527453718 }, "2021": { "obs_EconomicCapitalRatio": 0.2472761050128782 }, "2022": { "obs_EconomicCapitalRatio": 0.11342826064079066 }, "2023": { "obs_EconomicCapitalRatio": 0.12215537075834612 }, "2024": { "obs_EconomicCapitalRatio": 0.5680879390824175 }, "2025": { "obs_EconomicCapitalRatio": 0.7440503530902668 } }, "0001047335": { "2011": { "obs_EconomicCapitalRatio": 0.7030648064303432 }, "2012": { "obs_EconomicCapitalRatio": 0.7986366131163368 }, "2013": { "obs_EconomicCapitalRatio": 0.8810375321554819 }, "2014": { "obs_EconomicCapitalRatio": 1.0391703058215966 }, "2015": { "obs_EconomicCapitalRatio": 1.1792883497574127 }, "2016": { "obs_EconomicCapitalRatio": 1.4494970214093919 }, "2018": { "obs_EconomicCapitalRatio": 1.3317026977764668 }, "2019": { "obs_EconomicCapitalRatio": 1.2199733107599542 }, "2020": { "obs_EconomicCapitalRatio": 0.9159128240235758 }, "2021": { "obs_EconomicCapitalRatio": 0.974181561146432 }, "2022": { "obs_EconomicCapitalRatio": 1.0185115295379144 }, "2023": { "obs_EconomicCapitalRatio": 1.6164670839378312 }, "2024": { "obs_EconomicCapitalRatio": 1.6149386864581519 }, "2025": { "obs_EconomicCapitalRatio": 2.1616166738307125 } }, "0001125376": { "2011": { "obs_EconomicCapitalRatio": 1399.2430658223911 }, "2013": { "obs_EconomicCapitalRatio": 1.5989526445598863 }, "2014": { "obs_EconomicCapitalRatio": 2.650540849834678 }, "2015": { "obs_EconomicCapitalRatio": 1.0482953396008179 }, "2016": { "obs_EconomicCapitalRatio": 1.43190595552074 }, "2017": { "obs_EconomicCapitalRatio": 1.298859391390505 }, "2018": { "obs_EconomicCapitalRatio": 2.258510853301959 }, "2020": { "obs_EconomicCapitalRatio": 1.8301794320010123 }, "2021": { "obs_EconomicCapitalRatio": 1.9403448034625244 }, "2022": { "obs_EconomicCapitalRatio": 1.8563425494032437 }, "2023": { "obs_EconomicCapitalRatio": 1.8496058389879095 }, "2024": { "obs_EconomicCapitalRatio": 2.05284060578683 }, "2025": { "obs_EconomicCapitalRatio": 2.3535867345733354 } }, "0001320414": { "2011": { "obs_EconomicCapitalRatio": 0.4096752742860925 }, "2012": { "obs_EconomicCapitalRatio": 0.4783822969318578 }, "2019": { "obs_EconomicCapitalRatio": 0.44294593397271526 }, "2020": { "obs_EconomicCapitalRatio": 0.4886895190465231 }, "2021": { "obs_EconomicCapitalRatio": 0.5402804679327372 }, "2022": { "obs_EconomicCapitalRatio": 0.4248829592184213 }, "2023": { "obs_EconomicCapitalRatio": 0.42798358473497655 }, "2024": { "obs_EconomicCapitalRatio": 0.5226074625086464 }, "2025": { "obs_EconomicCapitalRatio": 0.37980794355505854 } }, "0000860730": { "2011": { "obs_EconomicCapitalRatio": 0.4286902706847537 }, "2012": { "obs_EconomicCapitalRatio": 0.7436572689093711 }, "2013": { "obs_EconomicCapitalRatio": 1.1206263058489003 }, "2014": { "obs_EconomicCapitalRatio": 1.6352993886568388 }, "2015": { "obs_EconomicCapitalRatio": 1.3417604658415376 }, "2016": { "obs_EconomicCapitalRatio": 1.2987056545778823 }, "2017": { "obs_EconomicCapitalRatio": 1.3588133779185207 }, "2018": { "obs_EconomicCapitalRatio": 1.690582150801402 }, "2019": { "obs_EconomicCapitalRatio": 1.8037161509724668 }, "2020": { "obs_EconomicCapitalRatio": 1.8890537469679993 }, "2021": { "obs_EconomicCapitalRatio": 2.5241883533491696 }, "2022": { "obs_EconomicCapitalRatio": 2.1212350019474413 } }, "0000744825": { "2011": { "obs_EconomicCapitalRatio": 0.3013270885313684 }, "2012": { "obs_EconomicCapitalRatio": 0.2786524695351668 }, "2014": { "obs_EconomicCapitalRatio": 0.32061093649804834 }, "2015": { "obs_EconomicCapitalRatio": 0.27328011615268516 }, "2016": { "obs_EconomicCapitalRatio": 0.507485494797134 }, "2019": { "obs_EconomicCapitalRatio": 0.47749793539701463 }, "2020": { "obs_EconomicCapitalRatio": 0.4205109400804776 }, "2021": { "obs_EconomicCapitalRatio": 0.5408241989221371 }, "2022": { "obs_EconomicCapitalRatio": 0.551218384744222 }, "2023": { "obs_EconomicCapitalRatio": 0.43442074411285875 }, "2024": { "obs_EconomicCapitalRatio": 0.4546792591572024 }, "2025": { "obs_EconomicCapitalRatio": 0.33160145828748444 } }, "0001124140": { "2011": { "obs_EconomicCapitalRatio": 8.166711011815341 }, "2012": { "obs_EconomicCapitalRatio": 10.92431895435195 }, "2013": { "obs_EconomicCapitalRatio": 11.153573080374903 }, "2014": { "obs_EconomicCapitalRatio": 13.87272928515707 }, "2015": { "obs_EconomicCapitalRatio": 4.498727547879557 }, "2016": { "obs_EconomicCapitalRatio": 7.186191888088503 }, "2017": { "obs_EconomicCapitalRatio": 18.744201313894912 }, "2018": { "obs_EconomicCapitalRatio": 6.328551540717717 }, "2019": { "obs_EconomicCapitalRatio": 5.219972902769483 }, "2020": { "obs_EconomicCapitalRatio": 5.8461764979525555 }, "2021": { "obs_EconomicCapitalRatio": 2.693158098121996 }, "2022": { "obs_EconomicCapitalRatio": 1.8966263786723718 }, "2023": { "obs_EconomicCapitalRatio": 2.675453724118233 }, "2024": { "obs_EconomicCapitalRatio": 2.2518786178746426 }, "2025": { "obs_EconomicCapitalRatio": 4.130870838625185 } }, "0001416876": { "2011": { "obs_EconomicCapitalRatio": 6.005379679717644 } }, "0001468328": { "2011": { "obs_EconomicCapitalRatio": 0.3339618789772089 }, "2012": { "obs_EconomicCapitalRatio": 0.7361666670249098 }, "2013": { "obs_EconomicCapitalRatio": 2.4221362236697006 }, "2014": { "obs_EconomicCapitalRatio": 2.247833539524948 }, "2015": { "obs_EconomicCapitalRatio": 2.1765194287839145 }, "2016": { "obs_EconomicCapitalRatio": 2.669870396751533 }, "2017": { "obs_EconomicCapitalRatio": 2.225023618015959 }, "2018": { "obs_EconomicCapitalRatio": 3.999238099074307 }, "2019": { "obs_EconomicCapitalRatio": 3.6416558946940984 }, "2020": { "obs_EconomicCapitalRatio": 2.8759264575125654 }, "2021": { "obs_EconomicCapitalRatio": 2.2511133868811335 }, "2022": { "obs_EconomicCapitalRatio": 2.6282063462550895 }, "2025": { "obs_EconomicCapitalRatio": 2.289809915160802 } }, "0000320017": { "2011": { "obs_EconomicCapitalRatio": 0.7845651461442082 }, "2017": { "obs_EconomicCapitalRatio": 0.8441397867838771 }, "2018": { "obs_EconomicCapitalRatio": 1.450029837906473 }, "2019": { "obs_EconomicCapitalRatio": 1.3779837923295708 }, "2020": { "obs_EconomicCapitalRatio": 1.4413081267952197 }, "2021": { "obs_EconomicCapitalRatio": 1.0188229702380915 }, "2022": { "obs_EconomicCapitalRatio": 0.4977353007777521 }, "2023": { "obs_EconomicCapitalRatio": 0.7478434592910281 }, "2024": { "obs_EconomicCapitalRatio": 1.2214669648900207 }, "2025": { "obs_EconomicCapitalRatio": 1.697675419723171 } }, "0000862692": { "2012": { "obs_EconomicCapitalRatio": 1.6030934401757337 }, "2013": { "obs_EconomicCapitalRatio": 1.4904801656352977 }, "2014": { "obs_EconomicCapitalRatio": 2.29460235161725 }, "2015": { "obs_EconomicCapitalRatio": 1.5555905563042072 }, "2016": { "obs_EconomicCapitalRatio": 0.8703509764233575 }, "2017": { "obs_EconomicCapitalRatio": 1.745275561455659 }, "2018": { "obs_EconomicCapitalRatio": 1.0071098975322699 }, "2019": { "obs_EconomicCapitalRatio": 0.9780748861936736 }, "2020": { "obs_EconomicCapitalRatio": 0.9549593957112342 }, "2021": { "obs_EconomicCapitalRatio": 1.392951720347594 }, "2022": { "obs_EconomicCapitalRatio": 0.49974368258860846 } }, "0001138476": { "2011": { "obs_EconomicCapitalRatio": 1.0159968197446956 }, "2012": { "obs_EconomicCapitalRatio": 2.6993579909368757 }, "2013": { "obs_EconomicCapitalRatio": 13.336168649980072 }, "2014": { "obs_EconomicCapitalRatio": 9.494406793998118 }, "2015": { "obs_EconomicCapitalRatio": 1.9380748685240585 }, "2016": { "obs_EconomicCapitalRatio": 2.7272575024723023 }, "2017": { "obs_EconomicCapitalRatio": 3.028696524958903 }, "2018": { "obs_EconomicCapitalRatio": 2.885688962134937 }, "2020": { "obs_EconomicCapitalRatio": 1.8494446405798506 }, "2021": { "obs_EconomicCapitalRatio": 1.8473038660504764 }, "2022": { "obs_EconomicCapitalRatio": 1.3523816738275818 }, "2023": { "obs_EconomicCapitalRatio": 1.4350490259676654 } }, "0001520697": { "2011": { "obs_EconomicCapitalRatio": 0.6081713564397228 }, "2012": { "obs_EconomicCapitalRatio": 1.2349126249303797 }, "2013": { "obs_EconomicCapitalRatio": 2.431136189781226 }, "2014": { "obs_EconomicCapitalRatio": 2.1113051231339535 }, "2015": { "obs_EconomicCapitalRatio": 1.3038377293511394 }, "2017": { "obs_EconomicCapitalRatio": 0.5522060999716568 }, "2018": { "obs_EconomicCapitalRatio": 0.4571543250579229 }, "2019": { "obs_EconomicCapitalRatio": 0.5212458993293995 }, "2020": { "obs_EconomicCapitalRatio": 0.7890311768704694 }, "2021": { "obs_EconomicCapitalRatio": 1.5307713118327542 }, "2022": { "obs_EconomicCapitalRatio": 2.1315460187424224 } }, "0000790526": { "2012": { "obs_EconomicCapitalRatio": 0.13358036301597942 }, "2013": { "obs_EconomicCapitalRatio": 0.09085026990368239 }, "2014": { "obs_EconomicCapitalRatio": 0.5431310806294178 }, "2015": { "obs_EconomicCapitalRatio": 0.3505983920433856 }, "2016": { "obs_EconomicCapitalRatio": 0.3682069337967622 }, "2017": { "obs_EconomicCapitalRatio": 0.5710188707297758 }, "2024": { "obs_EconomicCapitalRatio": 1.973558336079889 }, "2025": { "obs_EconomicCapitalRatio": 1.822716365763516 } }, "0000806517": { "2012": { "obs_EconomicCapitalRatio": 4.60715791025414 }, "2014": { "obs_EconomicCapitalRatio": 3.3264549819016556 }, "2015": { "obs_EconomicCapitalRatio": 2.6996817675995533 }, "2016": { "obs_EconomicCapitalRatio": 5.952072258353605 }, "2017": { "obs_EconomicCapitalRatio": 5.394572797693456 }, "2018": { "obs_EconomicCapitalRatio": 4.474632330961844 }, "2019": { "obs_EconomicCapitalRatio": 2.3961219464673005 }, "2020": { "obs_EconomicCapitalRatio": 1.3262727318756238 }, "2021": { "obs_EconomicCapitalRatio": 2.3750491230099042 }, "2022": { "obs_EconomicCapitalRatio": 2.026772375492911 }, "2023": { "obs_EconomicCapitalRatio": 1.8485765440798285 }, "2024": { "obs_EconomicCapitalRatio": 1.9825798798980514 } }, "0001505497": { "2012": { "obs_EconomicCapitalRatio": 0.0 }, "2013": { "obs_EconomicCapitalRatio": 0.0 }, "2014": { "obs_EconomicCapitalRatio": 0.0 }, "2015": { "obs_EconomicCapitalRatio": 0.0 }, "2016": { "obs_EconomicCapitalRatio": 0.0 }, "2017": { "obs_EconomicCapitalRatio": 0.0 }, "2018": { "obs_EconomicCapitalRatio": 0.0 }, "2021": { "obs_EconomicCapitalRatio": 1.3561386622109721 }, "2022": { "obs_EconomicCapitalRatio": 1.2272159903361468 }, "2024": { "obs_EconomicCapitalRatio": 1.3211056224972826 }, "2025": { "obs_EconomicCapitalRatio": 2.6392582155377524 } }, "0001089815": { "2012": { "obs_EconomicCapitalRatio": 0.27461324171750273 }, "2013": { "obs_EconomicCapitalRatio": 0.5652182034205951 }, "2014": { "obs_EconomicCapitalRatio": 0.5784619345201361 }, "2015": { "obs_EconomicCapitalRatio": 0.1633049803157926 }, "2016": { "obs_EconomicCapitalRatio": 0.2753162215937384 }, "2017": { "obs_EconomicCapitalRatio": 0.4022421591008146 }, "2018": { "obs_EconomicCapitalRatio": 0.3316176238371148 }, "2019": { "obs_EconomicCapitalRatio": 0.4783975439001473 }, "2020": { "obs_EconomicCapitalRatio": 0.919678507057958 }, "2021": { "obs_EconomicCapitalRatio": 0.9237462870829648 }, "2022": { "obs_EconomicCapitalRatio": 1.539192368372456 }, "2023": { "obs_EconomicCapitalRatio": 3.7939396247631856 }, "2024": { "obs_EconomicCapitalRatio": 6.231155648407009 }, "2025": { "obs_EconomicCapitalRatio": 7.171877525786021 } }, "0000802257": { "2013": { "obs_EconomicCapitalRatio": 0.0 }, "2014": { "obs_EconomicCapitalRatio": 0.0 }, "2015": { "obs_EconomicCapitalRatio": 0.0 }, "2020": { "obs_EconomicCapitalRatio": 1.9744005113966216 }, "2021": { "obs_EconomicCapitalRatio": 3.6904748791510964 }, "2022": { "obs_EconomicCapitalRatio": 18.356104790380286 } }, "0000948320": { "2013": { "obs_EconomicCapitalRatio": 19.122408312536397 }, "2014": { "obs_EconomicCapitalRatio": 12.544382169245214 }, "2015": { "obs_EconomicCapitalRatio": 10.709507411111359 }, "2018": { "obs_EconomicCapitalRatio": 3.298409579098017 }, "2019": { "obs_EconomicCapitalRatio": 1.7309580285301396 }, "2020": { "obs_EconomicCapitalRatio": 10.40786666630324 }, "2021": { "obs_EconomicCapitalRatio": 3.3516170514357024 }, "2022": { "obs_EconomicCapitalRatio": 2.1668311020786786 }, "2023": { "obs_EconomicCapitalRatio": 5.666378657404718 }, "2024": { "obs_EconomicCapitalRatio": 2.9540486786201483 }, "2025": { "obs_EconomicCapitalRatio": 2.8022594173750055 } }, "0001384101": { "2013": { "obs_EconomicCapitalRatio": 5.726396731332951 }, "2014": { "obs_EconomicCapitalRatio": 4.2258505750915285 }, "2015": { "obs_EconomicCapitalRatio": 4.002792419943674 }, "2016": { "obs_EconomicCapitalRatio": 2.907069930522243 }, "2017": { "obs_EconomicCapitalRatio": 3.6955164524484863 }, "2018": { "obs_EconomicCapitalRatio": 5.903084432595021 }, "2019": { "obs_EconomicCapitalRatio": 9.17221087672525 }, "2020": { "obs_EconomicCapitalRatio": 12.009349418296129 }, "2021": { "obs_EconomicCapitalRatio": 4.569266085280168 }, "2022": { "obs_EconomicCapitalRatio": 2.957324756862987 }, "2023": { "obs_EconomicCapitalRatio": 3.476700938886737 }, "2024": { "obs_EconomicCapitalRatio": 4.4085578126382945 }, "2025": { "obs_EconomicCapitalRatio": 4.485792425264168 } }, "0001443863": { "2013": { "obs_EconomicCapitalRatio": 3.48321910388931 }, "2014": { "obs_EconomicCapitalRatio": 3.4046294626511577 }, "2015": { "obs_EconomicCapitalRatio": 1.5631269234101999 }, "2016": { "obs_EconomicCapitalRatio": 1.1237533540614515 }, "2018": { "obs_EconomicCapitalRatio": 4.838143851132696 }, "2020": { "obs_EconomicCapitalRatio": 1.516717809911702 }, "2021": { "obs_EconomicCapitalRatio": 6.736268258202685 }, "2022": { "obs_EconomicCapitalRatio": 1.547614374795819 }, "2025": { "obs_EconomicCapitalRatio": 0.9131965951472314 } }, "0001597892": { "2016": { "obs_EconomicCapitalRatio": 0.4573910404286819 }, "2017": { "obs_EconomicCapitalRatio": 0.7307048923124139 }, "2018": { "obs_EconomicCapitalRatio": 1.0765984359761611 }, "2019": { "obs_EconomicCapitalRatio": 2.9112556811490666 }, "2020": { "obs_EconomicCapitalRatio": 0.0805492763350369 }, "2023": { "obs_EconomicCapitalRatio": 2.308586009655766 } }, "0001217234": { "2014": { "obs_EconomicCapitalRatio": 2.106099248600515 }, "2015": { "obs_EconomicCapitalRatio": 1.8606992876041615 }, "2016": { "obs_EconomicCapitalRatio": 0.8991741565472338 }, "2017": { "obs_EconomicCapitalRatio": 2.3625185935969757 }, "2018": { "obs_EconomicCapitalRatio": 10.988768401944188 }, "2019": { "obs_EconomicCapitalRatio": 9.295696048608347 }, "2020": { "obs_EconomicCapitalRatio": 15.894232884028792 }, "2021": { "obs_EconomicCapitalRatio": 7.107376945609629 }, "2022": { "obs_EconomicCapitalRatio": 1.868289639503857 }, "2023": { "obs_EconomicCapitalRatio": 1.9021864798831671 }, "2024": { "obs_EconomicCapitalRatio": 3.75555356135359 }, "2025": { "obs_EconomicCapitalRatio": 3.8258403033619546 } }, "0000811222": { "2015": { "obs_EconomicCapitalRatio": 0.0 }, "2016": { "obs_EconomicCapitalRatio": 0.0 }, "2017": { "obs_EconomicCapitalRatio": 0.0 }, "2018": { "obs_EconomicCapitalRatio": 0.0 }, "2022": { "obs_EconomicCapitalRatio": 0.0 }, "2023": { "obs_EconomicCapitalRatio": 0.0 }, "2024": { "obs_EconomicCapitalRatio": 2.313895027277619 }, "2025": { "obs_EconomicCapitalRatio": 1.2879555622882315 } }, "0001477449": { "2015": { "obs_EconomicCapitalRatio": 5.544764703239246 }, "2016": { "obs_EconomicCapitalRatio": 4.7132034470335 }, "2017": { "obs_EconomicCapitalRatio": 4.690116935020641 }, "2018": { "obs_EconomicCapitalRatio": 4.243448916525309 }, "2019": { "obs_EconomicCapitalRatio": 7.066330202032505 }, "2020": { "obs_EconomicCapitalRatio": 3.2033660875692913 }, "2021": { "obs_EconomicCapitalRatio": 1.6724116401293925 }, "2022": { "obs_EconomicCapitalRatio": 1.6400447522007024 }, "2023": { "obs_EconomicCapitalRatio": 1.4808360827926537 }, "2024": { "obs_EconomicCapitalRatio": 0.5824872091940608 }, "2025": { "obs_EconomicCapitalRatio": 0.5880410245147577 } }, "0001638833": { "2015": { "obs_EconomicCapitalRatio": 0.8690576081521365 }, "2016": { "obs_EconomicCapitalRatio": 0.5809479181547815 }, "2018": { "obs_EconomicCapitalRatio": 0.19992190836322066 }, "2019": { "obs_EconomicCapitalRatio": 0.28413337094038393 }, "2020": { "obs_EconomicCapitalRatio": 0.47610580888076925 }, "2021": { "obs_EconomicCapitalRatio": 1.3205930250979123 }, "2022": { "obs_EconomicCapitalRatio": 0.6666538559780858 }, "2023": { "obs_EconomicCapitalRatio": 1.1049807370417983 }, "2024": { "obs_EconomicCapitalRatio": 0.6276252284290024 }, "2025": { "obs_EconomicCapitalRatio": 0.46493861746268283 } }, "0001590750": { "2015": { "obs_EconomicCapitalRatio": 0.932903006677119 }, "2016": { "obs_EconomicCapitalRatio": 13.0711249565521 }, "2017": { "obs_EconomicCapitalRatio": 6.356633171990735 }, "2018": { "obs_EconomicCapitalRatio": 2.0254040755220735 }, "2019": { "obs_EconomicCapitalRatio": 0.6907471032007421 }, "2020": { "obs_EconomicCapitalRatio": 14.802536994480796 }, "2021": { "obs_EconomicCapitalRatio": 4.033972483760562 }, "2023": { "obs_EconomicCapitalRatio": 4.295100066488977 }, "2024": { "obs_EconomicCapitalRatio": 3.7757140806874343 }, "2025": { "obs_EconomicCapitalRatio": 5.655591493377748 } }, "0001604821": { "2015": { "obs_EconomicCapitalRatio": 3.240855334715597 }, "2016": { "obs_EconomicCapitalRatio": 3.9343020841567653 }, "2017": { "obs_EconomicCapitalRatio": 2.797164141426769 }, "2018": { "obs_EconomicCapitalRatio": 3.2298690908277656 }, "2019": { "obs_EconomicCapitalRatio": 5.987358295647832 }, "2020": { "obs_EconomicCapitalRatio": 12.840764363166384 }, "2021": { "obs_EconomicCapitalRatio": 9.697207220674155 }, "2022": { "obs_EconomicCapitalRatio": 3.8690619189941047 }, "2023": { "obs_EconomicCapitalRatio": 6.871334386701791 }, "2024": { "obs_EconomicCapitalRatio": 19.864753055012294 } }, "0000792935": { "2016": { "obs_EconomicCapitalRatio": 0.47107162549473863 }, "2019": { "obs_EconomicCapitalRatio": 0.06465501080251583 }, "2020": { "obs_EconomicCapitalRatio": 0.5290719268064846 }, "2021": { "obs_EconomicCapitalRatio": 0.2676343291130003 }, "2022": { "obs_EconomicCapitalRatio": 0.13585432723348395 }, "2024": { "obs_EconomicCapitalRatio": 0.2432404069211452 } }, "0001674930": { "2016": { "obs_EconomicCapitalRatio": 5.977117435291776 }, "2017": { "obs_EconomicCapitalRatio": 2.4695749151172817 }, "2018": { "obs_EconomicCapitalRatio": 2.079409314730264 }, "2019": { "obs_EconomicCapitalRatio": 5.306880144073147 }, "2020": { "obs_EconomicCapitalRatio": 2.8216283049254067 }, "2021": { "obs_EconomicCapitalRatio": 4.339147344390559 }, "2022": { "obs_EconomicCapitalRatio": 1.1938018387890712 } }, "0001680139": { "2017": { "obs_EconomicCapitalRatio": 3.9395693520833825 }, "2018": { "obs_EconomicCapitalRatio": 6.2256973384254515 }, "2019": { "obs_EconomicCapitalRatio": 3.533160492046391 }, "2021": { "obs_EconomicCapitalRatio": 15.437613384223065 }, "2022": { "obs_EconomicCapitalRatio": 3.5079397431580226 }, "2023": { "obs_EconomicCapitalRatio": 4.4482071080504575 } }, "0001603454": { "2018": { "obs_EconomicCapitalRatio": 17.66433991837258 }, "2019": { "obs_EconomicCapitalRatio": 9.527163233702987 }, "2021": { "obs_EconomicCapitalRatio": 3.7696196477965644 }, "2022": { "obs_EconomicCapitalRatio": 1.8690407255909658 }, "2023": { "obs_EconomicCapitalRatio": 2.9173109469879184 }, "2024": { "obs_EconomicCapitalRatio": 2.485696746340044 }, "2025": { "obs_EconomicCapitalRatio": 11.243231230995297 } }, "0001713210": { "2023": { "obs_EconomicCapitalRatio": 14.39400262713444 }, "2024": { "obs_EconomicCapitalRatio": 2.0773963940030575 }, "2025": { "obs_EconomicCapitalRatio": 0.44125322995284166 } }, "0000070318": { "2018": { "obs_EconomicCapitalRatio": 0.08552924410432898 }, "2019": { "obs_EconomicCapitalRatio": 0.17754638364786196 }, "2020": { "obs_EconomicCapitalRatio": 0.16463973728908057 }, "2021": { "obs_EconomicCapitalRatio": 0.33521955077878823 }, "2022": { "obs_EconomicCapitalRatio": 0.20317691382837733 }, "2023": { "obs_EconomicCapitalRatio": 0.30062697803053423 }, "2024": { "obs_EconomicCapitalRatio": 0.4934054549593957 }, "2025": { "obs_EconomicCapitalRatio": 0.6933671309524378 } }, "0001576280": { "2018": { "obs_EconomicCapitalRatio": 9.409998338204176 }, "2019": { "obs_EconomicCapitalRatio": 14.015133034824808 }, "2020": { "obs_EconomicCapitalRatio": 8.033623509502428 }, "2021": { "obs_EconomicCapitalRatio": 5.378829839582666 }, "2022": { "obs_EconomicCapitalRatio": 1.8770406090353164 }, "2023": { "obs_EconomicCapitalRatio": 1.9270482881595639 }, "2024": { "obs_EconomicCapitalRatio": 2.4823202710500136 }, "2025": { "obs_EconomicCapitalRatio": 6.1920599604917745 } }, "0001766400": { "2019": { "obs_EconomicCapitalRatio": 2.2358107646248047 }, "2020": { "obs_EconomicCapitalRatio": 3.7377872544961175 }, "2021": { "obs_EconomicCapitalRatio": 1.317407127445334 }, "2022": { "obs_EconomicCapitalRatio": 0.7196383548705427 }, "2023": { "obs_EconomicCapitalRatio": 0.8927955560969081 }, "2024": { "obs_EconomicCapitalRatio": 1.7720749372810554 }, "2025": { "obs_EconomicCapitalRatio": 1.2970657367956044 } }, "0001274737": { "2019": { "obs_EconomicCapitalRatio": 5.3105465475101905 }, "2020": { "obs_EconomicCapitalRatio": 2.660107841280965 }, "2021": { "obs_EconomicCapitalRatio": 2.2167256957939694 }, "2022": { "obs_EconomicCapitalRatio": 0.6076712499435017 }, "2023": { "obs_EconomicCapitalRatio": 0.654214032721451 }, "2024": { "obs_EconomicCapitalRatio": 2.2025057987368397 }, "2025": { "obs_EconomicCapitalRatio": 2.875555288576213 } }, "0001447362": { "2019": { "obs_EconomicCapitalRatio": 6.498753866445175 }, "2020": { "obs_EconomicCapitalRatio": 6.026288703848502 }, "2021": { "obs_EconomicCapitalRatio": 4.175460360278498 }, "2022": { "obs_EconomicCapitalRatio": 2.4739768633055252 }, "2023": { "obs_EconomicCapitalRatio": 2.256072832055694 }, "2024": { "obs_EconomicCapitalRatio": 2.501859695117348 }, "2025": { "obs_EconomicCapitalRatio": 3.3619067449345166 } }, "0001527753": { "2019": { "obs_EconomicCapitalRatio": 2.953743430117927 }, "2020": { "obs_EconomicCapitalRatio": 10.527770127762217 }, "2021": { "obs_EconomicCapitalRatio": 2.645722439374889 }, "2022": { "obs_EconomicCapitalRatio": 0.47315593157114144 } }, "0001725255": { "2019": { "obs_EconomicCapitalRatio": 0.5857155046057619 }, "2020": { "obs_EconomicCapitalRatio": 1.4955681062795707 }, "2021": { "obs_EconomicCapitalRatio": 0.7234441813573314 }, "2022": { "obs_EconomicCapitalRatio": 0.6234341278934857 }, "2023": { "obs_EconomicCapitalRatio": 0.26119597375409453 }, "2024": { "obs_EconomicCapitalRatio": 0.35440894588014293 }, "2025": { "obs_EconomicCapitalRatio": 0.3887325800588612 } }, "0001551306": { "2019": { "obs_EconomicCapitalRatio": 23.128888643767834 }, "2020": { "obs_EconomicCapitalRatio": 21.25263485685163 }, "2021": { "obs_EconomicCapitalRatio": 19.928211362808444 }, "2022": { "obs_EconomicCapitalRatio": 8.182587418805609 }, "2023": { "obs_EconomicCapitalRatio": 7.48169024244033 }, "2024": { "obs_EconomicCapitalRatio": 3.143226224073416 }, "2025": { "obs_EconomicCapitalRatio": 4.595221185166977 } }, "0001729149": { "2019": { "obs_EconomicCapitalRatio": 3.9141912518645925 }, "2020": { "obs_EconomicCapitalRatio": 4.377758147257698 }, "2021": { "obs_EconomicCapitalRatio": 3.1175442632229804 }, "2022": { "obs_EconomicCapitalRatio": 4.165808200790573 }, "2023": { "obs_EconomicCapitalRatio": 3.0905943820113806 }, "2024": { "obs_EconomicCapitalRatio": 2.8280699797927302 }, "2025": { "obs_EconomicCapitalRatio": 2.208374174708051 } }, "0001729944": { "2019": { "obs_EconomicCapitalRatio": 0.80033022263604 }, "2020": { "obs_EconomicCapitalRatio": 0.8939501524991209 }, "2021": { "obs_EconomicCapitalRatio": 1.670257709676602 }, "2022": { "obs_EconomicCapitalRatio": 0.7555010825436428 }, "2023": { "obs_EconomicCapitalRatio": 1.486124730980496 }, "2024": { "obs_EconomicCapitalRatio": 0.5100288861637816 } }, "0001799191": { "2020": { "obs_EconomicCapitalRatio": 1.9354663360497144 }, "2021": { "obs_EconomicCapitalRatio": 1.4314265160413502 }, "2022": { "obs_EconomicCapitalRatio": 0.5369289711729511 }, "2024": { "obs_EconomicCapitalRatio": 0.09570735084291766 }, "2025": { "obs_EconomicCapitalRatio": 2.001660729797598 } }, "0001439725": { "2020": { "obs_EconomicCapitalRatio": 4.899553478061839 }, "2021": { "obs_EconomicCapitalRatio": 1.7991006973357486 }, "2022": { "obs_EconomicCapitalRatio": 0.9045190531820879 } }, "0001737523": { "2021": { "obs_EconomicCapitalRatio": 671.1968392005622 }, "2022": { "obs_EconomicCapitalRatio": 385.49382888758356 }, "2023": { "obs_EconomicCapitalRatio": 1.5191647865482536 }, "2024": { "obs_EconomicCapitalRatio": 0.7490768181400523 }, "2025": { "obs_EconomicCapitalRatio": 2.0065585272756072 } }, "0001759655": { "2021": { "obs_EconomicCapitalRatio": 5.9854315421959114 }, "2022": { "obs_EconomicCapitalRatio": 4.9874077872328435 }, "2023": { "obs_EconomicCapitalRatio": 3.9996069884808416 }, "2024": { "obs_EconomicCapitalRatio": 3.0209663872592287 }, "2025": { "obs_EconomicCapitalRatio": 3.0134479613948315 } }, "0001803901": { "2021": { "obs_EconomicCapitalRatio": 2.3239919326101237 }, "2022": { "obs_EconomicCapitalRatio": 1.1649813946676386 } }, "0001818331": { "2021": { "obs_EconomicCapitalRatio": 3.031702783280354 }, "2022": { "obs_EconomicCapitalRatio": 0.2650382635460216 }, "2023": { "obs_EconomicCapitalRatio": 0.2340008975350877 }, "2024": { "obs_EconomicCapitalRatio": 7.1433325795924105 }, "2025": { "obs_EconomicCapitalRatio": 10.607580330133818 } }, "0001822359": { "2021": { "obs_EconomicCapitalRatio": 4.529492069938443 }, "2022": { "obs_EconomicCapitalRatio": 2.771063189488642 }, "2023": { "obs_EconomicCapitalRatio": 1.6728383727412641 }, "2024": { "obs_EconomicCapitalRatio": 1.4843694887626384 }, "2025": { "obs_EconomicCapitalRatio": 0.5634025375829321 } }, "0001834376": { "2021": { "obs_EconomicCapitalRatio": 1.9802948402224156 }, "2022": { "obs_EconomicCapitalRatio": 2.439532779220166 }, "2023": { "obs_EconomicCapitalRatio": 1.8744085157804056 }, "2024": { "obs_EconomicCapitalRatio": 1.3621909662118414 } }, "0001773751": { "2021": { "obs_EconomicCapitalRatio": 4.971853684184344 }, "2022": { "obs_EconomicCapitalRatio": 6.128488895753875 }, "2023": { "obs_EconomicCapitalRatio": 6.554674754785222 }, "2024": { "obs_EconomicCapitalRatio": 12.126553207078992 }, "2025": { "obs_EconomicCapitalRatio": 4.04039885819204 } }, "0001870940": { "2021": { "obs_EconomicCapitalRatio": 5.033081838177257 }, "2022": { "obs_EconomicCapitalRatio": 1.132782907988652 }, "2023": { "obs_EconomicCapitalRatio": 2.5947989753230587 }, "2024": { "obs_EconomicCapitalRatio": 1.8671046483783382 } }, "0001534969": { "2021": { "obs_EconomicCapitalRatio": 2.8842820361801325 }, "2022": { "obs_EconomicCapitalRatio": 0.5713512984391965 }, "2023": { "obs_EconomicCapitalRatio": 3.1922358214415856 } }, "0001822479": { "2021": { "obs_EconomicCapitalRatio": 2.6314647506130555 }, "2022": { "obs_EconomicCapitalRatio": 0.7794445581652086 }, "2023": { "obs_EconomicCapitalRatio": 1.6169003077959527 }, "2024": { "obs_EconomicCapitalRatio": 1.317382776714733 }, "2025": { "obs_EconomicCapitalRatio": 1.6819107661299355 } }, "0001831097": { "2021": { "obs_EconomicCapitalRatio": 10.135987542140258 }, "2022": { "obs_EconomicCapitalRatio": 5.716884020987739 }, "2023": { "obs_EconomicCapitalRatio": 3.6117017245510086 }, "2024": { "obs_EconomicCapitalRatio": 0.5237840028274809 }, "2025": { "obs_EconomicCapitalRatio": 0.2429987445135107 } }, "0001844392": { "2021": { "obs_EconomicCapitalRatio": 3.102693963604072 }, "2022": { "obs_EconomicCapitalRatio": 0.36018627065159414 }, "2024": { "obs_EconomicCapitalRatio": 0.5451364493905979 }, "2025": { "obs_EconomicCapitalRatio": 0.3728897696807099 } }, "0001832511": { "2022": { "obs_EconomicCapitalRatio": 0.14225887468579412 }, "2023": { "obs_EconomicCapitalRatio": 0.21200771759380008 }, "2024": { "obs_EconomicCapitalRatio": 0.045389475358619244 } }, "0001892316": { "2023": { "obs_EconomicCapitalRatio": 110.39054612853406 }, "2024": { "obs_EconomicCapitalRatio": 94.60058336986788 } }, "0001635077": { "2022": { "obs_EconomicCapitalRatio": 0.0 }, "2023": { "obs_EconomicCapitalRatio": 0.0 }, "2024": { "obs_EconomicCapitalRatio": 0.0 }, "2025": { "obs_EconomicCapitalRatio": 0.5450667778424255 } }, "0001803737": { "2022": { "obs_EconomicCapitalRatio": 0.5721263204730309 }, "2023": { "obs_EconomicCapitalRatio": 0.4928465005438502 }, "2024": { "obs_EconomicCapitalRatio": 0.4077090775440418 }, "2025": { "obs_EconomicCapitalRatio": 0.5377770193692863 } }, "0001826667": { "2023": { "obs_EconomicCapitalRatio": 5.747039577983446 }, "2024": { "obs_EconomicCapitalRatio": 3.6673040258093965 }, "2025": { "obs_EconomicCapitalRatio": 6.744892845411586 } }, "0001965040": { "2023": { "obs_EconomicCapitalRatio": 0.8853775922144298 }, "2024": { "obs_EconomicCapitalRatio": 0.5806666737511045 }, "2025": { "obs_EconomicCapitalRatio": 0.6601762335313033 } }, "0001938046": { "2023": { "obs_EconomicCapitalRatio": 7.485743735641145 }, "2024": { "obs_EconomicCapitalRatio": 0.7342890394360521 }, "2025": { "obs_EconomicCapitalRatio": 1.2366752765702367 } }, "0001699031": { "2024": { "obs_EconomicCapitalRatio": 0.36247445601460876 }, "2025": { "obs_EconomicCapitalRatio": 2.141226559604184 } }, "0001960262": { "2024": { "obs_EconomicCapitalRatio": 20.758484759101325 } } } }